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Huntington disease (HD) is an extremely variable inherited neurodegenerative 
disorder caused by expansion of an unstable CAG trinucleotide repeat in the 
huntingtin gene (HTT). Somatic instability in HD exhibits an age-dependent, 
expansion-biased and tissue-specific pattern, and the highest level of somatic 
instability is found in tissues that are most susceptible to the disease pathology. 
Therefore, the aim of this project was to test the hypothesis that somatic 
instability of the HD CAG repeat plays a major role in disease pathology by 
quantifying somatic instability in the number of CAG repeats by next generation 
sequencing (NGS) technology in buccal cell DNA. 
We developed a method to sequence and genotype HTT alleles from blood and 
buccal swab DNA of the Scottish and Venezuelan populations respectively. A 
total of 210 individuals from the Scottish general population and 742 HD patients 
and unaffected individuals from the Venezuelan HD cohort were sequenced on 
the MiSeq platform. We established that it was possible to sequence and 
genotype the CAG repeats, the polymorphic CCG repeat and the flanking 
sequences. Our data highlight the utility of NGS technology as an approach to 
genotype HTT alleles, detect sequence variants and quantify somatic instability 
of the CAG repeat. Our data emphasise that the somatic instability in HD is age-
dependent and expansion-biased, also could be a major factor in disease 
progression, and could be a potential therapeutic target in HD. 
We also investigated the possibility that there are trans-acting modifier factors 
involved in determining the degree of somatic instability in HD patients. We 
genotyped polymorphisms in candidate mismatch repair (MMR) genes and 
examined their effect, if any, on the residual variation of somatic instability. 
Individuals carrying the minor allele of rs3512 in FAN1 have a higher level of 
somatic instability than average, suggesting that some of the variations in HD 
somatic instability could be accounted for by genetic variation in the DNA 
mismatch repair pathway. The search for modifier genes might have 
consequences in understanding the pathological process in HD, and may 
therefore provide therapeutic targets for future investigations.  
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Chapter 1 Introduction 
1.1 Trinucleotide repeat diseases  
Nearly 40 inherited human disorders result of expansions of unstable DNA simple 
sequence repeats (Gomes-Pereira and Monckton, 2006; McMurray, 2010). Most of 
these disorders involve expansions of a trinucleotide repeat, including expanded 
CAG repeats at the Huntington disease (HD), dentatorubral-pallidoluysian 
atrophy (DRPLA), spinal and bulbar muscular atrophy (SBMA) and a group of 
spinocerebellar ataxias (SCA1, 2, 3, 6, 7, 8, 12 and 17), expanded CTG repeats 
at the myotonic dystrophy type 1 (DM1), expanded CGG repeats at the fragile X 
syndrome and expanded GAA repeats at the Friedreich ataxia (FRDA) locus. 
These diseases are variable and often have unusual inheritance patterns. The 
expanded alleles become highly unstable in both germline and somatic tissues 
(Cleary and Pearson, 2003; Pearson, 2003). Almost all of these disorders exhibit 
wide symptomatic variability in terms of severity and age of onset, ranging from 
mild late onset forms to severely congenital forms. Moreover, repeat expansion 
rates have been linked with increased disease severity and an earlier age of 
onset (Swami et al., 2009; Morales et al., 2012). 
1.2 Huntington’s disease (HD) 
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder 
that affects striatal neurons, resulting in emotional, cognitive and motor 
disturbances. HD affects 4-8 per 100,000 individuals in Caucasian populations 
(Harper, 1992). The phenotype is very variable between patients in terms of 
disease course and range of symptoms. The characteristic symptom of HD is the 
presence of involuntary movements called chorea. It affects individuals usually 
in mid-life (approximately 3rd to 4th decade of life), and the disease progresses 
for 10-15 years after onset to predictable death (Bates, 2005). Subsets of HD 
cases are associated with the juvenile form of the disease. These patients have a 
more severe phenotype compared with adult-onset patients and onset before 20 
years of age (Nance and Myers, 2001; Andresen et al., 2007). HD shows a trend 
towards an increase in disease severity in subsequent generations and earlier age 
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at onset mostly seen through paternal transmission, known as anticipation 
(Telenius et al., 1993). 
Offspring of an affected individual have a 50% chance of inheriting the disease 
and those who inherit the mutation eventually develop the disease assuming 
that they do not die of other causes before the age of onset because penetrance 
is very high in HD. Males and females are equally at risk of HD, and it can be 
transmitted from mothers and fathers, although the juvenile cases tend to be 
inherited from fathers (Telenius et al., 1993; Nahhas et al., 2005). 
1.3 Genetics of HD 
The HD mutation was first mapped to the short arm of chromosome 4 through 
linkage analysis using polymorphic DNA markers in humans in 1983 (Gusella et 
al., 1983). The Huntington’s Disease Collaborative Research Group (1993) used 
haplotype linkage disequilibrium to spotlight a small segment of 4p16.3 as the 
likely location of the HD-causing genetic variant in affected individuals of 75 HD 
families examined. They identified a polymorphic CAG repeat near the 5’ end of 
the huntingtin (HTT) gene, which was expanded and unstable on disease 
chromosomes (Huntington’s Disease Collaborative Research Group, 1993).  
HD is caused by a CAG repeat expansion located in exon 1 of the HTT gene. The 
CAG repeat is highly polymorphic, the repeat size in the non HD-causing 
chromosomes varies in length from 10 to ~35 repeats (Duyao et al., 1993; 
Huntington’s Disease Collaborative Research Group, 1993; Snell et al., 1993). 
Most non HD-causing CAG repeats are stable through inheritance. Although 
alleles between 27 and 35 repeats are in the non-disease causing range, they are 
defined as intermediate alleles (Goldberg et al., 1995). These alleles can be 
unstable through paternal transmission and can expand into the full mutation 
upon transmission, resulting in the HD phenotype in the offspring (Semaka, 
Collins and Hayden, 2010). An allele with 36 to 39 repeats is considered to have 
a reduced penetrance, i.e. some individuals in that range develop HD and others 
do not. Most HD patients with adult-onset inherit 40 to 50 repeats in the HD 
gene that are fully penetrant (Kremer et al., 1994; Rubinsztein et al., 1996). 
The largest CAG repeat reported in a patient contained approximately 200 
repeats (Nance et al., 1999). Patients carrying >50 repeats often have the severe 
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juvenile form of the disease (Andresen et al., 2007). The expanded CAG repeat 
is immediately adjacent to a polymorphic CCG repeat of 4 to 12 repeats that is 
stably transmitted. Most non disease-causing and disease-causing chromosomes 
have seven CCG repeats (Andrew et al., 1994). 
1.4 Molecular pathogenesis of HD 
The CAG repeat expansion results in the elongation of a polyglutamine array at 
the N-terminus of the huntingtin (HTT) protein (Pennuto, 2010). The expanded 
allele results in greater levels of cell death, dysfunction of a variety of cellular 
processes, and hence more severe phenotype. This dysfunction is thought to be 
mediated by gain of function, meaning the mutation result in the mutant protein 
gaining toxic function (Ross and Tabrizi, 2011). The mutant proteins appear to 
form aggregate in cells, forming neuronal inclusions bodies (Pennuto, 2010). 
However, there is evidence of RNA toxicity triggered by expanded CAG repeats 
through mechanisms involving gene expression (Marti, 2016). 
HTT is required for normal development and survival of central nervous system 
cells. HTT is widely expressed at different tissue and cellular levels. HTT has a 
role in vesicle transport, regulates gene transcription, regulates protein 
synthesis and RNA trafficking (Cattaneo et al., 2005; Sadri-Vakili and Cha, 2006). 
The greatest expression of the protein found in the central nervous system. The 
mutant expanded polyglutamine leading to the hallmark pathology of HD causing 
atrophy in the striatum and also other brain regions. 
1.5 Genotype-phenotype correlations 
The CAG repeat expansion is the only mutation resulting in clinical symptoms of 
HD in familial and sporadic HD cases (Myers et al., 1993; Kremer et al., 1994). A 
strong inverse correlation exists between the number of CAG repeats in the 
expanded alleles and the age at onset for motor signs in HD and severity of the 
disease (Andrew et al., 1993; Duyao et al., 1993; Gusella and MacDonald, 2009). 
An increase of a single CAG repeat is associated with a reduction in age at onset 
by ~2 years (Andrew et al., 1993; Gusella and MacDonald, 2009). Therefore, one 
inherited repeat length difference in HD patients can have a noticeable effect in 
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the prediction of age at onset. Most HD patients have age at onset in midlife due 
to inheriting repeats of 40-50 CAG repeats. 
The length of the CAG repeat is the primary determinant of age at onset of 
clinical symptoms, accounting for approximately 70% of the variation in age at 
onset (Duyao et al., 1993; The U.S.–Venezuela Collaborative Research Project 
and Wexler, 2004). The remaining variation and variable range of age at onset 
associated with each expanded alleles indicate the influence of unknown genetic 
or environmental modifying factors that are likely to be involved in determining 
the age of onset. The identification of these factors offers a promising route to 
finding factors that may delay disease onset in HD patients. 
1.6 Genetic instability in HD  
The expanded alleles are unstable in both germline and somatic tissues of 
affected individuals. This instability in HD may explain some features of HD such 
as the anticipation and progressive and tissue-specific aspects of the disease. 
1.6.1 Germline instability in HD 
The non HD-causing alleles with <27 CAG repeats are genetically very stable with 
germline mutation rates that result in a change in repeat length < 1% per 
generation (Duyao et al., 1993; Kremer et al., 1995). The expanded HD alleles 
are unstable in about 80% of intergenerational transmissions, showing both 
decreases and increases in size (Leeflang et al., 1999). However, expansions are 
more frequent, particularly in the paternal germline (De Rooij et al., 1993; 
Duyao et al., 1993; Snell et al., 1993; Telenius et al., 1994). Longer alleles have 
a higher mutation frequency that can approach as high as 98% per generation 
with an expansion bias in the male germline (Leeflang et al., 1999). As longer 
alleles are associated with the more severe form of the disease, expansion-
biased intergenerational instability often results in a decreasing age of disease 
onset from one generation to the next. Thus, germline instability explains the 
anticipation phenomenon observed within HD families and also other 
trinucleotide disorders such as Myotonic dystrophy type 1(DM1), where an earlier 
age at onset and increased severity of symptoms is observed in successive 
generations. 
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Germline instability also provides an explanation for the parental sex of origin 
effects associated with HD (Duyao et al., 1993; Kremer et al., 1995). Indeed, the 
expanded alleles have been shown to behave differently in the male and female 
germline. Smaller expansions (<7 repeats) occur more frequently in the offspring 
of affected females than in the offspring of affected males (Kremer et al., 
1995). 
1.6.2 Somatic instability in HD 
The number of CAG repeats have been shown to vary within and between 
somatic tissues of individuals affected by HD (Telenius et al., 1994; De Rooij et 
al., 1995). The expanded HD allele is particularly unstable within regions in the 
brain such as the striatum and cortex that are primarily affected in the disorder 
when compared to peripheral tissues (Telenius et al., 1994; De Rooij et al., 
1995). Somatic instability was most noticeable in juvenile-onset cases of HD, 
where cells in the striatum and cortex had gained expansions larger than cells in 
other areas of the brain such as cerebellum (Telenius et al., 1994). 
Sensitive small pool PCR (SP-PCR) analyses have been used to analyse the 
mutation length profiles from different brain regions in HD cases (Kennedy et 
al., 2003). The results have revealed somatic expansions in some cells in the 
striatum and cortex that have acquired expansions of up to 1,000 repeats in 
length, in HD patients who inherited alleles with 40 to 50 repeats. These data 
support the idea that somatic instability may play a crucial role in the tissue-
specific pathology and the progressive nature of the disease. Although such very 
large expansions appear to occur earlier in the striatum than in the other areas 
of the brain, in end-stage brain tissue, a high level of mutation instability was 
still present in the cortex, but not in the striatum (Kennedy et al., 2003). This 
finding suggests that striatal cells with the largest HD mutation expansions might 
be lost during the disease process. The fact that the mutation profile in 
different regions of the brain correlates with the neuropathological involvement 
of the disease is consistent with the hypothesis that somatic instability may 
contribute to the tissue specificity and progressive nature of HD. 
Analysis of patients with extremely early age at onset relative to the number of 
repeats inherited has revealed larger expansions in the cortex compared to 
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patients with later age at onset (Swami et al., 2009). These data further support 
the hypothesis that somatic instability contributes to the pathogenic process, 
with higher somatic instability significantly associated with disease progression 
and earlier age at onset. 
While analyses of HD repeat instability in the affected brain regions provides an 
understanding of the somatic instability preceding the disease onset, they do not 
allow determination of the contribution of somatic instability to disease onset 
and HD pathogenesis in most patients. This is because brain tissues cannot be 
evaluated until death, and it is difficult to analyse the most affected tissues 
because a high proportion of cells has already been lost during the disease 
process. However, it is possible to evaluate the level of somatic instability in 
other peripheral tissues, such as buccal cells. Although buccal cell DNA showed a 
low level of somatic instability in HD patients, it can be measured, and the 
degree of instability varied between individuals (Veitch et al., 2007). This 
variation in somatic instability provided evidence for the major role of inherited 
allele length in driving somatic instability that accounts for ~70% of the variation 
in somatic instability observed in individuals with identical age at sampling 
(Veitch et al., 2007). Thus, if the somatic instability in the brain is reflected in 
peripheral tissues, these peripheral tissues could be used to further understand 
the mechanisms and pathogenesis of somatic instability in HD. This study showed 
a low level of somatic instability using single molecule PCR that is impractical 
and labour intensive for high-throughput analysis in a large cohort of patients. 
To overcome the limitation of the previously used method, a novel method 
should be developed to facilitate high throughput analysis of somatic instability. 
Together, these data emphasise that the somatic instability in HD is age-
dependent, expansion-biased and tissue-specific. Somatic instability is therefore 
likely to be a major determinant of disease progression and also can be a 
potential therapeutic target in HD. 
1.7 Molecular mechanisms of expansion 
Multiple pathways of DNA metabolism have been implicated in generating repeat 
expansions in humans, such as DNA replication and mismatch repair. 
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It has been assumed that replication slippage is linked to the mechanism for 
generating somatic expansion in HD (Kunkel, 1993; Chi and Lam, 2005). 
However, there is evidence suggesting that DNA replication is not a major 
pathway in somatic expansions. The replication slippage model predicts the 
somatic expansion is cell cycle-dependent. However, the fact that somatic 
expansions occur in non-replicating cells such as neurons (Shelbourne et al., 
2007) argues against the involvement of DNA replication and cell division in 
generating mutations in somatic tissues in HD and supports the involvement of 
DNA repair pathways. 
1.7.1 Role of mismatch repair (MMR) genes 
The critical function of the DNA mismatch repair (MMR) pathway is to correct for 
misincorporation errors during DNA replication. The MMR can correct for base-
base mismatches as well as for insertions/deletions that arise from replication 
slippage events.  
MMR proteins that are present in mammalian somatic cells are composed of two 
heterodimers: the MutS homologues (MSH2, MSH3 and MSH6) and the MutL 
homologues (MLH1, PMS1, PMS2, and MLH3). DNA mismatches are recognised by 
complexes of either MSH2 with MSH3, to form MutSβ, or MSH6, to form MutSα, 
depending on the type of DNA lesion that they recognise (Palombo et al., 1996; 
Bellacosa, 2001). MutSα is critical for recognition of single base mismatches and 
MutSβ for recognition of small insertions/deletions up to 12 bp. MutS proteins 
recruit the MutL dimer to the lesion. Likewise, there are two components of 
MutL: the MutLα complex (MLH1 and PMS2), and the MutLβ complex (MLH1 and 
MLH3) (Li and Modrich, 1995; Lipkin et al., 2000). The MutLα complex recognises 
single base mismatches, small and large insertions/deletions, while the MutLβ 
complex also recognises small insertions/deletions.  
Mouse models have been used to reveal the critical role and involvement of the 
mismatch repair genes in the somatic instability of the HTT CAG repeat. These 
studies have been carried out by crossing the Hdh knock-in (expanded CAG 
repeats were inserted at the mouse HD locus) or Htt transgenic mice (insertion 
of human HD gene, or a fragment of it, randomly into the mouse genome) with 
mismatch repair gene knockout mice to generate mouse models that have a 
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targeted mismatch repair inactivating mutation (Manley et al., 1999; Wheeler et 
al., 2003; Pinto et al., 2013). The effect of the mismatch repair genes (Msh2, 
Mlh1 and Mlh3) knockout is to eliminate somatic expansion. Studies in transgenic 
R6/1 mice (that were generated by incorporating a human genomic fragment 
including HTT promoter elements, the entire exon 1 including ~ 116 CAG repeats 
and a portion of intron 1) which were crossed with Msh2 deficient mice, have 
demonstrated that the loss of Msh2 alleles were required to produce an effect 
on somatic instability in transgenic mice (Manley et al., 1999). This finding 
demonstrates that Msh2 deficiency stabilises the HD repeat in the R6/1 mice 
model. 
The data from HD knock-in mice have shown that the deficiency of Msh2, Msh3, 
Mlh1 and Mlh3 mismatch repair genes eliminate the somatic instability and delay 
the phenotype (Wheeler et al., 2003; Dragileva et al., 2009; Pinto et al., 2013). 
These data support the role of the mismatch repair pathway in somatic 
instability. This is consistent with the data from transgenic mouse models 
(Manley et al., 1999). 
Similarly, there is also evidence from myotonic dystrophy type 1 (DM1) knock-in 
mice with expanded 84 CTG repeats placed into the mouse DM1 locus, that MMR 
components Msh3 and Msh6 have an impact on variation in the degree of somatic 
instability (van den Broek et al., 2002). Deficiency of Msh3 resulted in complete 
suppression of somatic instability in the mouse model, compared with Msh6 
deficient mice, which exhibited a greater somatic instability. It was suggested 
that competition of Msh3 and Msh6 for binding to Msh2 in MMR complexes might 
explain the opposite effects of those two MMR proteins. Although Msh2–Msh3 and 
Msh2–Msh6 repair complexes recognise unusual DNA structures formed by 
insertions/ deletions, they have slight differences in their specification. The 
Msh2–Msh3 complex has a preference for binding to large insertion/deletion 
loops, whereas the Msh2–Msh6 complex prefers to bind to a single base mismatch 
(Palombo et al., 1996; Bellacosa, 2001). 
Transgenic mouse data in DM1 have shown that the MutL protein, Pms2, is also 
required for somatic expansions (Gomes-Pereira et al., 2004). However, Pms2 
does not appear to be absolutely required for expansions, as in deficient mice, 
there is a reduction of somatic expansions rate by ~50%, relative to the wild-
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type mice. Indeed, the requirement of DNA MMR genes, such as Msh2, Msh3 and 
Pms2 in mediating repeat expansions strongly implicates the DNA mismatch 
repair pathway rather than replication slippage. The proposed model that can 
account for these observations based on the involvement of MMR in an 
expansion-biased manner is shown in Figure 1-1. This supports the role of the 
MMR pathway and the possible requirement of other repair pathways as 
candidate modifiers of somatic instability. MMR proteins are thus potential 
therapeutic targets in HD and DM1. 
 
Figure 1-1 A model for the mismatch repair (MMR) involvement in the somatic trinucleotide 
repeat expansion and deletion in non-dividing cells. The figure represents the process of 
loop formation and expansion repair by inappropriate DNA MMR. In a double-stranded DNA 
molecule (a), both strands containing the repeat are separated (b), when the repeats re-
anneal, they could cause a misalignment within the repeat region (c). Such misalignment 
will lead to the formation of loop-out structures. These loop-outs can be targeted by the 
MMR machinery (d). The correct template strands cannot be distinguished by MMR 
machinery in the absence of any replication specific signals. Therefore, the MMR machinery 
might be biased towards loop-outs incorporating DNA rather than deleting it, and that 
probably requires a single-stranded nick on the opposite strand to create a site of gap 
extension (e). Then, the single-stranded gaps are filled by polymerase extension and mutant 
expanded products are generated that are larger by the size of the original loop-outs (f). 
Multiple rounds of this process may occur leading to large expansions in non-dividing 
somatic cells. Flanking DNA region are indicated by thick lines, CTG-CAG repeat as thin 
lines, newly synthesized DNA as dashed lines and MMR enzymes are shaded circles. The 
image is reproduced from (Gomes-Pereira et al., 2004).  
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Consistent with the role of MMR genes in mediating somatic instability in mouse 
models, it also has been shown that polymorphisms in MMR genes modify the 
expansion dynamics in DM1 (Morales et al., 2016) and the disease progression 
and age at onset in HD (GeM-HD Consortium, 2015). There is evidence from DM1 
patients for an association between a polymorphism in the MSH3 gene and 
variation in the degree of somatic instability in blood DNA from Costa Rican 
patients, although no association with age at onset was detected (Morales et al., 
2016). This polymorphism is associated with an increase in somatic expansions in 
DM1 patients. This finding implicates the role of the DNA repair pathway in the 
variation of somatic instability in DM1 patients. 
In human HD, there is a clear link between the genes involved in DNA mismatch 
repair and the disease process from Genome-wide association study (GWAS). 
GWAS are a powerful method of evaluating genetic modifiers that could affect 
the disease progression. The study involves assessing the entire genome or part 
of it, to determine genetic variants in the genome, such as deletions, insertions 
and single nucleotide polymorphism (SNPs) that associate with the disorder 
understanding. The utility of this unbiased approach has great power to identify 
naturally occurring genetic variations that modify the disease process.  
GWAS was performed by the Genetic Modifiers of Huntington’s Disease (GeM-HD) 
Consortium. They discovered significant modifiers associated with modification 
of age at onset of motor signs (GeM-HD Consortium, 2015). GWAS was carried 
out on 2,131 individuals of European ancestry. Analysis of the GWAS data 
revealed a genome-wide significant signal in new genetic modifiers of the 
disease onset that are located in the FAN1 and MTMR10 as well as the RRM2B 
genes. In addition, a further interesting locus on chromosome 3 is the MLH1 
gene. Although this locus did not achieve genome-wide significance, MLH1 was 
revealed as a potential modifier. This locus is particularly attractive given that 
MLH1 is known to regulate somatic instability of CAG repeats and is a modifier of 
the phenotype in mouse HD knock-in models (Pinto et al., 2013). This study 
supports the role of MMR genes in modifying HD pathogenesis and implicates DNA 
mismatch repair as a process of HD modification.  
The association between age at onset and those candidate genes in the DNA 
repair pathway identified by GWAS were replicated and validated in a separate 
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study of HD and polyglutamine spinocerebellar ataxia (SCA) patients 
(Bettencourt et al., 2016). The study involved 1,462 patients of HD and SCAs 
type 1, 2, 3, 6, 7 and 17. SNP analysis, which tested the effect of 22 SNPs on age 
at onset, was examined. The analysis of the combined samples for all 
polyglutamine diseases (HD and SCAs) yielded a significant association between 
age at onset and polymorphism at FAN1 and PMS2 and for all the SCAs patients 
yielded association with only PMS2. The results revealed the involvement of DNA 
mismatch repair genes in modifying age at onset and disease progression in HD 
patients. In addition, this study suggested that somatic instability might play a 
role that modifies the age at onset of other polyglutamine diseases. 
Although GWAS analysis in HD did not evaluate the correlation between the DNA 
repair genes and somatic instability, several analyses have shown that DNA 
mismatch repair genes are required to generate repeat expansions in mice. In 
addition, the candidate gene study suggested that somatic expansion 
mechanisms are most likely explained by the genetic variations that alter 
disease progression and age at onset of polyglutamine disorders (Bettencourt et 
al., 2016). This evidence supports the hypothesis that somatic expansion is 
mediated by DNA mismatch repair. MMR proteins are thus credible therapeutic 
targets in trinucleotide repeat disorders.  
1.8 Molecular methods of HD genotyping 
1.8.1 Polymerase chain reaction (PCR) 
The standard diagnostic method for assessing trinucleotide repeat length is 
based on fragment length analysis using polymerase chain reaction (PCR). A PCR 
based method was originally developed using a primer set that amplifies a region 
containing both the CAG and CCG repeats (Warner, Barron and Brock, 1993). The 
assessments of CAG repeat length assumed that the CCG repeat did not 
demonstrate any variation. However, in both normal and affected individuals, 
the CCG repeat varies in size between 7 to 10 repeats in most cases (Andrew et 
al., 1994), and also the CCT repeat following the CCG repeat can vary from 2 to 
3 repeats in size (Pêcheux et al., 1995). If the CAG repeat size is estimated by 
this PCR fragment size, there may be errors in the identification of the mutation 
in individuals carrying borderline CAG repeats, because of the variable size of 
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the CCG repeat repeats. Therefore, using a PCR assay that amplifies the CAG 
and the CCG repeats independently was proposed (Andrew et al., 1994). This 
assay is important for detection of a second allele in cases where only a single 
allele is detected by the CAG amplification. This may be used to rule out the 
presence of a rare mutation that can lead to failure of the standard PCR assay 
for repeat sizing. The PCR protocol consists of PCRs that amplify the CAG tract 
alone, the CCG tract alone and the whole region containing both the CAG and 
the CCG repeats (Andrew et al., 1994). 
 
Figure 1-2 Schematic representation of the CAG and CCG polymorphic region in the HD 
gene and primers used for the determination of estimated CAG and CCG repeats. Both CAG 
and CCG repeats are shown and also the primer locations are indicated by arrows for the 
corresponding sequences. The region between CAG and CCG repeats is the intervening 
sequences: CAACAGCCGCCA. This method involves three PCRs that amplify the CAG 
repeats alone using HD344 and HD447 primers (a), the CCG repeat region using HD419 and 
HD482 primers (b) amplify both CAG and CCG repeats region using HD344 and HD482 
primers (c). Method and the primers are indicated as in the study by Andrew et al.1994. 
 
The length of the CAG repeat can be determined from DNA samples with primers 
HD344 and HD447 (Figure 1-2). The adjacent CCG repeat was measured using 
HD419 and HD482 primers and the entire region containing both the CAG and the 
CCG repeats using HD344 and HD482 primers as described by Andrew et al. 1994. 
Then, the amplified products sizes were determined by capillary or gel 
electrophoresis. 
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This method is considered as a rapid method for diagnosis of HD. However, large 
expanded alleles (>100 CAG repeats) do not amplify efficiently, and they cannot 
be detected using this approach (Warner et al., 1996). Therefore, a true normal 
homozygous individual cannot be differentiated from heterozygous patients with 
one normal allele and one large allele of such an expanded allele. Thus, the 
standard PCR method is not capable of detecting very large expansion and also a 
new mutation within or flanking the repeats. Such mutations can lead to assay 
failure, or inaccurate estimation of CAG repeats length. 
1.8.2 Triplet repeat primed PCR (TP-PCR) 
Use of triplet repeat primed (TP-PCR) is required for the detection of large 
repeat expansions. This was first introduced by Warner et al. 1996. TP-PCR 
provides an advantage in rapidly identifying large repeat expansions that are 
difficult to amplify with standard PCR. The TP-PCR assay is based on amplifying 
the repeats using a fluorescently labelled forward primer (P1) paired with two 
specific reverse primers (P3 and P4) as shown in Figure 1-3 (Warner et al., 
1996). These two reverse primers bind to different positions within the repeats. 
The P4 primer has a 5’ extension with identical sequence to another reverse 
primer (P3). This technique generates different fragment sizes giving a 
characteristic ladder on a fluorescence electropherogram, enabling the 
identification of both the size of smaller alleles and the presence of or absence 
of expanded alleles. The products obtained are resolved by capillary 
electrophoresis and visualised using a laser fluorescent sequencer. Traces 
obtained from the fluorescent sequencer are analysed for detection of the 
repeat. 
Although TP-PCR is a robust and reliable method that also rapidly detects the 
larger expanded repeats, it does not provide an accurate estimate of the 
expanded repeat size. The need for very exact measurement of repeat length is 
important for predicting the risk of the individuals. In addition, this approach 
does not measure the somatic instability that could underlie disease severity.  
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Figure 1-3 The Triplet repeat primed PCR (TP-PCR) method for detecting large repeat 
expansions. (A) Specific flanking fluorescent-labelled forward primer (P1) and CAG specific 
reverse primers (P4) are used. P4 is a long primer which is complementary to the CAG 
repeat and has common 5’sequnce (tail) that is not complementary with the triplet repeat 
region or any known human sequence. P4 binds at multiple sites within the repeat during 
the first multiple cycles. This will give rise to a mixture of products of many different sizes. 
(B) The second reverse primer (P3) binds to the 3’ end of products that are complementary 
to the tail of P4 sequences, and pairs with (P1) forward primer in subsequent cycles to 
complete the extension of full-length products with variable sizes. This allows for rapid 
identification of large pathogenic repeats. Image modified from Warner et al. 1996. 
 
1.8.3 Small pool PCR (SP-PCR) 
Small pool PCR (SP-PCR) is a highly sensitive technique used in analysing mutant 
alleles and assessing somatic instability ( Gomes-Pereira et al. 2004). This 
method is based on diluting bulk DNA templates to the level of a few DNA 
molecules in each reaction. This allows the amplification and detection of 
products derived from single-input molecules (Figure 1-4). The advantage of SP-
PCR over the standard PCR method relies on amplifying very few molecules 
allowing the generation of a detailed distribution of repeat sizes present in any 
given sample to be assessed. 
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Figure 1-4 Small pool PCR (SP-PCR) method. The top section represents traditional bulk 
PCR for DNA sample that contains both normal alleles (circles) and a low number of mutant 
alleles (stars). In bulk PCR analysis, only normal alleles are revealed at the bottom of the gel 
(white bands). This PCR fails to reveal any mutant alleles in an agarose gel. The middle 
section represents a serial dilution of the template DNA sample and the expanded alleles 
are detected by Southern blot hybridization as black bands of variable sizes. The normal 
allele is also detected at the bottom of the gel (intense black bands). In this step, each SP-
PCR amplification has a few DNA molecules as input. The bottom of the figure represents a 
further dilution of template DNA to the single molecule level per reaction in which the 
normal and expanded alleles are detected as sharp bands on a gel. This results from 
amplification of single molecule per reaction generating a single allele per lane. This image 
is taken from Gomes-Pereira et al, 2004. 
A previous HD study had shown SP-PCR and agarose gel-based methods could not 
quantify somatic instability in the majority of cases (Veitch et al., 2007). 
Therefore, a sensitive assay based on single molecule PCR was designed for HD 
to investigate mutation length changes in given samples, which allows for 
accurate sizing of a single repeat difference (Veitch et al., 2007). For each 
individual, a DNA sample was diluted to produce an average of 0.5 molecules of 
template. Then, DNA templates are amplified by PCR. These amplified products 
are resolved by agarose gel electrophoresis to detect the presence of expanded 
alleles. Agarose gel electrophoresis is used in this step, as it is more cost-
effective than polyacrylamide gel electrophoresis. Then, those products from 
the expanded HD alleles are re-amplified by PCR with fluorescently nested 
primers. Then, subsequent detection of both normal and expanded alleles can 
be sized using the capillary-based system. 
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The allele length distribution obtained from SP-PCR analysis allows for assessing 
the level of somatic instability. This approach allows estimating of the repeat 
size and can reveal the full range of mutation lengths present in a given tissue or 
cell sample. However, SP-PCR is labour intensive and time-consuming. In 
addition, this approach cannot detect any variants within or flanking the 
repeats, which may alter the stability of DNA, and possibly the symptoms. 
Therefore, new technologies are required that are more rapid and involving 
higher throughput. 
1.9 Massively parallel sequencing technologies  
The standard diagnostic and research approaches used in genotyping HD alleles 
(described earlier in the previous sections of this chapter) have some limitations 
in terms of sensitivity, accuracy and measuring somatic instability because they 
are not precise in determining allele sizes and fail to define the extent of 
somatic instability. In addition, these approaches cannot detect any variant 
repeats within or flanking the repeats. There is a demand for a cost-effective, 
rapid and a higher throughput approach, for instance, massively parallel 
sequencing using next generation sequencing (NGS) technology. The advantage 
of NGS over conventional approaches lies mainly in the cost per base, analysis 
duration and accurate quantification of allele length variations. However, 
technical challenges in sequencing and data analysis must be taken into account 
when using NGS. 
It would be worthwhile to evaluate the utility of this technology as an approach 
to genotype HD alleles, detect sequence variants and quantify somatic instability 
of the CAG repeat. 
1.9.1 Illumina MiSeq technology  
There are many platforms of high throughput sequencing that could be used in 
NGS that vary in sequencing chemistry and read length (Quail et al., 2012). 
Several sequencing platforms that could be used in NGS include Illumina (MiSeq 
and HiSeq), Ion Torrent Personal Genome Machine (PGM) and the Pacific 
Biosciences (PacBio). Each of these platforms has relative advantages and 
disadvantages and, the technical specification of each of these platforms are 
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summarized and compared in Table 1-1. In this project, the main factors for 
selecting the appropriate platform for HD study are read length and throughput.  
 
Table 1-1 Comparison between next generation sequencing (NGS) platforms. These 
platforms are Ion Torrent Personal Genome Machine (PGM), the Pacific Biosciences 
(PacBio) RS and Illumina (MiSeq and HiSeq) (Liu et al., 2012; Quail et al., 2012). 
The Illumina MiSeq has a fast turnaround time and outputs intended for targeted 
sequencing of small genomes. MiSeq has been developed to be used in smaller 
laboratories and diagnostic clinics and produces low error data for the most 
complex sequencing samples. The developed Illumina MiSeq platform generates 
sequence output of 15 GB of high-quality sequence data, which consists of up to 
25 million sequencing reads. The read length is up to 600 bp, which should be 
capable of sequencing a large HD allele. With MiSeq, the unique barcodes must 
be incorporated into the DNA template to be run on MiSeq platform. MiSeq 
libraries may be prepared with PCR amplification using locus-specific primers 
incorporating MiSeq adapters plus a unique dual index bases in order to enable 
differentiation between each DNA sample (Caporaso et al., 2011). These 
fragments are added to the flow cell and hybridised to complementary 
sequences that are located on the surface of the flow cell (Bentley et al., 2008). 
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The fragments are then amplified to generate millions of clusters through a 
bridge amplification process to form DNA clusters from each fragment.  
 
Figure 1-5 Illumina MiSeq protocol for sequencing HTT alleles. The locus-specific primers 
combined with MiSeq adapters that are used for amplifying HTT allele and allow the 
amplicon to be sequenced in the MiSeq platform. The DNA fragment contains CAG and CCG 
repeats with P5 and P7 sequences, indices, spacer, sequencing primer binding site and 
locus-specific primers. P5 and P7 sequences are oligos at the end of each library fragment 
which anneal to their complementary oligos immobilised on the flow cell surface. Index (i7) 
and (i5) are used to identify each sample. The sequencing primer site is complementary to 
the sequencing primer on the MiSeq platform. The spacer is used to increase base diversity 
and for cluster identification on MiSeq sequencing. The MiSeq library is prepared by PCR 
amplification, and the adapters are incorporated to both fragment ends. These amplicons 
are loaded into a flow cell and hybridized to the flow cell surface. Each fragment is amplified 
by bridge amplification and generates clusters from each molecule. Each cluster is 
sequenced using fluorescently labelled, reversible terminator nucleotides. The signal is 
generated upon incorporation of the first nucleotide and detected through the imaging 
system. Before the next cycle proceeds, the fluorophore from each incorporated base is 
removed to allow the incorporation of the next base. This cycle is repeated to create a read 
from the whole molecule. Image modified from (https://bitesizebio.com/13546/sequencing-
by-synthesis-explaining-the-illumina-sequencing-technology/). 
 
The sequencing chemistry of MiSeq is based on the sequencing-by-synthesis 
approach utilising fluorescently labelled reversible terminator nucleotides for 
sequencing a single-stranded DNA template (Liu et al., 2012). Identification of 
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nucleotides is based on a cyclic reversible termination strategy, which sequences 
one nucleotide from the template strand at a time through multiple rounds of 
base incorporation, imaging and cleavage followed by cycle termination. These 
fluorescently labelled ddNTPs are used to stop the polymerization reaction, 
enabling removal of unincorporated bases and imaging to identify the added 
nucleotide. This process continues in a similar manner allow the determination 
of the sequence of the whole DNA template.  
Illumina MiSeq can potentially be used for genotyping HD alleles because a very 
large number of HD alleles may be sequenced simultaneously. This is mainly 
because it is high throughput, relatively low cost and has a suitable read length 
(up to 600 bp single read or 2x300 bp paired-end reads). 
1.10 PhD hypothesis 
Huntington disease is an extremely variable inherited human disorder caused by 
expansion of CAG trinucleotide repeats that are unstable in both germline and 
soma. In this project, I will investigate the use of next generation massively 
parallel DNA sequencing technologies to detect the presence and distribution of 
additional sequence variants within and flanking the repeat. These data will be 
used further to clarify the relationship between genetic diversity and 
symptomatic variation and will lead to the development of improved diagnostic 
tests. 
Previous evidence from studies of repeat instability in mouse models and human 
HD patients suggested that somatic instability might be a major modifier of HD 
pathogenesis (Kennedy and Shelbourne, 2000; Kennedy et al., 2003; Veitch et 
al., 2007; Swami et al., 2009). Therefore, we sought to test the hypothesis that 
the somatic instability of the HD CAG repeat is driving the disease pathology and 
to understanding the role of somatic instability in HD by quantifying somatic 
variation in the number of CAG repeats by NGS technology. In addition to 
genotyping HTT alleles and quantifying somatic instability by NGS technology, 
we will determine whether sequence polymorphisms in potential trans-acting 
modifier genes are involved in modulating somatic instability in HD patients. 
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Chapter 2 Materials and methods 
2.1 Material 
The majority of molecular biology reagents were supplied by Sigma and 
ThermoScientific. Other materials are mentioned in the appropriate section. All 
kits and reagents were used according to the manufacturer's instructions unless 
otherwise stated. 
2.2 DNA samples  
Blood DNA samples were collected from a subset of Scottish DM1 patients who 
were recruited from outpatient clinics and sent to our lab for DM1 genetic 
studies. Patients consented to participate in DM1 genetic variations (DMGV) 
study led by Professor Darren G Monckton at the University of Glasgow and also 
consented to participate in other genetic studies in the laboratory. Therefore, 
we chose to use the DMGV DNA samples as control samples to amplify and 
genotype non HD-causing alleles. These samples were selected because they 
were available in our laboratory for research studies and also because they have 
no known association with HD. Therefore, the DMGV samples can represent a 
random population in respect to HD locus. 
Buccal cell swab DNA samples were collected by the US-Venezuela Collaborative 
Research Project from 767 unaffected and affected individuals from HD families 
that are part of the Lake Maracaibo cohort in Venezuela. Samples were air dried 
and shipped from Venezuela to Glasgow. In Glasgow, the samples were stored at 
-20°C and then DNA was extracted from buccal swabs. 
2.3 Molecular methods  
2.3.1 Primer design 
Sequences of all primer oligonucleotides used in this project were purchased 
from Sigma. The locus-specific primer sequences for amplifying the HTT 
CAG/CCG repeat are listed in Table 2-1. 
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Table 2-1 Sequences for the locus-specific set of primers that were used in our study for 
amplifying the HTT CAG/CCG repeat. 
MiSeq primers were designed by incorporating Illumina adapter sequences at the 
5’end of the locus-specific primers (HD319/33935.5, MS-1F/MS-1R short and 
31329/33934). These locus-specific primer sequences are shown in Table 2-1. 
The MiSeq primers were designed to include the P5 and P7 sequences, 8 base 
index sequences (Index 1 and 2), forward and reverse sequencing primer-binding 
site (Table 2-2). In addition, spacers of different length (0-9 bases) were added 
between the sequencing primer binding site and locus-specific primer in each 
forward primer set. These components of MiSeq primers are described in Figure 
1-5. An example of MiSeq primers designed is shown in Table 2-2 using the 
HD319F/33935.5 set of primer as locus-specific primers. The MiSeq primer design 
was carried out in the same way for the other locus-specific primers (MS-1F/MS-




Table 2-2 MiSeq primers designed for amplifying the HD locus. These primers include P5 and P7 sequences, 8 base index sequences (Index 1 and 2), 
forward and reverse sequencing primer-binding site, a spacer (0-9 bases) and locus-specific primers. 
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2.3.2 Amplifying the HTT CAG/CCG repeat locus using MiSeq 
primers 
The HD CAG and the adjacent CCG repeats were amplified from genomic DNA 
using the locus-specific primer pair (HD319F/33935.5, MS-1F/MS-1Rshort or 
31329/33934) combined with MiSeq barcoded Illumina adapters that allow the 
PCR product to be sequenced using MiSeq. 
PCR amplification was carried out for 2 µl DNA (10 ng), with 2 µl of each primer 
(5 µM), 0.2 µl of 1 U of Taq DNA polymerase (Sigma), 1.5 µl 1X Custom PCR 
Master mix (45 mM Tris-HCl (pH 8.8), 11 mM (NH4)2SO4, 4.5 mM MgCl2, 0.113 
mg/ml BSA, 0.048% 2-mercaptoethanol, 4.4 µM EDTA, 1 mM each of dATP, dCTP, 
dGTP and dTTP) (Thermo Scientific, ABgene UK), 1.5 µl of DMSO (BioReagent, for 
molecular biology, ≥99.9%, Sigma-Aldrich) and 5.8 µl of water in a final volume 
of 15 µl. 
PCR was carried out using a thermal cycler (Eppendorf). The PCR cycle 
conditions were 96°C for 5 minutes followed by 28 cycles of DNA denaturation at 
96°C for 45 seconds, primer annealing at 58.50°C for 45 seconds, polymerase 
extension for 3 minutes at 72°C, with a final extension step at 72°C for 10 
minutes. The HD locus-specific primers used were HD319 and 33935.5. 
MS-1F/MS-1R and 31329/33934 primers have the same PCR conditions, as HD 319 
and 33935.5, except the annealing temperatures were 59°C for both of them. 
2.3.3 MiSeq library preparation  
Different types and combinations of indices can be used for Illumina sequencing. 
Dual indexed libraries were prepared with Illumina TruSeq adapters by adding 
unique indices to each sample. Index 1 (i7) is an 8 base index adjacent to P7 on 
the reverse primer. Index 2(i5) is an 8 base index adjacent to P5 on the forward 
primer. These unique indices act as a unique tag to each DNA sample so 
sequencing reads can be associated to a DNA sample. Therefore, there are 96 
unique combinations generated from the pairwise combination of these indices 
that are uniquely dual-indexed adapters (these 12 (i7) and 8 (i5) indices). Taking 
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advantage of these 96 TruSeq barcodes from Illumina, the PCR were manually 
prepared in 96-well plates (8 forward barcodes x 12 reverse barcodes = 96 
barcode pairs) as described in Chapter 3. The PCR plates used was 96-well PCR 
plate, skirted, low profile (STAR LAB, E1403-5200) and those plates were sealed 
with 12 Strip PCR Caps, domed (STAR LAB, I1400-1200). After PCR amplification, 
all samples were pooled. 
2.3.4 Gel electrophoresis  
Visualisation of PCR products was conducted by running the products on 2% 
agarose gels allowing for separation of the DNA fragments by size. 2% agarose gel 
was prepared by adding 2 g of agarose to 100 ml of 0.5x TBE buffer. This mixture 
was heated until the agarose completely dissolved. Once cooled, ethidium 
bromide was added to give the final concentration of 0.2 µM that is widely used 
to visualise the DNA bands by staining the agarose gel. This mixture was poured 
into a gel cast containing the appropriate comb and left to set on an even 
surface for 15-30 minutes at room temperature. Once set the comb was 
removed, and the gel was placed in a tank and was immersed in 0.5x TBE buffer. 
The PCR products were mixed with loading dye and loaded into the wells. The 
molecular weight marker used was a 1 kb ladder (60 ng/µl 1 kb ladder, 1X DNA 
loading dye in 1X TBE) that was added to the end lanes of each PCR agarose gel. 
Half of each PCR (7.5 µl) was mixed with 10x loading dye (0.6% (w/v) Orange G, 
50% glycerol in H2O) and loaded in each of the lanes. The no DNA controls were 
also loaded onto the gel. The loaded gel was run at 100-120 V at room 
temperature for the appropriate time to allow the separation of PCR products.  
For PCR product visualisation, the gel was removed from the tank and placed on 
a transilluminator (UVP image store 7500 system). A gel documentation system 
with high sensitivity camera, which was placed above the transilluminator, was 
used to photograph the gel. 
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2.3.5 DNA purification  
2.3.5.1 Gel extraction 
QIAquick gel extraction kit (250, Qiagen) was used to clean-up DNA from gels. 
The kit is used for the clean-up of PCR products and provides spin columns, 
buffers and collection tubes. A gel purification method was used for some of the 
libraries after PCR amplification to purify PCR products from a gel and get rid of 
primer dimers. This purification procedure removes agarose, excess primers, 
nucleotides, enzymes and other impurities from DNA samples. Specialised 
binding buffers are utilized with this method to promote selective binding of 
DNA fragments within a particular size range. Then, the purified DNA for the 
library can be used for sequencing on MiSeq platform.  
2.3.5.2 PCR clean-up by AMPure beads  
PCR products from some of the libraries were also purified with Agencourt 
AMPure XP PCR purification system using a paramagnetic bead technology 
(Beckman Coulter). This AMPure purification step was performed to remove 
primer dimers and to concentrate the sequencing library. The PCRs for the 
whole pooled library were split into 2 tubes. One tube of the library was stored 
and saved to allow repeat of library preparation or sequencing if required. The 
remaining half of the 96 PCRs were also pooled into 2 pools of 48 samples. Each 
pool was then purified with AMPure XP beads (0.6 µl of beads/ µl of PCR 
product, elution in 100 µl) using a magnetic stand for AMPure XP beads for 1.5 
ml tubes. This step was performed to get rid of the primer dimers and to 
concentrate the library. The two purified pools were then pooled together, and 
another round of AMPure XP bead clean-up was performed (1.6 µl of beads/ µl of 
PCR product, elution in 55 µl) to concentrate the library further. 
An optimized buffer was used with Agencourt AMPure XP technique to promote a 
DNA size selection of 100 bp and larger to bind to the paramagnetic beads. 
Agencourt AMPure XP method is based on utilizing magnetic separation and 
requires no centrifugation or filtration. Excess primers, nucleotides and salts can 
be removed using a simple washing procedure. The resulting purified PCR 
products can be used for sequencing.  
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2.3.6 DNA quantification  
The concentration of DNA samples and libraries were determined by Qubit 
fluorometer using the Qubit dsDNA HS (High Sensitivity) Assay Kit 
(ThermoFisher). The Qubit fluorometer method allows measuring double-
stranded DNA concentration in the range of 10 pg/µL to 100 ng/µL. 
In addition, Bioanalyzer (Agilent) analysis was used to evaluate the quality and 
quantity of the sequencing libraries, to check the fragment had the expected 
size, that primer dimers were absent and to estimate the molarity of the library. 
This Bioanalyzer analysis was performed at Glasgow Polyomics facilities at the 
University of Glasgow. Two DNA fragments of known size and molarity are run 
with each sample on the Bioanalyzer, which are lower and upper markers. These 
markers are used for estimating the DNA size of the tested samples. DNA 
quantification was done using the upper marker in which the area under the 
peak for this marker was compared with the sample peak areas. Therefore, the 
concentration of each sample can be estimated by comparing to the known 
concentration of the upper marker. At that stage, the aim is to have at least 25 
µl of a sequencing library at 10 nM. 
2.3.7 MiSeq run 
The libraries were submitted to the Glasgow Polyomics facilities for sequencing 
using MiSeq platform following the standard guidelines for a MiSeq run. MiSeq 
Reagent Kit v3 (600 cycles) was used with the 600 cycles of sequencing being 
performed by 2x300 bp or 400 bp forward and 200 bp reverse and 5% PhiX spike-
in. After the run (~56 hours) the MiSeq reporter software was used to 
demultiplex the reads based on the 96 TruSeq barcodes pairs. The MiSeq 
reporter software outputs the sequencing reads in fastq files, two (forward and 
reverse reads) for each of the 96 barcodes with a maximum output of 15 GB per 
run.  
2.3.8 KASP assay library preparation 
A pilot study for KASP (Kompetitive Allele Specific PCR, www.lgcgenomics.com) 
assay was conducted for genotyping 31 SNPs in 24 DNA samples including 22 HD 
patients from the Venezuelan cohort and two positive controls. These positive 
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controls were added into each plate for assay validation. These controls had 
good DNA quality and high concentration compared to the buccal swab DNAs 
from the Venezuelan cohort, but these were of unknown genotypes. Two no 
template controls were included into each plate to improve confidence in the 
validity of the genotyping results. 
DNA aliquots of 95 µl were assembled in PCR plates for each sample and sent to 
the LGC Genomics laboratories in Hoddesdon, UK. Thermo Scientific 96-well PCR 
plates (AB-0800) and adhesive PCR plate sealing sheets (AB-0558) were used to 
send these samples. The KASP assay protocol was carried out in the LGC 
Genomics laboratories according to their protocol. The submitted DNA sample 
validation, primer design and optimisation of the assay conditions were also 
conducted by LGC Genomics laboratories. 
From the pilot study result, 19 SNPs for the KASP assay were validated by the 
LGC laboratory. Therefore, these 19 SNPs were tested in 412 HD patient 
samples; an additional 59 unaffected individuals and 20 controls from the 
Scottish population were also genotyped. DNA volume of 60 μl was assembled in 
96 PCR well plates and sent to the LGC Genomics laboratories. 
2.4 Statistical data analysis software 
Most of the graphs were prepared using GraphPad Prism 6. Some of these graphs 
were prepared using Microsoft Excel. Adobe Illustrator was used to creating most 
of the figures and diagrams. IBM SPSS (version 22) was used for the regression 
analysis and for most of the data analysis. IBM SPSS was used to perform linear 
regression analysis between somatic mosaicism and age at sampling, inherited 
allele length and their interactions for HD patients from the Venezuelan cohort. 
This software was also used for the genotype/phenotype correlation among HD 
patients by performing linear regression analysis between age at onset and 
inherited CAG repeats. An independent sample T-test was applied to evaluate 
the significant difference in the mean age at onset between homozygous and 
heterozygous individuals for the HD mutation, using IBM SPP. Similarly, the 
differences in mean age at onset were evaluated between males and females 
using an independent sample T-test (using SPSS). 
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Genotype/phenotype data analysis was performed by gPLINK (version2.050, 
http://zzz.bwh.harvard.edu/plink/gplink.shtml), graphical user interphase for 
the PLINK software. gPLINK performs a wide range of basic and large-scale 
genetic analyses. Allele frequencies, Hardy-Weinberg equilibrium tests, linear 
regression analyses and family-based association study were performed by 
gPLINK. gPLINK was also used for regression analyses to test the association of 
the residual variation of somatic instability with each SNP genotype. Also, a 
family-based quantitative trait association analysis (QFAM) was tested, that 
combines a linear regression of phenotype on genotype with a permutation test, 
which accounts for relatedness among family members. gPlink was used to test 
an association of residual variation in somatic instability across all SNPs. For 
multiple corrections for SNPs association with somatic instability, the Bonferroni 
multiple significance tests was used through gPlink software.  
2.5 Web-based bioinformatics resources  
Genetic databases used in this project to check for variant types, population 
allele frequency were: Ensemble genome database 
(https://www.ensembl.org/index.html), the 1000 Genome database 
(http://www.internationalgenome.org) and dbSNP 
(https://www.ncbi.nlm.nih.gov/projects/SNP/).  
2.6 Bioinformatics data analysis tools 
2.6.1 CLC genomic workbench 
This software was used for the alignment of sequencing reads generated by the 
Illumina MiSeq platform. The sequencing reads obtained were mapped with CLC 
Genomics Workbench Version 7.5 to reference sequences including the region 
flanking the repeats and various numbers of CAG and CCG repeats: 1 to 100 CAG 
repeats and 1 to 20 CCG repeats in order to facilitate alignment for the 
sequence and genotyping the HTT alleles. Also, CLC was used to apply quality 
control analysis on reads, read filtering (demultiplexing and adapter trimming), 
alignment parameter optimisation, visualisation of the aligned reads and 
genotype identification. 
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Demultiplexing was required in some MiSeq runs, if the library was sequenced 
with other samples from our group and barcodes were shared with other users. 
Also, trimming adapter step is essential for samples for which the insert size is 
below the specified sequencing length (if the insert size is 200 bp, and the MiSeq 
is sequencing 300 bp), the adapter will be sequenced. In this case, the 
sequences of corresponding library adapter can be present in the output files at 
the 3’ end of the reads. Therefore, removing the adapter sequencing from these 
samples is detrimental to obtain a better read alignment. 
2.6.2 Tablet 
Visual representation of obtained sequencing read alignments (from CLC 
genomic workbench) was performed using Tablet. Tablet is a graphical viewer 
for NGS alignment (Milne et al., 2013). Tablet displays read coverage, read 
names, and it allows searching for specific coordinates across the dataset.  
2.6.3 KASP software (SNPviewer) 
The SNPviewer software enables genotyping KASP data and for all SNPs to be 
viewed as a cluster plot for each plate 
(https://www.lgcgroup.com/products/genotyping-
software/snpviewer/#.WmcLrhS3mOo). 
The SNP genotyping data were analysed after being received from the 
genotyping service at LGC genomics laboratory. LGC genotyping results files are 
provided as SNPviewer file that is designed to be viewed with SNPviewer 
software. This allowed for visualising the genotyping clusters plate by plate 
graphically. SNPviewer was used in our project to genotype SNPs from candidate 
modifier genes of genetic instability in the Venezuelan cohort of HD patients. 
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Chapter 3 Non-disease associated allele 
genotyping using MiSeq sequencing  
3.1 Introduction  
The CAG size ranges were defined as follows: normal alleles have 9 to 26 CAG 
repeats and intermediate alleles have 27 to 35 CAG repeats (Goldberg et al., 
1995). Alleles with 36 to 39 CAG repeat show reduced penetrance, while alleles 
with 40 or more repeats are fully penetrant (Kremer et al., 1994; Rubinsztein et 
al., 1996). Most normal size CAG repeats are stable through inheritance, while 
several studies have shown that intermediate alleles are unstable and can be 
transmitted as an expanded allele upon transmission to offspring (Goldberg et 
al., 1993; Semaka, Collins and Hayden, 2010). Nevertheless, individuals who 
carry intermediate alleles have a normal phenotype. There is a high frequency of 
people carrying intermediate alleles in the general population with no known 
association with HD (5.8%) (Semaka et al., 2013). Small numbers of individuals 
with incomplete penetrance alleles manifest HD symptoms with later onset. The 
HD allele, in individuals carrying 40 CAG or more, demonstrates complete 
penetrance that gives rise to disease within the average lifespan. Also, disease 
alleles may either increase or decrease in length during transmission to the next 
generation (MacDonald et al., 1993). CAG repeat length changes occur in 
transmissions from either parent, although large increases are mainly seen in 
paternal transmission (Leeflang et al., 1995). 
In patients with HD, the CAG repeat length is inversely correlated with the onset 
of clinical symptoms (Andrew et al., 1993; Duyao et al., 1993; Gusella and 
MacDonald, 2006; Andresen et al., 2007), most juvenile cases of HD are 
transmitted from affected fathers and are associated with a large CAG repeat 
size (60 CAG or above) and a more severe phenotype (Telenius et al., 1993; 
Nahhas et al., 2005). The observation of increasing disease severity and 
decreasing age at onset with each successive generation, known as anticipation, 
is seen in HD and other trinucleotide repeat disorders (Telenius et al., 1993). 
This phenomenon of anticipation arises mainly from CAG repeat instability 
during male transmission. 
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Although the molecular basis of HD is the expansion of CAG repeats, there is 
another polymorphic CCG triplet sequence identified downstream to the CAG 
tract (Barron et al., 1994). CCG repeats vary from 6 to 12 repeats, but 7 and 10 
CCG repeats are predominant in most populations (Andrew et al., 1994; Squitieri 
et al., 1994; Pêcheux et al., 1995). The smallest CCG allele identified contains 4 
CCG repeats in the Indian population (Pramanik et al., 2000). CCG 7 is strongly 
associated with affected chromosomes in most populations where HD has a high 
prevalence (Europe and Venezuela)(Squitieri et al. 1994; Barron et al. 1994; 
Costa et al. 2006). In Japan, where HD has a low prevalence, HD chromosomes 
are strongly associated with an allele of CCG 10 (Morovvati et al., 2008). 
In an HD study, the main factors for selecting the appropriate platform are read 
length and throughput. The developed Illumina MiSeq platform generates 
sequence output of up to 15 GB of high quality sequence data, which consists of 
up to 25 million sequencing reads. The read length is up to 600 bp, therefore it 
should potentially be capable of sequencing a large HD allele (Illumina, 2006). 
 
Figure 3-1 The minimum fragment length required for sequence based genotyping. The top 
allele structure indicates the minimum amplicon and fragment length that is necessary to be 
sequenced to genotype the CAG repeats. Assuming it is 50 CAG repeats, that would be 190 
bp, if the primers were positioned immediately flanking the 5’ prime of the repeat and 
spanning the intervening sequence on the 3’ prime side. The intervening sequence is: 
CAACAGCCGCCA and is located between the CAG and CCG repeats. The bottom diagram 
shows that the minimum fragment size required to genotype 50 CAG and the CCG repeats 
assuming 10 CCG is 232 bp, if the primers were located immediately flanking the 5’ prime of 
the CAG repeat and the CCG repeats on the 3’ prime side. 
For sequencing expanded alleles using MiSeq sequencing, there are several kits 
that can be used. The standard sequencing run for MiSeq is 2x300 bp. Most HD 
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patients have CAG repeats between 40 to 50 repeats. For instance, the length of 
an HD allele of 50 repeats will be 150 bp, and 20 bp for each primer pair 
positioned immediately flanking the 5’ prime of the repeat and spanning the 
intervening sequence on the 3’ prime side (190 bp) (Figure 3-1). Therefore, a 
minimum 190 bp reads are required to sequence the CAG repeats alone. For 
determining the intervening sequences and CCG repeats to identify any atypical 
allele structures, 232 bp read length are necessary for a patient with 50 CAG 
repeats and 10 CCG repeats (Figure 3-1). Therefore, a 2x300 bp run can be used 
to sequence most HD patients’ DNA. However, theoretically sequencing longer 
CAG repeats (170 repeat alleles) could be done using a 600 bp run. Therefore 
400 bp and 600 bp runs were tested to determine whether longer alleles could 
be genotyped.  
Sequencing the repeat is challenging and can pose a problem for the assembly of 
short reads. Therefore, paired-end reads have proven to be a valuable solution 
to detect repetitive sequences by including part of flanking region in both the 5’ 
and 3’ end of the sequence. Paired-end sequencing allows users to sequence 
both ends of a fragment and generate high quality sequencing data. For 
sequencing HD alleles, paired-end might be useful to sequence CAG repeat along 
with flanking region and CCG repeats from the same direction. For longer 
alleles, sequencing CAG repeats can be done from one direction, and the CCG 
repeats from the other direction because we cannot match or merge the reads in 
the middle of the repeats.  
In our study, we chose to use DM1 patient DNA samples as control samples to 
amplify and genotype HD normal alleles. These samples were selected as they 
are available in our Laboratory for research studies and also they have no known 
association with HD. Also, DNA samples collected from HD families from the 
region of Lake Maracaibo in Venezuela were sequenced to genotype HD 
chromosomes from both unaffected and affected individuals (The U.S.–
Venezuela Collaborative Research Project and Wexler, 2004). The US-Venezuela 
Collaborative Research project team collected buccal cell swabs from each 
individual in HD families in this area. The Venezuelans represent a large HD 
population and also have the highest prevalence in the world. These cohort 
members have been involved in over 20 years of studies including genetic, 
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cognitive and neurological studies. All the affected individuals of these kindreds 
are descendants of one woman who lived on Lake Maracaibo in the early 1800s. 
She had the disease, and her affected chromosomes have been passed through 
generations. 
The aim of the chapter is to develop massively parallel sequence approaches to 
genotype HD CAG repeats. Genotyping by sequencing has the potential to detect 
insertions, deletions or other sequence variants within or flanking the repeat. 
Also, investigation of the use of NGS to detect the distribution and pattern of 
additional sequence variants. We describe an optimised library preparation for 
MiSeq sequencing to genotype HD alleles. In this study, we report the analysis of 
the normal allele in a large sample. The aims were to characterise the 
distribution of the CAG repeat alleles in Scottish and Venezuelan HD families and 
to test a potential association of the CCG repeat size with CAG length. 
3.2 Results 
3.2.1 Optimisation of MiSeq library preparation protocol 
The sequencing platform of choice was the Illumina MiSeq platform with which a 
DNA molecule can be sequenced up to 300 bp in both directions or up to 600 bp 
in one direction, or in any other combination up to 600 bp in total. Using 600 bp 
run has the potential to allow the sequencing of relatively long expansions (>170 
repeats)(Table 3-1). 
 
Table 3-1 The expected maximum number of CAG repeats that could be sequenced using 
the three different primer pairs and different type of MiSeq run. The three different primer 
pairs: 31329/33934, HD319/33935.5 and MS-1F/MS-1R short can be used for sequencing the 
CAG repeats, when aiming at sequencing 30 bp before the CAG repeat and 30 bp beyond 
the CAG repeat and also using a different type of MiSeq run. These sequencing runs are 
sequencing 300 bp in both directions, sequencing 600 bp from one direction and 400 bp 
from one direction and 200 bp from the other direction. 
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There are two sets of HD primers routinely in use in our laboratory 
(31329/33934) and (MS-1F/MS-1R) either of which could be used to design MiSeq 
primers for direct sequencing of the product including adapters and patient-
specific barcodes. The first experiment was to test both pairs of locus-specific 
primers. PCR products of 143 bp and 417 bp were obtained from two different 
DNA templates using HD primers (31329/33934) and (MS1F/MS1R) respectively 
(Figure 3-2). This is consistent with the expected sizes of flanking region of 86 
and 360 bps. 
Primers (31329/33934) were chosen to design MiSeq primers as it has a shorter 
flanking region of 86 bp whereas (MS-1F/MS-1R) has a flanking region of 360 bp. 
(31329/33934) primer pairs were chosen for designing the sequencing primers. 
	
 
Figure 3-2 Agarose gel electrophoresis of the same DNA sample using two different 
combination MiSeq primers (31329/33934 and MS-1F /MS-1R short primers) for the target 
sequence. Lanes show PCR products obtained from sample (DMGV 128) using two different 
sets of MiSeq primers. The band size was obtained for the sample as expected, primer 
dimer is seen here at the bottom of the gel. 
 
The principle for designing the MiSeq primer is to generate primers with 
additional Illumina adapters already incorporated at the 5′ end. These primers 
described in Figure 1-5 and Figure 3-3 were designed to include the P5 and P7 
sequences, 8 base index sequence (index i5 and i7), and forward and reverse 
sequencing primer-binding site. Also, spacers of different length (0-9 bases) 
were added between the sequencing primer binding site and the locus-specific 
primer in each of the 8 forward primer sets. 
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The P5 and P7 sequences are oligos at the end of each library fragment were 
used to allow PCR products to anneal to their complementary oligos immobilised 
on the flow cell surface and to generate clusters. The forward and reverse 
primer binding sites are gene specific sequences used to amplify the HD 
fragment. The short spacers have been used to shift sequences in template DNA 
increasing base diversity across the length of the entire sequence reads, which 
are produced using the same pair of locus-specific primers and amplifying a 
highly repetitive region. Therefore, the sequencing for forward reads starts at 
the different spacers before each forward gene specific primer, which is critical 
for cluster identification in the first cycle of MiSeq sequencing. PCR was carried 
out using modified primers with a 5’ extension with the adapter sequence. The 
resulting PCR products were then pooled and sequenced using the Illumina MiSeq 
platform. 
 
Figure 3-3 Primers designed for next generation sequencing using MiSeq platform. The 
location of PCR primers used for PCR amplification of HTT CAG repeat associated with HD 
relative to the DNA fragment that has CAG and CCG repeats. Three different locus-specific 
primers: (31329/33934), (HD319/3935.5) and (MS-1F/MS-1R short) combined with MiSeq 
adapters that are used to amplify HTT allele in different libraries and to allow the amplicon 
to be sequenced in the MiSeq paltform. DNA fragments that contain CAG and CCG repeats 
with P5 and P7 sequences, indices, sequencing primer binding site and locus-specific 
primers. These MiSeq primer components are described in Figure 1-5. The bottom of the 
figure shows the final amplicon ready to be sequenced on the MiSeq sequencing platform. 
Different combinations of indices can be used using MiSeq primers. Dual indexed 
libraries were prepared with Illumina TruSeq adapters by adding unique indices 
to each sample. Index 1 (i7) is an 8 base index adjacent to P7 on the reverse 
primer. Index 2 (i5) is an 8 base index adjacent to P5 on the forward primer. 
These unique indices act as an ID tag to each sample so sequencing reads can be 
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associated with an individual. There are 96 unique combinations of indices 
generated using 8 forwards and 12 reverse indices that are uniquely dual indexed 
adapters. The 96 combinations can be used for this experiment. 
To optimise Miseq library preparation, several experiments were performed, 
including selecting primers, sequencing run type and other slight modifications. 
The data analysis using CLC Genomics workbench was also optimised. 
3.2.1.1 MiSeq sequencing for HD normal alleles of 14 individuals using a 
2x300 bp run 
A library was prepared for sequencing the HD normal allele using the MiSeq 
platform. The HD CAG and the adjacent CCG repeats were amplified from 14 
DM1 patients using the locus-specific primers combined with MiSeq barcoded 
Illumina adapters that allow the PCR product to be sequenced using MiSeq. 
Different combinations of 14 indices were used in this experiment. Then, the 
PCR products were resolved by agarose gel electrophoresis. This step was 
performed to check the amplification using half of each PCR. The negative 
controls were checked for absence of contamination in the same way. The aim 
was to check that PCR amplification could be confirmed on the gel for the vast 
majority of the samples.  
 
Figure 3-4 Bioanalyzer trace of the final library after pooling individual samples. The X-axis 
represents the product size in bp, and the Y-axis is the fluorescence intensity units (FU). 
The blue arrow points at a peak that potentially corresponds to primer dimers, black arrows 
point to the expected sizes for normal and expanded alleles in the library. The two peaks at 
35 and 10,380 bp are the lower and upper markers that are run with each of the samples for 
estimating the size range and for analysing the data correctly. 
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The use of these primers was associated with the production of primer dimers 
during the PCR. Such primer dimers made it necessary to purify the library from 
a gel. Agarose gel purification is efficient to recover primer dimer-free PCR 
products, and it is inexpensive and relatively simple. However, this method is a 
low throughput and multistep procedure. PCR was followed by gel purification 
using a gel extraction kit supplied by Qiagen. 
Then, the DNA concentration was measured using a Qubit fluorimeter using the 
Qubit dsDNA HS Assay Kit (Life Technologies) and a Bioanalyzer (Aligent). The 
Bioanalyzer analysis was used to evaluate the quality and quantity of the 
sequencing libraries, to check the fragment had the expected size, the primer 
dimers were absent and to estimate the molarity of the library. An example of a 
bionalyzer result is shown in Figure 3-4 for one of the prepared libraries. After 
that, the library was prepared by pooling the different samples at equimolar 
concentration. 
Those sequencing libraries were sent to Glasgow Polyomics Facility for 
sequencing using MiSeq platform with the 600 cycles of sequencing being 
performed by 2x300 bp in both forward and reverse directions. Libraries were 
sometimes sequenced with other samples from our group. CLC genomic 
workbench software was used to analyze sequencing data for the HTT locus 
allele. This software allows the user to analyze, visualize, and compare the data 
from all major high throughput-sequencing platforms such as Illumina. 
Sequencing data were received for all samples. From this data, we aimed to 
determine the genotype for each sample. Genotyping for these samples and the 
rest of the libraries are explained in more details in section 3.2.2.4. We 
established that it was possible to sequence and genotype normal HTT CAG 
alleles and the adjacent CCG repeats using the MiSeq platform by amplifying the 
region using the internal (31329/33934) locus-specific primers combined with 
MiSeq sequencing adapters (Figure 3-3). Data from similar studies in DM1 have 
shown that the region immediately flanking the repeat is a hotspot for sequence 
variants (Braida et al., 2010). Thus, using PCR pair of primer 31329 and 33934, 
which are very close to the CAG and CCG repeats, might not be the best 
approach, as these primers may not detect any additional sequence variants in 
this region.  
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To address these issues, we considered the use of additional primer pairs 
flanking the HD CAG repeats. Primers (MS-1F and MS-1Rshort) were used instead 
(Figure 3-3), which are located further apart from the repeats and yielded good 
amplification of the CAG repeats. There are not many primers we can use for 
amplifying the CAG repeats because of the extreme GC content in the flanking 
region of the repeats. 
3.2.1.2 MiSeq sequencing for HD normal alleles of 19 individuals using 
2x300 bp and 600 bp run 
Another library was prepared for sequencing the HD normal allele. The HD 
normal alleles were amplified from 19 DM1 patients and were allocated different 
combinations of indices using MS1F/MS1R short MiSeq primers. By using (MS1F 
and MS1Rshort) primers, it was possible to purify the sequencing library without 
the use of gel purification. This can be done using the paramagnetic beads 
(Agencourt AMPure XP reagent, supplied by Beckman coulter) based approach to 
clean up the PCR, as there is a greater size difference between the full-length 
amplification products and primer dimers. The PCR Products were cleaned up 
using a ratio of AMPure beads allowing size selection to remove the primer dimer 
using (0.6 µl of the bead solution for each µl PCR). The second round of AMPure 
clean up was necessary to concentrate the library (using 1.4 µl of bead solution 
for each µl of sequencing library). 
Single (1x600 bp) and also paired-end reads (2x300 bp) were used to compare 
between both runs in terms of sequencing quality and a number of reads 
obtained for each run (Figure 3-5). Dual indexed libraries were prepared with 
adapters containing two indices for both libraries (as the previous library). 
	
Figure 3-5 Number of reads obtained for each sample in two different MiSeq runs. Total 
number of reads obtained for MiSeq 2x300 bp and 600 bp run. 
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The accuracy of DNA sequencing is assessed by a Phred score, which represents 
base call accuracy (Ewing and Green, 1998; Ewing et al., 1998). The Phred score 
provides the probability that the base called is correct. For each base call, 
parameters of the cluster, including signal-to-noise ratio and intensity profile 
are measured. These are then compared against a quality table of standard data 
obtained by sequencing a range of well-characterised loci and alignment against 
reference genomes. The Phred score is presented on a logarithmic scale that 
provides a quality score for each base. The assigned quality scores are a measure 
of the accuracy of the base call of the sequencing platform. This results in a 
graph showing the base position and quality score. These scores ranged from 0 to 
63 with higher scores corresponding to higher quality. Phred scores of 20 and 
above are considered high quality bases. The sequencing quality score of 20 
represent an error of 1 in 100, which means there is a 99% chance the base is 
called correctly. High and low quality reads can be identified by looking at 
individual sequences. It is normal to see the sequencing quality dropping off 
near the end of reads, as many errors are more likely to occur at the 3’ end of 
the reads. Such low quality ends can be trimmed off using the trim sequences 
tool. The quality assessment for the 2x300 bp run, more than 50% of the reads 
have a Phred score of more than 30. This quality score of 30 represents an error 
of 1 in 1,000, indicating a smaller probability of error. However, for the 600 bp 
run, by 400 bp the Phred score goes down to 6 representing an error of 1 in 10. 
That means there is only a 90% chance the base is called correctly. This low 
score can result in a significant proportion of the reads not being useable and 
may also lead to increased false positive variant calls leading to inaccurate 
genotyping. We found that the sequencing quality drops down significantly after 
400 bp( Figure 3-6), therefore, the 2x300 bp or 400x200 bp run was used to 
sequence HD alleles in order to sequence the CAG repeats from the forward 
strand and the CCG repeats from the reverse strand in longer CAG repeats (> 
113). 
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Figure 3-6 Quality assessment for each run showing the quality values per base position for 
2x300 bp and 600 bp runs. The top graph shows the quality distribution for 2x300 bp run 
and the bottom graph shows the quality distribution the for the 600 bp run. (The graphs 
obtained from CLC workbench software for creating quality control report). 
 
3.2.1.3 MiSeq sequencing for HD normal alleles of 96 samples using 2x300 
bp run 
Sequencing the HD normal allele in 96 unaffected individuals was carried out in 
this experiment. The PCRs were manually prepared in 96 well plates (8 forward 
barcodes x 12 reverse barcodes = 96 barcode pairs) using 96 combinations of 
Illumina TruSeq barcode set from Illumina as indicated in Figure 3-8. Therefore, 
96 different combinations of indices were used in preparing the library using 
MS1F/MS1R short primers. Paired-end reads (2x300 bp) were used in this 
experiment. 
After PCR amplification was checked by gel electrophoresis, the vast majority of 
the PCR amplifications were successful. The remaining half of the 96 PCRs were 
then pooled (2 pools of 48 samples). Each pool was then purified with AMPure XP 
beads (using 0.6x ratio of beads / µl of PCR product) allowing the size selection 
to remove of the primer dimers. Then, the two purified pools were pooled and 
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another round of AMPure XP beads (1.4 µl of beads / µl of PCR product) to 
concentrate the library further. After that, the DNA concentration was measured 
using a Qubit fluorimeter using the Qubit dsDNA HS Assay Kit and was then 
evaluated by capillary electrophoresis on a Bioanalyzer (Aligent) to check the 
fragment had the expected size.  
3.2.1.4 Further optimisation of the library preparation protocol 
 
Figure 3-7 Strategy to sequence the HD normal allele. A library was prepared by pooling 
different samples at equimolar concentration. The completed library was sent to Glasgow 
Polyomics for sequencing on MiSeq platform. 
 
After a few sequence runs, our laboratory protocol was modified to do PCR for 
90 test DNA samples and 6 controls in one 96 PCR well plate without the need to 
use agarose gel electrophoresis to confirm amplification. The overall sequencing 
strategy for sequencing HTT alleles is illustrated in Figure 3-7. The figure 
illustrates our current method in the lab. The PCRs were manually prepared in 
96 well plates. This library included 6 controls instead of 96 for each primer 
combination because sequencing no template DNA controls are more sensitive 
than gel electrophoresis (Figure 3-8). Previously we discovered that some 
samples did not have visible bands on an agarose gel, but they still gave 
sufficient amount of reads to allow genotyping by MiSeq sequencing. Therefore, 
checking the PCR products by gel electrophoresis is not necessary. After that, we 
evaluated the quality and quantity of the sequencing libraries, by Bioanalyzer 
analysis to check the library had the expected size and that the primer dimers 
were absent. 
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Figure 3-8 96 PCR well plate includes 90 test DNA and 6 controls including 0 DNA (no DNA 
template), 2 positive HD patients and HD mice controls. Blue wells represent DNA samples 
with a different combination of indices including forward (i7) index and reverse (i5) index. 
Grey wells represent the control samples used with each plate. These controls can be 
placed in any wells with a different combination of indices.  
 
Although we obtained genotypes of all samples using MS1F/MS1R short, long CAG 
repeats (> 76) cannot be identified using these outer primers because those 
primer pairs lie quite a distance from the repeat. Therefore, Dr. Marc Ciosi in 
our group managed to optimise another primer pair (HD319 F/33935.5) for MiSeq 
sequencing (Figure 3-3). The new PCR primers were designed to minimize the 
length of the flanking region as well as to avoid the region immediately flanking 
the repeat, which could be polymorphic. In addition, reduced flanking region 
would potentially allow the sequencing of longer CAG repeats (Table 3-1). The 
intermediate primer pair (HD319 F/33935.5) was selected, as it was associated 
with good amplification of the CAG repeats and quality sequencing data. Also, it 
is still possible to purify the sequencing library using AMPure beads based 
approach to clean up the PCR rather than gel purification.  
We have developed an optimised assay for the detection of CAG repeat length in 
the HTT gene. After that, further libraries were prepared for genotyping the 
normal alleles of the unaffected and affected individuals from the Venezuelan 
cohort. 
  Chapter 3, 55 
 
3.2.2 Analysis of the NGS data using CLC Genomics Workbench 
software 
To determine the genotype for samples, CLC Genomics Workbench Version 7.5 
was used to visualize and analyse NGS sequencing data. CLC Genomics 
Workbench provides a user-friendly interface and is capable of performing 
multiple analyses. This software has a major advantage in flexibility in the 
parameters option for read assembly. CLC is relatively expensive, and its licence 
is no longer available for use by University of Glasgow staff and students. 
Therefore, our group has moved to using Galaxy software that has been widely 
used for NGS data analysis, and it is free software. 
 
Figure 3-9 Workflow for analysis of MiSeq sequencing data using CLC genomic workbench. 
After library preparation, samples are sequenced on MiSeq platform. The next steps are 
quality assessment, read alignment, followed by genotyping the samples and visualisation 
of the data. 
 
The analysis of our data using CLC genomic workbench was composed of: quality 
assessment of the raw data, alignment parameter optimisation, read alignment 
to the reference and genotype identification and visualization of the data 
(Figure 3-9). In the following sections, each of these steps will be explained 
briefly.  
3.2.2.1 Quality assessment  
After completing the sequencing run, it is important to evaluate the quality of 
raw reads and to remove or trim reads that might have multiple errors and low 
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quality reads. The raw data generated by MiSeq sequencing might include base 
calling errors, insertions/deletions, poor quality reads and adapter 
contamination. Therefore, it is necessary to perform a base quality assessment, 
read filtering and trimming of reads before performing any downstream analysis 
for enhancing mapping accuracy.  
To assess the sequencing data quality, CLC provides various tools including 
visualization of sequence read lengths, base coverage, nucleotide contribution, 
GC-content distribution, ambiguous base content and quality distribution. 
Creating a quality control (QC) report provides quality control checks on raw 
sequence data that gives a clue of whether your data has any problems before 
doing any further analysis. The quality analysis examines quality scores of bases 
and sequences that feature individual Phred score in 64 bins from 0 to 63 of its 
base qualities as shown in (Figure 3-6). Running QC report yields summary graphs 
and tables to assess the data quality. 
For some MiSeq libraries, indices were shared with other users sequencing 
different loci. In this case, demultiplexing of the sequencing data was required 
to separate the reads into their corresponding samples before further analysis. 
The sample-specific tag, also called the barcode can be used to distinguish 
between the different samples when using the demultiplexing tool in CLC. In our 
data, the sample specific spacer and locus-specific forward primer can be used 
to distinguish between different loci when analysing the sequencing data. The 
forward reads for the shared index libraries were demultiplexed using the spacer 
plus 10 bases of the locus-specific forward primer as a barcode. Demultiplexing 
was carried out on the sequencing reads if the sequencing reads contain an 
exact match to any of the barcode sequences provided. The demultiplexed reads 
will be generated as output for each specific barcode and also the demultiplex 
reads report showing the number of reads with and without a barcode. 
The trimming tool offers a number of ways to trim sequence reads prior to 
mapping, including adapter trimming, quality trimming and filtering on length. If 
the insert size is below the specified sequencing length (if the insert size is 200 
bp, and the MiSeq is sequencing 300 bp), the adapter will be sequenced. In this 
case, the sequences of corresponding library adapter can be present in the 
output files at the 3’ end of the reads. To remove these sequences and prevent 
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issues with alignment, adapter trimming can be performed with CLC software by 
selecting the sequence of the reverse sequencing primer-binding site as an 
adapter sequence to be trimmed. When an adapter sequence is specified for 
trimming, the adapter and sequence of the 5’ end of the adapter will be 
removed. Trimming these sequences would remove the insert because it is at 
the 5’ end of the adapter sequence. Therefore, we must remove the reverse 
compliment of the adapter sequence that is found in the minus strand. The 
adapter sequence that is used as recognition site and 3’ of the adapter is 
removed from the raw reads data in relation to the positive strand. The 
trimming parameters were used in our data: Mismatch cost = 1; gap cost = 2; 
minimum score for internal matches = 6; minimum score for end matches = 3. 
These trimming parameters were optimised by my colleague Dr. Marc Ciosi. 
After trimming, a list of sequences that have passed the trim will be produced 
for each input sequence list when the sequences are selected. Also, the trimmed 
report shows a number of nucleotides after trimming and read length 
distribution before and after trimming (Figure 3-10). 
 
Figure 3-10 Trim summary with statistics and graph are generated from trimming the 
specified adapter sequences for MiSeq sequencing data by CLC workbench software. The 
trim summary shows the number and the average length of the reads in the input file, the 
number and percentage of reads after trimming and the average length of trimmed reads. 
The graph shows the number of read length before and after trimming to see how the 
trimming has affected the read lengths. 
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3.2.2.2 Mapping  
After reads were processed, the reads were mapped to custom references 
including the region flanking the repeats and various numbers of CAG and CCG 
repeats. Four thousand reference sequences were considered (1 to 200 CAG 
repeats and 1 to 20 CCG repeats) in order to obtain the genotype. This choice of 
CAG and CCG ranges were included in the reference to represent most possible 
repeat sizes found in the normal and expanded alleles in unaffected and 
affected individuals. As most HD patients have CAGs from 40 to 50 repeats and 
CCG repeats varying from 4 to 12 repeats. This customised reference will yield 
greater alignment by allowing the alignment software to map reads to the closet 
match in terms of CAG and CCG length for each sample. To start read mapping, 
the sequences containing the sequencing data and the reference sequences 
should be selected. Single sequences or a list of sequences can be used as a 
reference. The software can generate a summary report about the mapping 
process.  
The first library was prepared by amplifying the repeats by inner primers 
(3139/335), so the reference was designed to have a flanking region of the pair 
of primers. Then, we used the outer primers (MS1F/MS1R short) to amplify HTT 
allele in few libraries. After that, another primer pair HD319 F/33935.5 
(intermediate primers) was used for library preparation for MiSeq sequencing. 
The new PCR primers were used to minimize the length of the flanking region 
from the outer primers as well as to avoid the region immediately flanking the 
repeat using the inner primers. Therefore, the rest of libraries were prepared 
using intermediate primers and the custom references were designed to have 
the flanking region of these primers. 
For each allele, the CAG/CCG genotype was defined to be the genotype of the 
reference against which the highest number of reads had aligned. Both CAG and 
CCG repeat sizes were determined for all individuals. By alignment of the 
obtained reads to the reference flanking regions, the start and end of both 
repeat regions can be determined, which allows the exact length and sequence 
of the region to be obtained. Mapping parameters will be discussed in detail in 
the next section. 
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3.2.2.3 Alignment parameter optimisation  
The alignment parameters in CLC allow mismatch and gap costs to be adjusted. 
The mismatch cost, insertion cost and deletion cost parameters refer to the 
score for a match between the sequencing reads and reference for the 
mismatch, insertion and deletion. Adjusting these parameters can improve the 
alignment quality.  
Mismatch, insertion and deletion cost ranged from 1 to 3. We selected a 
mismatch cost of 2 for our data because we expect the PCR errors and possible 
atypical alleles to generate mismatches in the sequencing reads. Therefore, we 
lowered the mismatch cost to allow for such errors in reads, as the reference is 
sometimes expected to differ from the sequenced reads. Increasing parameter 
scores for insertion and deletion cost to 3 results in the reads mapping to a 
reference with an exact match without insertions and deletions. However, it is 
important to note that the custom reference includes a variable number of CAG 
and CCG repeats to allow the obtained reads to map to the closest length of 
repeats. 
To discover if these selected parameters are optimal for alignment of the 
obtained sequence reads, a single sample was selected to compare and find the 
optimal parameters for the reads based on the cost parameters. The optimal 
alignment parameters of the reads were determined. The mapping process 
involved the following mapping parameter values: mismatch cost =2, insertion 
cost =3, deletion cost = 3, length and similarity fractions = 0.9. Those were 
identified based on the accuracy and the highest proportion of reads that were 
aligned to the reference. 
After the optimal alignment of the read is found, a filtering process determines 
whether this match between the reads and reference is suitable for the read to 
be included in the alignment output. The filtering process is determined by 
length fraction and similarity fraction. Length fraction refers to how much of the 
read must match the reference sequence to the level of similarity for this read 
to be mapped. The selected threshold was 0.9; that means at least 90% of the 
read needs to align to the reference. Similarity fraction specifies how similar the 
sequence reads must be for the reference to be mapped. We used 0.9 for 
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similarity fraction and 0.9 for length fraction; it means that at least 90% of the 
read should align with 90% similarity in order to be mapped. The mapping 
process involved the following mapping parameter values: mismatch cost = 2, 
insertion cost = 3, deletion cost = 3, length fraction = 0.9 and similarity fractions 
= 0.9.  
3.2.2.4 Genotyping identification and visualisation  
Validation and visualisation of the generated results are important steps in NGS 
data analysis. Visual representation of obtained data is very useful for the 
interpretation of the result. CLC workbench supports the NGS visualization tool 
by displaying aligned reads and identified any mismatches. We also used another 
graphical viewer for NGS alignment, Tablet, to visualize the read mappings 
(Milne et al., 2013). Tablet displays read coverage, reads names and it allows 
searching for specific coordinates across the dataset. 
 
Figure 3-11 Sample reads were aligned against a set of reference sequences with (CAG) 1-200 
and (CCG) 1-20 using CLC genomics workbench software. The target CAG repeats are seen 
and also CCG and the intervening sequences. The intervening sequences are 
CAACAGCCGCCA. This is the alignment for an allele that has 11 CAG repeats and 7 CCG 
repeats. Visual representation of obtained read mapping was performed using Tablet. 
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Analysing the mapped reads confirms the presence of both flanks to the repeats. 
An example of mapped reads with 11 CAG repeats and 7 CCGs with flanking 
sequences, is shown in Figure 3-11. Normal allele length distributions are 
presented in Figure 3-12 for one individual. That individual is heterozygous for 
11, and 17 CAG repeats normal alleles as well as heterozygous for 7 and 10 CCG 
repeats. One of the HD alleles has 17 CCG repeats with 7 CCG repeats, and other 
allele has 11 CAG repeats and 10 CCG repeats. The mapped reads of the normal 
allele with 11 CAG repeats showed putative PCR slippage where multiple reads 
were mapped against references of different lengths, resulting in multiple peaks 
(Figure 3-12). Putative slippage results in reads mapping against 9, 10 and 12 
repeats. Also, the alignment for the 17 repeat allele shows PCR slippage that 
results in reads mapping against 13, 14, 15, 16 and 18 repeats (Figure 3-12). This 
is also seen for CCG slippage in which multiple reads were mapped against 
references of different lengths. PCR slippage clearly occurs and becomes more 
noticeable as the allele gets bigger. 
 
Figure 3-12 Normal allele length distribution of 11 and 17 CAG repeats against a number of 
reads for one individual. The reads were aligned against the references. Most of the reads 
that aligned against the 10 CCG reference mapped against 11 CAG repeats, represented as 
the heighest blue peak. Also, a large number of the reads that aligned against the 7 CCG 
references aligned against 17 repeats, represented as the highest purple peak. 
 
3.2.3 Analysis of CAG and CCG repeats in normal alleles 
The analysis of the HTT alleles was carried out on 210 blood DNA samples from 
unaffected Scottish individuals and 742 buccal swab DNAs from the US-
Venezuelan Collaborative Research Project consisting of unaffected and affected 
individuals from HD families. Our samples from Venezuela compromised 131 
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families. The family size ranged from 1 to 20 individuals with an average of 3.6. 
Of the 210 Scottish samples, 96 samples were prepared by my colleague Dr. Marc 
Ciosi working on a CHDI funded project. Also, he prepared one of the libraries 
that included 91 samples to amplify HD alleles from affected individuals from 
the Venezuelan cohort, and I carried out the data analysis for those libraries. 
3.2.3.1 Analysis of CAG repeats in normal alleles of unaffected Scottish 
individuals 
  
Figure 3-13 Distribution of CAG repeats of HD alleles from 210 individuals from the Scottish 
population. The distribution is shown for the number of CAG repeats observed on 420 
chromosomes from the unaffected Scottish population.  
 
Among the Scottish population with no association to HD, CAG sizes were 
determined for 420 chromosomes. CAG sizes are considered the length of pure 
CAG repeats in the HTT gene. The CAG size of the chromosomes ranged between 
9 and 33 repeats, with the most common size being 17 CAG. The mean CAG size 
of normal alleles was 24. The CAG size distribution of these general population 
chromosomes is illustrated in Figure 3-13. In this study, 21 intermediate alleles 
(27 to 35 CAG repeats) were identified representing an allele frequency of 5% in 
the Scottish population. The mean CAG size of intermediate alleles was 29.1, 
and the median was 29 CAG. No reduced penetrance HD alleles (36 to 39 CAG) 
were identified in this population (Table 3-2). 
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3.2.3.2 Analysis of CAG repeats in normal alleles of unaffected and affected 
individuals from the Venezuelan cohort 
For this study, Venezuelan kindred members can be separated into four groups 
according to the length of CAG repeats in their HTT alleles: unaffected 
individuals who have normal sized alleles on both chromosomes, individuals with 
intermediate alleles who inherited CAG between 27 to 35 repeats, individuals 
who have low penetrance alleles (36 to 39 CAG repeats) and affected individuals 
who have full penetrance alleles (40 CAGs or more).  
 
Figure 3-14 Distribution of CAG repeats in unaffected individuals and affected of HD families 
from the Venezuelan cohort. The CAG allele frequencies of normal alleles were estimated 
from 333 unaffected individuals (666 alleles) and from 400 HD patients (400 alleles). 
 
We assessed CAG repeat length in the 742 unaffected and affected individuals of 
HD families of the Venezuelan cohort. The distribution of CAG repeats sizes on 
the non-disease associated alleles are presented for 333 unaffected individuals 
with two normal chromosomes (Figure 3-14). This gave a total of 666 normal 
alleles in unaffected individuals of HD families.  
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Table 3-2 CAG allele frequency in the normal allele, intermediate allele and reduced 
penetrance allele ranges in unaffected individuals from Scottish population, unaffected and 
affected individuals of HD families from the Venezuelan cohort. The number of alleles, mean 
and median were estimated for each CAG allele range for all populations. No.= number of 
alleles. 
 
The range of the CAG number on the normal chromosomes was 10 to 39 repeats 
in unaffected individuals. The 17 CAG repeats were the most common length for 
the normal allele. Out of a total of 333 individuals (666 alleles), 31 individuals 
had CAG repeat lengths in the intermediate range with a mean length of 30.6 
CAG and median of 29 CAG (Table 3-2). Approximately 4.65% have intermediate 
alleles. Nineteen (2.85%) individuals have alleles of reduced penetrance with a 
median of 39 (Table 3-2). 
We determined the size of CAG normal alleles of 409 affected individuals with 
HD. In 400 patients, one normal and one expanded allele were found, while 9 
subjects were homozygous for two expanded alleles. The expanded alleles 
genotyping and distribution will be discussed in detail in Chapter 4. In the 400 
heterozygous subjects, who carried one expanded allele, the normal alleles 
contained 10 to 26 CAG repeats with a mean of 17.97 and a median of 17. The 
17 CAG repeats were the most common allele in the shorter allele of HD 
patients, which is similar to the unaffected individuals’ result. Ten (2.5%) alleles 
were found in the intermediate allele range. One allele was found in the 
reduced penetrance range (0.25%). The distribution of the normal alleles in the 
HD patients was similar to the distribution in the normal chromosomes analysed 
in the unaffected individuals. However, there are a few differences in which 17 
CAG frequency was slightly higher in affected than in unaffected individuals, and 
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intermediate alleles occur at a lower frequency in affected individuals than in 
unaffected individuals. 
3.2.3.3 Analysis of CCG repeats in normal alleles of unaffected Scottish 
individuals  
 
Figure 3-15 The distribution is shown for the number of CCG repeats observed on the HTT 
normal chromosomes from 120 unaffected Scottish population. 
 
The CCG repeat alleles in 121 Scottish individuals were assessed. Three different 
CCG repeats were identified 7 (60.23%), 9 (8.8%) and 10 (30.95%) repeats (Figure 
3-15). 
3.2.3.4 Analysis of CCG repeats in normal alleles of unaffected and affected 
individuals from the Venezuelan cohort 
In 333 unaffected individuals, we identified five CCG repeat allele lengths, 
repeat numbers 6 (0.45%), 7 (55.7%), 9 (15.6%), 10 (28%) and 11 (0.15%). We also 
identified five CCG alleles in the 409 HD patients. HD patients inherited 6 
(0.97%), 7 (57.9%), 9 (13.9%), 10 (25.6%) and 11 (1.46%) in their normal allele. 
The 7 repeat allele was the most frequent in both unaffected individuals and HD 
patients. The 10 repeat was the next most frequent. The result shows that five 
HD patients and one unaffected individual were associated with 11 CCG repeats. 
Out of five HD patients who inherited 11 CCG repeats, three of them were 
siblings. We also identified 6 CCG repeats in four HD patients and three 
unaffected individuals. Among individuals with 6 CCG repeats, two patients were 
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siblings, and two other HD patients and one unaffected individual were siblings 
as well.  
 
Figure 3-16 The distribution is shown for the number of CCG repeats observed on 1,066 HTT 
normal chromosomes from 333 unaffected and 400 affected individuals from the Venezuelan 
population.  
 
3.2.4 Haplotype analysis of normal chromosomes 
We have constructed haplotypes based on the length of both CAG and CCG 
repeats for all individuals who were either homozygous or heterozygous at the 
CAG or CCG locus. We determined the haplotypes for normal alleles of the 
Scottish and Venezuelan population from the NGS data for each individual.  
3.2.4.1 Haplotype analysis of normal chromosomes in the Scottish 
population  
In the unaffected Scottish population, we determined the haplotype for those 
individuals for the CAG-CCG locus. This method helped us to determine 40 
haplotypes in 420 normal chromosomes using NGS sequencing. Haplotype CAG 
17-CCG 7 has the maximum frequency (18.8%), and CAG 17-CCG 10 has the 
second highest frequency (9.8%) among all haplotypes (Figure 3-17). 
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Figure 3-17 Haplotype analysis of HTT in 210 unaffected Scottish population. The graphs 
show the distribution of CAG sizes on normal chromosomes for individuals carrying 7 CCG, 
9 CCG and 10 CCG repeats. 
 
With haplotype 7 CCG, CAG 17 has the highest frequency (18.8%) followed by 20 
CAG (6.2%). CAG repeats from 12 to 33 were represented in this haplotype. Also, 
17 CAG (9.8%) was the most common in haplotype 10. The second most frequent 
allele in haplotype 10 was 18 CAG repeats (7.4%), which is different than the 7 
CCG haplotype. CAG repeats from 10 to 22 were represented in the haplotype 
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10. Haplotype 9 CCG was associated with a lower number of samples. The 18 
CAG (3.1%) was the most common in haplotype 9. Most CAGs ranged from 9 to 19 
with haplotype 9 CCG, though one allele had 26 CAG repeats. 
We calculated the percentage of HTT chromosomes, mean CAG size and ranges 
of CAG repeat length associated with different CCG repeats (Table 3-3). The 
mean CAG size and range of CAG repeats were different with 7 and 10 CGG. HD 
chromosomes with 7 CCG were associated with a larger range of CAG repeat 
lengths and higher mean CAG length than 9 and 10 CCG alleles. The mean CAG 
repeats sizes on chromosomes with 7, 9 and 10 CCG repeats were 19 ±	0.26, 
16.92 ±	0.56 and 16.98 ±	0.17 respectively. The mean CAG size was similar for 9 
and 10 CCG repeats. 
 
Table 3-3 CCG repeat frequency in normal chromosomes among 210 unaffected Scottish 
individuals and 333 unaffected and 400 affected of HD families from the Venezuelan 
population. The mean CAG repeat size and range of CAG repeat lengths were estimated for 
each CCG allele length from 6 to 11 repeats. 
 
3.2.4.2 Haplotype analysis of normal chromosomes in the Venezuelan 
population  
Analysis of CCG repeats revealed the HD normal alleles presented five different 
haplotypes with a size of 6, 7, 9, 10 and 11 CCG repeats in the unaffected and 
affected individuals from the Venezuelan population. We determined the 
haplotype in 1,066 normal chromosomes of individuals from HD families. We 
found 45 different haplotypes in the normal chromosomes of HD families. 
Haplotype CAG 17-CCG 7 has the maximum frequency (14.1%), and CAG 18-CCG 9 
has the second highest frequency (9%) among all haplotypes (Figure 3-17). 
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CAG 17-CCG 7 has the maximum frequency with haplotype 7 CCG. The second 
most frequent allele in haplotype 7 was 15 CAG repeats (8.3%). The haplotype 
analysis for 10 CCG revealed CAG 17-CCG 10 has the highest frequency (8.3%), 
followed by CAG 19-CCG 10 that has the second most frequent allele (6.1%) in 
haplotype 10. With haplotype 9 CCG, CAG 18 has the highest frequency (9%). For 
haplotype 6 and 11 CCG, 15 CCG has the highest frequency of 0.1% and 0.38%, 
respectively. These haplotypes (6 and 11 CGG) were least common and were 
associated with small numbers of chromosomes. 
The mean CAG length was calculated for the Venezuelan population for the five 
haplotypes as shown in Table 3-3. A mean CAG repeat size of 19.78±	0.21 was 
observed in individuals carrying 7 CCG haplotype, that is higher than the mean 
CAG repeat size in individuals with 9 and 10 CCG haplotype. The 9 and 10 CCG 
alleles were associated with a similar mean CAG repeat size. This is similar to 
haplotype analysis for the Scottish population in which 7 CCG has the highest 
CAG repeat mean size and the 9 and 10 CCG alleles were associated with a 
similar mean CAG repeat. The least common haplotypes (6 and 11 CCG) were 
associated with a smaller mean of CAG repeat lengths. 
In addition, no effects of the size of the CCG repeat in normal alleles for 
haplotype 9 and 10 were observed for the size of CAG repeats, since individuals 
have no significant differences in the mean of CAG repeat size for these 
haplotypes. Haplotype CCG 7 was the most common haplotype in normal alleles, 
which represents 56.19% and 60.23% for the Venezuelan HD families and the 
Scottish population, respectively. CCG 7 was associated with longer CAG repeat 
lengths on normal chromosomes in Scottish and Venezuelan populations. 
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Figure 3-18 Haplotype analysis of HTT in unaffected and affected individuals of HD families 
from the Venezuelan population. The graphs show the distribution of CAG size on normal 
chromosomes in the 1,066 normal chromosomes for individuals carrying the 7 CCG, 9 CCG 
and 10 CCG. 
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3.2.5 Characterization of atypical alleles 
The sequence of the 12 bp segment between the CAG and the adjacent CCG 
tracts in the HD gene may also significantly contribute to the instability of the 
CAG repeats. We were able to identify atypical HD alleles from sequencing HTT 
alleles in Scottish and Venezuelan populations. Atypical HD alleles were 
different than the typical structure: (CAG)nCAACAGCCGCCA(CCG)n . 
3.2.5.1 Characterization of atypical alleles in the Scottish population 
In our study, five different variants were identified from sequencing HTT normal 
chromosomes in unaffected individuals from the Scottish population. The first 
variant was observed in 13 chromosomes and was only seen in alleles having 15 
CAG or 16 CAG with 7 CCG repeats (Figure 3-19). This variant was characterized 
by changes of the adjacent CCA CCG into a CCG CCG sequence. This variant 
could result from A→G substitution or a duplication of CCG repeats and deletion 
of the CCA codon. It is a silent mutation as both codons still code for proline. 
This variant has been reported in Margolis et al, 1999 as a rare variant that was 
found in one case among 1,236 cases tested for HD (0.04% of normal 
chromosomes). This variant was found in an unaffected spouse of a patient with 
HD. In contrast, this variant was found in ~ 4% of normal chromosomes in our 
study. That is higher compared to published data, which may be as our sample 
size is very small or because this variant is at a higher frequency in the Scottish 
DM1 population. 
The second atypical allele involved the changes of the adjacent CAA CAG into 
CAG CAG sequence (Figure 3-19). This variant could result from an A→G 
substitution or a duplication of CAG repeats and deletion of the CAA codon. This 
variant was observed in two chromosomes and was only seen in alleles having 24 
CAG and 29 CAG with 9 CCG repeats. 
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Figure 3-19 MiSeq sequencing of 27 atypical HD alleles. Five different structures were seen 
in unaffected individuals of the Scottish population. The majority of chromosomes (393) 
have the typical structure of the gene: (CAG) n CAACAG CCGCCA (CCG) n, which is 
presented in the schematic representation on the top. The atypical alleles presented here 
are different from the typical structure in the intervening sequences and also within the 
repeats (CAG, CCG and CCT). The number on the right corresponds to the number of times 
each of these allele types was genotyped. The number on the left corresponds to the 
number of CAG repeats, which were associated with each allele. 
The third variant that was analysed involves an additional CAA CAG at the 3’- 
end of the CAG repeat, along with the addition of a CCT sequence to the CCT 
duplication following the CCG repeat (Figure 3-19). This allele was observed in 
six normal chromosomes in our data from the Scottish population. This atypical 
allele was only seen in alleles that have 15 CAG or 16 CAG with 7 CCG repeats. 
This variant could result from a duplication of the CAA CAG sequence at the 3’-
end of the CAG repeat, or a base substitution of G→A in the second last CAG of 
the uninterrupted CAG stretch. CAA still codes for glutamine. Also, the addition 
of a CCT sequence to the CCT that follows the CCG repeats could be a 
duplication of CCT normally present at the end of the CCG repeats or a base 
substitution of G→T for the last CCG repeat. This allele is more likely to have 
occurred because of length change mutations rather than a base substitution 
because otherwise it would have originated from an extremely rare 8 CCG allele. 
This atypical allele has been reported in previously published data (Pêcheux et 
al., 1995). 
  Chapter 3, 73 
 
The fourth atypical allele also involved an additional CCT sequence at the end of 
the CCG repeat (Figure 3-19). This atypical allele was observed in five 
chromosomes. This allele was found with 9 CCG repeats and CAG repeat size of 
10 and 19. Therefore, the CCT triplet number may also account for the size 
variation of the CCG region in HTT chromosomes. CCT repeats can be either two 
or three (rare) triplets in length.  
The last atypical allele has not been described before and is associated with 
interruption of CCG repeats into the CAG repeats tract, deletion of CAA in the 
intervening sequence along with an additional CCT sequence to the CCT 
duplication present at the end of the CCG repeat.  
3.2.5.2 Characterization of atypical alleles in the Venezuelan population 
We identified three atypical normal allele structures from sequencing HD 1,066  
 
Figure 3-20 MiSeq sequencing of 107 atypical HTT alleles. Three different structures are 
seen in unaffected and affected individuals of HD families from the Venezuela population. 
The majority of chromosomes (959) have typical structures of the gene: (CAG) n CAACAG 
CCGCCA (CCG) n that is represented in the schematic representation on the top of the 
figure. The number on the right corresponds to the number of times each of these allele 
types was genotyped. The number on the left corresponds to the number of CAG repeats 
that were associated with each allele. 
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normal chromosomes from unaffected and affected individuals of the 
Venezuelan population. 
The first atypical allele was observed 104 times (Figure 3-20). This allele is 
characterized by a change of the CCA CCG into CCG CCG sequence. This atypical 
allele was observed with alleles having 9 CCG repeats and a variable number of 
CAG repeat: 16, 17, 18, 19, 20 and 24 repeats. A high number of alleles (76) 
have 18 CAG repeats. This atypical allele was the most common allele among the 
three atypical alleles.  
The second atypical allele involves an additional CAA CAG sequence at the 3’-
end of the CAG repeat, along with an additional CCT sequence at the end of the 
CCG tract (Figure 3-20). This allele was observed in 25 normal chromosomes of 
unaffected and affected individuals. This atypical allele was seen mostly in 
alleles having 15 CAG with 7 CCG repeats, and in one allele with 14 CAG repeats.  
The last atypical allele was observed 42 times, which involves an additional CCT 
sequence at the end of the CCG repeat. This allele was found with 9 CCG 
repeats, and a variable number of CAG repeats: 15, 16, 17, 18, 20 and 26 (Figure 
3-20). The most common CAG repeat lengths associated with this atypical allele 
were 15 and 17 repeats.  
All three atypical alleles were also found in Scottish samples sequenced in the 
previous section. There are no atypical alleles identified in this cohort from the 
sequencing of intermediate or reduced penetrance HD alleles. The actual 
alignment for three atypical alleles is illustrated in Figure 3-21. 
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Figure 3-21 MiSeq sequencing reads of atypical HD alleles. Three alleles were shown in our 
data from Scottish and Venezuelan populations. Atypical HD alleles were different than the 
typical structure: (CAG)nCAACAGCCGCCA(CCG)n . These atypical alleles were described in 
detail in sections: 3.2.5.1 and 3.2.5.2. Black arrows indicate the change in each atypical 
allele from the typical allele structure. Tablet was used for visualisation the aligned reads. 
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3.3 Discussion  
Since the discovery of the HTT gene, molecular genotyping in HD has been 
limited by examining the CAG repeat by automated fragment length analysis of 
PCR products. It is complicated by the presence of an adjacent polymorphic CCG 
repeat and provides no information on variant repeats or flanking sequence 
differences. In this chapter, we discussed the methodological and bioinformatic 
issues associated with next generation sequencing to develop new sequence-
based approaches to high-throughput genotyping of the CAG repeat in HD. This 
new approach makes it feasible to consider NGS as a clinical tool in the near 
future. We have demonstrated the ability of NGS technology using the MiSeq 
platform to be able to genotype and characterize the size distribution of the 
CAG repeats of the HTT gene, including the polymorphic CCG repeats and the 
flanking sequences. 
It is important to note the sensitivity of this sequencing method and the ability 
to identify sequence variants within the repeat region. The accuracy observed in 
sequencing the repeat and flanking CAG repeat region at great coverage 
produced sufficiently accurate sequence to genotype repeat number and detect 
variant repeats. 
We have developed an optimised library preparation method using this 
approach. We can test 96 samples in each library. We established that it was 
possible to sequence and genotype normal HD CAG alleles and the adjacent CCG 
repeat using the MiSeq platform by amplifying the region using locus-specific 
primers combined with MiSeq sequencing adapters. The optimal primer pair 
(HD319 F/33935.5) was used for MiSeq sequencing to ensure sequencing of the 
region immediately flanking the repeat, which could be polymorphic, and also to 
minimize the length of the flanking region. Reduced flanking region would 
potentially allow the sequencing of longer CAG repeats. Although these primers 
(HD319 F/33935.5) produced a prominent primer dimer, it was possible to 
separate the desired products via an AMPure beads based approach because of 
the greater size difference between the full-length amplification products and 
primer dimers. This step is essential for product purification and to generate 
enough products to yield excellent HD sequence reads. 
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To investigate the utility of MiSeq sequence read data to genotype potentially 
longer CAG repeats (170 repeat allele), we evaluated the use of a MiSeq 
sequencing run up to 600 bp. Two sequencing libraries were prepared using 
locus-specific primers incorporating the sequencing adapters for the same DNA 
samples. After that, the two sequencing libraries were then sequenced using a 
600 bp single direction run, and a paired-end read run (2x300 bp). Although we 
conducted a 600 bp unidirectional read, most of the fragments were less than 
600 bp in length. However, most of the reads generated were 600 bp long. At 
least part of the reason for this is that we sequence through the fragment and 
into the adapter sequence. In this case, the adapter sequences would be present 
in the output file at the 3’-end of the reads. However, some of the sequences 
were even longer than that, i.e. they extended beyond the end of the fragment 
length. The reason for this is unclear but could be due to some sequencing signal 
from neighbouring sequence clusters on the MiSeq flow cell. A major drop in 
sequence quality was observed after about 400 bp. Thus simple quality trimming 
cannot be used to address this problem. Sequencing CAG repeats along with 
flanking region and CCG repeats from the same direction can be performed for 
most of the alleles before a significant drop off in sequencing quality. However, 
sequencing quality and mapping efficiency were lower when sequencing longer 
alleles because a drop in sequencing quality occurred within the CCG repeats 
and at the 3-end flanking regions. Thus, we have explored the utility of the 
reverse reads when conducting sequencing reaction in the 2x300 bp or 400x200 
bp sequencing format. These data have revealed that good quality sequences 
may also be obtained on the reverse strand and that these can be used to 
improve the efficiency of genotyping the CCG repeat and the 3’-flanking DNA 
sequence. Thus, sequencing longer CAG alleles can be done from one direction, 
and the CCG repeats from the other direction because we cannot match or 
merge the reads in the middle of the CAG or CCG repeats. Therefore, using the 
2x300 bp or 400x200 bp run to sequence HD alleles that performed better than 
at 600 bp read for MiSeq in terms of the number of reads and mapping coverage. 
The obtained sequencing reads were then processed using CLC genomics 
workbench software as an NGS mapping tool for analysing the read alignment 
and visualizing the data. CLC can be used for alignment of both paired-end and 
single-end reads. The analysis of our data proceeded via quality assessment of 
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the raw data, trimming, demultiplexing, read alignment to the references, 
visualization of the data and genotype determination. The reads were aligned to 
custom references including the region flanking the repeats and various numbers 
of CAG and CCG repeats that yielded a greater alignment for each sample in 
comparison to a single reference. The optimal alignment parameters of the 
reads were determined based on the accuracy and the highest proportion of 
reads that were aligned to the reference. Adjusting these parameters improved 
the alignment quality to allow us to genotype normal HTT alleles. Examination 
of actual alignments revealed that highly accurate read alignments were 
generated, across the repeat region. 
The aligned reads showed differences from the references that are shown as 
mismatches throughout the reads. These differences might occur as a result of 
PCR error during library preparation or bridge amplification during MiSeq 
sequencing, genuine somatic variation or error in base calling during sequencing.    
Using this approach, we sequenced normal HTT alleles in 210 unaffected Scottish 
individuals and 733 unaffected and affected individuals from HD families from 
Venezuela. These data have revealed accurate genotypes, i.e. the exact length 
and sequence of both CAG and CCG repeat for most individuals. The length of 
the CAG repeats varied from 9 to 32 repeats in 210 unaffected Scottish 
individuals, with the 17 CAG allele occurring most frequently (30%). The size of 
CAG repeats in the Scottish population was similar to those reported among 
Caucasians (Kremer et al., 1994; Squitieri et al., 1994; Costa et al., 2006; Warby 
et al., 2011). 
The Venezuelan kindreds are unique in that they comprise the largest 
genetically related HD community in the world. The normal allele distribution 
for Venezuelan population was 10 to 39 CAG repeats among 333 unaffected 
individuals and 400 HD patients. The most common allele was 17 repeats found 
in 21.1% of normal chromosomes of unaffected individuals and 28.8% in HD 
patients. The distribution of the CAG repeat size in the Venezuelan population 
was similar to that observed in HD families in the same population (The U.S.–
Venezuela Collaborative Research Project and Wexler, 2004). 
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Our findings suggest that intermediate alleles (27 to 35 CAG) for HD are 
relatively common among individuals in the Scottish DM1 population with no 
association with HD. The relative number of intermediate alleles found in our 
data was 5% (21/420) in the Scottish population. The allele frequency is higher 
than in a previous study that has examined the frequency of intermediate alleles 
in Western populations (3.13%)(458/14,630) (Kay et al., 2016). However, there 
were marginally significant differences in the intermediate allele frequencies 
(chi-square= 5.25, P =0.021) between the normal allele in Scottish population 
and the published result in three Western countries (United States, Scotland and 
British Columbia, Canada). 
The intermediate allele frequency was 4.65% of unaffected individuals and 2.5% 
of affected individuals from Venezuelan HD families. The intermediate allele 
frequency was 3.84% (41/1,066) in HD families from our data. Alleles in the 
intermediate range were estimated at 4.34% in the general population from 
Brazil (Raskin et al., 2000). That is similar to our result of HD families in 
Venezuela. Intermediate alleles are linked with a higher risk of expansion in the 
next generation, giving rise to new cases of HD. Approximately 10% or greater of 
HD new mutations cases, who develop the clinical disease, have parents who 
were carriers of intermediate alleles (Falush et al., 2000). Intermediate alleles 
which expand into the reduced penetrance or full mutation range of HD, are 
more likely seen with a paternal transmission (Goldberg et al., 1993; Telenius et 
al., 1993). The chance of transmitting an expanded allele to the offspring is 
higher with longer CAG repeats (Brocklebank et al., 2009). A study showed when 
intermediate alleles have more than 30 CAG repeats, the higher will be the 
chance of transmission of an expanded allele, with complete penetrance, to the 
next generation (Semaka et al., 2013). 
There were no reduced penetrance alleles identified in the Scottish population. 
However, 0.1% (15/14,630) of alleles were identified within the reduced 
penetrance range among tested alleles in Western populations (Kay et al., 
2016). The reduced penetrance allele frequencies on normal chromosomes of 
the Scottish population were not significantly different (chi-square P=0.4) from 
Western populations in general. The undetected reduced penetrance alleles in 
Scottish population may be due to our study having a small sample size. Utilizing 
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much larger samples of different ethnic populations is required to estimate the 
frequency of reduced penetrance alleles in the general population.  
There were nineteen reduced penetrance HD alleles (36 to 39 CAG) identified in 
the unaffected Venezuelan population and one allele identified in an HD patient. 
This presented an allele frequency of 2.85% in unaffected and 0.25% in the 
affected Venezuelan population. This gives a frequency of reduced penetrance 
alleles of 1.8% (20/1,066) within HD families in Venezuela. The proportion of 
reduced penetrance alleles varied between 1 and 2% in individuals from HD 
families previously analysed in the same population (The U.S.–Venezuela 
Collaborative Research Project and Wexler, 2004; Paradisi, Hernández and Arias, 
2008). We obtained a similar frequency compared to previous studies in the 
Venezuelan population.  
For these experiments, although the Scottish DM1 patient’s population was 
analysed as a control, they are not a random selection of the Scottish population 
with respect to DM1 patients. However, there is no known association between 
DM1 and HD. Both disorders are caused by independent expansions at different 
genetic loci. There is no reason to think that HD will be under or over 
represented in DM1 patients. Therefore, with respect to the HD locus, these DM1 
patients should be representative of the general population in Scotland. 
However, it can be ruled out that there may be a bias in potential modifier loci 
variants in this population. 
Among the individuals studied in the Venezuelan population, alleles in the 
intermediate and reduced penetrance ranges were observed more in unaffected 
individuals than in affected. The differences between them may be because we 
tested the non-mutant chromosome in affected individuals, and both 
chromosomes in the unaffected individuals. Some of the intermediate and 
reduced penetrance alleles in the unaffected individuals may arise from 
contractions or deletions transmitted from affected individuals. The second 
allele is prone to expand to a full mutation in unaffected individuals when 
transmitted to the offspring. 
Intermediate and reduced penetrance allele frequencies are high in our samples, 
which could correspond to a high prevalence of HD in the Venezuelan 
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population. Also, the observed difference in intermediate and reduced 
penetrance alleles between the Scottish and Venezuelan populations may be due 
to a difference in the ethnic origin.  
Individuals with reduced penetrance alleles may show the HD phenotype in 40% 
of cases (Agostinho et al., 2013), such that they may have a very late onset of 
symptoms, which may be similar to the classic HD phenotype, milder symptoms, 
or other clinical presentation unrelated to classic symptoms. It is worth 
examining a large number of individuals with reduced penetrance alleles to 
determine if they have any clinical presentation over a long period of time. 
Those individuals with reduced penetrance alleles may also represent the source 
of new mutations for HD.  
We emphasize the importance of determining the frequency of intermediate and 
reduced penetrance alleles in the general population and within HD families 
because of the risk of expansion and subsequent risk of new mutation. Also, 
individuals who have CAG sizes in the intermediate or reduced penetrance sizes 
range may benefit from better information on the risk estimate of developing 
the disease, and the risk of new mutations in their offspring. 
CCG 7 alleles were the most common in both populations. In the Scottish 
population, the 7 CCG repeats were found at 60.23% and at a frequency of 
56.19% in the Venezuelan population. The CCG 10 repeat was the second most 
common allele in both populations being present with a frequency of 30.95% and 
27.39% in Scotland and Venezuela respectively. Together those two alleles (7 
and 10 CCGs) account for the majority of normal chromosomes in both 
populations. 
The distribution of CCG repeats in the Scottish population is similar to that in 
other western European populations (Andrew et al., 1994; Squitieri et al., 1994) 
in which CCG 7 and 10 were the most prominent alleles. However, we did not 
observe any 8, 11 and 12 CCG repeats which have been found in previous 
studies. The distribution of CCG repeat sizes in the Venezuelan cohort showed a 
difference to that in other Latin American populations (Agostinho et al., 2012). 
We have observed the 9 and 11 CCG alleles, but the previous study showed 
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individuals of HD families having 6, 7, 8 and 10 CCG repeats. Also, we did not 
observe any 8 CCG repeat alleles in our data. 
No difference was found between the numbers of CCG repeats in the unaffected 
and affected individuals of HD families. However, the allele frequencies of the 
CCG repeat in the HD families were different to those obtained in the Scottish 
population. There were three alleles identified in the Scottish population, while 
five alleles were identified in the Venezuelan cohort. The 6 and 11 CCG repeats 
were not found in Scottish individuals.  
Haplotype analysis, comprising CCG and CAG polymorphic markers, revealed the 
existence of two haplotypes that were over-represented among our data. 
Haplotype CAG 17-CCG 7 has the highest frequency, and CAG 17-CCG 10 has the 
second highest frequency among all haplotypes in the Scottish population. 
Haplotype analysis in the Venezuelan population showed that the CAG 17-CCG 7 
has the highest frequency and CAG 18-CCG 9 has the second highest frequency 
among all haplotypes. Therefore, there is a difference between the two 
populations in the frequency of the second haplotype.  
The carriers of 7 CCG repeats were associated with a higher CAG mean and 
longer CAG repeat lengths on normal chromosomes in both populations. The 
difference was not significant and was not associated with differences in mean 
CAG size between the two populations. The mean CAG repeat size was higher in 
normal chromosomes containing 7 CCG allele than in those with 9 and 10 CCGs. 
The 9 and 10 CCG haplotypes were associated with a similar mean CAG repeat 
size. The distribution of CAG repeat sizes among the 7 CCG haplotype was 
similar to the total distributions for both. There was no large variation in the 
mean CAG size among the Scottish and Venezuelan populations. 
Our data have revealed the existence of atypical alleles from sequencing normal 
HTT alleles. Most of the atypical alleles have been reported in published data, 
suggesting that we determined the accurate genotyping for HD alleles. The 
similarity of our data confirms the general validity of our interpretation. Thus, 
we are confident that these atypical alleles are genuine germline variants 
existing in normal alleles, and are not PCR and/ or sequencing errors.  
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Five atypical haplotypes were analysed in 27 normal alleles from sequencing HTT 
alleles in the Scottish population. One of these atypical alleles identified was 
with an intermediate repeat allele (29 CAG repeats). We observed three atypical 
normal allele structures from 107 normal alleles from the Venezuelan 
population. All the three atypical alleles were also found in the Scottish 
population from our data. There were no atypical alleles identified in this cohort 
from the sequencing of intermediate or reduced penetrance alleles in the 
Venezuelan population. 
Among the Scottish population, only one of these atypical alleles was not a 
previously described HD allele. This last atypical allele is associated with 
interruption of CCG repeats into the CAG repeat tract, deletion of CAA in the 
intervening sequence, along with an additional CCT sequence to the CCT 
duplication present at the end of the CCG repeat. 
The variant repeats may potentially expand less or more in both the soma and 
germline and can modify the disease severity. For instance, the atypical allele 
was seen for the first time in our data, may stabilise the repeat in both soma 
and germline and may be associated with reduced severity if it is found with HD 
expanded alleles. Some variant repeats may have an impact leading to increase 
severity and level of instability. For example, variants that lead to longer 
uninterrupted CAG repeats tracts are predicted to be more unstable and biased 
toward expansion. The presence of atypical allele structures may have an impact 
on the stability of the DNA and possibly the symptoms. Those atypical alleles in 
HD are present in the general population, and they expand to the disease size 
range. 
Variant repeats in DM1, SCA1 and Fragile X syndrome have been shown to modify 
the mutational dynamics by reducing the amount of germline and somatic 
instability (Chung et al., 1993; Zhong et al., 1995; Musova et al., 2009; Braida et 
al., 2010). Thus, we expect the atypical alleles with more variant repeats to be 
more stable, and those with less variant repeats to be more unstable, 
predisposing alleles to expansion and eventually to disease status. The level of 
instability is greater for longer uninterrupted CAG repeat tracts, and these are 
biased toward expansion. Notably, the presence of CCG interruptions which 
break the CAG repeat into three smaller repeat tracts in our data may stabilise 
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the alleles with an overall repeat number greater than 35. We expect these 
alleles to be associated with less somatic instability and to be less prone to 
expansion when transmitted to the next generation. Therefore, for most of the 
trinucleotide repeats disorders, the interruptions provide genetic stability to the 
repeat tract and the interrupted tracts are less likely to expand upon 
transmission. The identification of those atypical alleles can be difficult in the 
diagnostic test using PCR analysis, as it does not take into account the allele 
structure. Therefore, sequencing those alleles is necessary as they have an 
implication for the individual’s risk as well as alleles stability through life and 
transmission to offspring.  
By sequencing these atypical allele structures, we have clarified some of the 
discrepancies between our results and previously published data. First, the CAG 
15 alleles were relatively underrepresented in previous studies. This can be 
explained by the presence of atypical alleles that involved an additional CAA 
CAG sequence at the 3’-end of the CAG repeat, along with an additional CCT 
sequence at the end of the CCG tract. This atypical allele was seen mostly in 
alleles having 15 CAG. Therefore, using fragment length approaches for 
genotyping this allele would give the incorrect genotype of 17 CAG repeats 
because of the assumption that the length of the fragment is equal to the repeat 
number. Also, we didn’t find any 8 CCG alleles in our data. Although, it was 
reported as a rare allele in a previously published paper (Squitieri et al., 1994; 
Pramanik et al., 2000; Costa et al., 2006). This also might happen as the result 
of an atypical allele with an additional CCT sequence at the end of the CCG 
tract. That could lead to inaccurate determination of CCG repeat length using a 
standard method that does not take into account any structural variation of the 
region, and based on the assumption that the length of the fragment is equal to 
the repeat number. Therefore, the genotype obtained for this allele would be 8 
CCG and 2 CCT of the 3’-end of the CAG repeats. These atypical allele structures 
would be almost impossible to characterise accurately without NGS.  
Analysis of HD alleles sequences has shown that the presence of CAA, CCT, etc 
within the alleles could yield a distinct pattern of mutations termed as 
mutational signatures. These mutational signatures may relate to DNA repair 
processes. We have not searched for mutational signature specific to HD alleles, 
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as germline sequence changes are present at a low frequency in our data. 
However, a detailed analysis using a larger data set could be performed to 
detect mutational signatures in HD alleles. Understanding the link between the 
HD alleles and mutational signatures is relevant given the implications for the 
development of therapeutic approaches potentially directed towards a typical 
allele structure.  
The limitation of fragment length approaches for genotyping is inaccurate 
genotyping of CAG and CCG repeats because of the assumption that the length of 
the fragment is equal to the repeat number. Therefore, it is important to shed 
light on the classification of HTT alleles by repeat length. This could facilitate 
data discussion and analysis among different studies, and also would lead to 
more reliable studies for determination of actual frequencies of different allele 
ranges in the general population and in HD families. We noticed the variation of 
HTT allele frequencies between our data and previously published data. That 
can be resolved by using the classification of HTT alleles by accurately 
determining the repeat length. 
In summary, the classification of HD alleles by repeat length would lead to 
better data sharing and comparison as well as the actual determination of allele 
frequencies of different allele ranges. NGS approach represents an efficient 
method compared to other testing methods, which can be applied using new, 
rapid sequencing technology and offer diagnosis within a few days. Genetic 
testing using NGS to determine the length of the CAG repeat is essential as it 
provides a definite diagnosis of the disease. Therefore, NGS is more likely to 
have significant clinical utility. We illustrate the success and challenges of using 
NGS in trinucleotide disorders and suggest that our experience is likely to be 
applicable to many other expanded repeat alleles.  
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Chapter 4 Development of next generation 
sequencing based approaches to genotype the 
Huntington disease CAG repeat  
4.1 Introduction  
HD prevalence is estimated at approximately 4-8 per 100,000 in Caucasian 
populations (Harper, 1992), but occurrs at variable prevalence in different parts 
of the world. In Japan and China, there is a lower frequency (0.1-0.5 per 
100,000 persons) (Leung et al., 1992; Rawlins et al., 2016). The lowest 
frequencies have been found in black South Africans, with 0.02 affected persons 
per 100,00 but this could be an underestimate of prevalence because there were 
only a few cases detected (Rawlins et al., 2016). However, geographic isolates 
of Lake Maracaibo in Venezuela has a prevalence of 7 cases per 1,000 (Castilhos 
et al., 2016). This is a very high frequency of the disease and is due to a founder 
effect 
The CAG repeat length is the primary determinant of age at onset of clinical 
symptoms (Duyao et al., 1993; Andrew et al., 1994). The inherited repeat length 
is inversely correlated with age at onset, in which the contribution of each 
additional CAG repeat unit reduced the age at onset by approximately 2 years 
(Andrew et al., 1993; Gusella and MacDonald, 2009). Therefore, accurate 
determination of CAG repeats size has an implication for determining the 
average age at onset, and also for genetic counselling for at risk and affected 
individuals. Symptoms onset usually begins between 35 and 55 years of age, and 
the median survival time is 15 to 18 years. About 10% of patients have juvenile 
HD onset (before age 20 years) that occurs in individuals with repeat lengths of 
more than 65 CAG repeats (Telenius et al., 1993). Juvenile cases tend to be 
inherited through the male germline.  
The length of the expanded HD CAG repeats is unstable when transmitted from 
parents to offspring. It has been shown that the CAG repeat length changes are 
biased toward increases in most cases, but male transmission can result in large 
increases in size (De Rooij et al., 1993; Duyao et al., 1993; Telenius et al., 
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1993). Also, the HD anticipation phenomenon has been shown to be more intense 
in paternal transmission, that is offspring having symptoms at earlier ages of 
onset and longer repeat length than their affected parents (Telenius et al., 
1993). 
Most HD is inherited, but there are some occurrences of new sporadic HD cases, 
in which an affected individual have the disease but has no previous family 
history (Myers et al., 1993). The frequency of these chromosomes in the general 
population is quite low. Sporadic HD cases can occur from the instability of 
intermediate alleles that may lead to expansion into HD affected range upon 
transmission. 
The HTT repeat region is complex because it comprises a polymorphic mixture of 
CAG and CAA glutamine codons followed by another polymorphic mixture of 
CCG, CCA, and CCT proline codons. The fully penetrant range of the HD 
mutation is 40 or greater CAG repeats. The CAG repeats at HTT gene vary 
between 40 to 120 CAG repeats in expanded alleles. The CAG repeat is 
immediately adjacent to a polymorphic CCG repeat that varies from 6 to 12 
repeats in length (Andrew et al., 1994; Squitieri et al., 1994; Pêcheux et al., 
1995), although a CCG 4 allele was the smallest repeat identified in India 
(Pramanik et al., 2000). Most normal chromosomes and the majority of disease 
chromosomes are strongly associated with the 7 CCG repeats allele in high 
prevalence areas of HD (Barron et al., 1994; Squitieri et al., 1994; Costa et al., 
2006). In Japan where HD has a low prevalence, HD chromosomes are strongly 
associated with an allele of CCG 10 (Morovvati et al., 2008).  
Molecular genotyping in HD is traditionally performed by fragment length 
analysis of PCR products amplified across the CAG repeat tract. This method 
fails to identify atypical sequence variants or flanking sequence differences but 
provides an estimation of the size of CAG repeat tract. In this project, we have 
addressed many of the methodological issues associated with next generation 
sequencing (NGS) to develop new sequence based approaches to high-throughput 
genotyping of CAG repeats. 
Previously, we established that it was possible to sequence and genotype normal 
HD CAG alleles and the adjacent CCG repeats using the MiSeq platform by 
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amplifying the region using locus-specific primers combined with MiSeq 
sequencing adapters (see Chapter 3). NGS technology has been shown to be 
more informative and more accurate than methods that depend on the fragment 
length analysis. 
To establish whether this approach (MiSeq sequencing) is also suitable for 
genotyping the HD locus in affected individuals, we have initiated the 
sequencing of the HD repeat in buccal cell DNA from the Venezuelan Lake 
Maracaibo population. The aim of this chapter was to sequence and genotype HD 
alleles in HD patients using MiSeq sequencing.  
4.2 Results 
4.2.1 Library preparation  
As described in Chapter 3, we established that it was possible to sequence and 
genotype normal HD CAG alleles and the adjacent CCG repeats using the MiSeq 
platform by amplifying the region using locus-specific primers combined with 
MiSeq sequencing adapters. Although these primers produced a prominent 
primer dimer, we managed to separate the products by AMPure beads based 
approach and generate a product that yielded good quality sequencing data. The 
AMPure bead based approach was used because of the large size difference 
between the full-length amplification products and primer dimer. 
We have noticed in sequencing the HD repeat that PCR amplification and 
sequencing bias yielded more reads for shorter alleles. This had been observed 
in heterozygotes where the smaller allele is clearly sequenced to a greater 
depth than the larger allele (see Chapter 3). It was clear that the difference in 
the number of reads between the two alleles was dependent on the relative 
difference in size between those alleles. The most common normal allele in HD 
is 17 CAG repeats; however, the vast majority of expanded alleles only carry 40 
to 50 repeats. This is not a large length difference suggesting that it may not be 
necessary for gel purification for the expanded alleles to be carried out.  
After library purification, the PCR products were pooled, and the quality of the 
sequencing libraries assessed by capillary electrophoresis on a Bioanalyzer, to 
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check the fragment had the expected size and that primer dimer was absent or 
present in relatively small quantity.  
Although we had previously generated good quality data, we noticed a drop in 
sequence quality was observed after about 400 bp when using a 600 bp run. 
Therefore, we explored the utility of reverse reads when sequencing longer HD 
CAG repeats. Thus, it is possible to genotype longer CAG repeats by sequencing 
through the CAGs and into the intervening sequence using a long forward read, 
while the CCG repeats can be genotyped using the shorter reverse read. This is 
necessary because reads cannot be matched or merged in the middle of the 
repeats. Our data have revealed that good quality sequences may also be 
obtained on the reverse strand, and that these can be used to improve the 
efficiency of genotyping the CCG repeat and the 3’-flanking DNA sequence. 
Therefore, using the 2x300 bp or 400x200 bp run to sequence HD alleles 
performed better than a 600 bp run for MiSeq sequencing. 
Also, we previously observed with the data from a 600 bp MiSeq run (see Chapter 
3) that many of the reads were longer than the DNA molecules sequenced. An 
examination of the sequencing reads that were longer than the template DNA 
molecules revealed that most of them corresponded to a high sequencing error 
rate at the end of those reads, making it more difficult for initial adapter 
trimming to correctly recognise and remove the sequencing adapters at the end 
of those reads. This problem can be resolved by performing an additional 
adaptor trimming procedure before mapping the reads to the reference. 
To investigate the utility of the MiSeq sequencing approach to genotype 
expanded HD alleles, HD alleles were amplified from 409 buccal swab DNAs from 
the US-Venezuelan Collaborative Research Project consisting of affected 
individuals from HD families. 91 samples were prepared by my colleague Dr. 
Marc Ciosi working on a CHDI funded project. I carried out the data analysis for 
this library. 
Sequencing libraries were prepared using locus-specific primers incorporating 
the sequencing MiSeq adapters, using the primer pair HD319 F/33935.5. Those 
sequencing libraries were sent to the Glasgow Polyomics Facility for sequencing 
using the MiSeq platform. The libraries were sequenced using either the 400 
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bp/200 bp or the standard 2x300 bp run parameters in both forward and reverse 
directions. 
Trueseq barcodes for MiSeq sequencing have 96 unique combinations of indices 
generated by using 8 forward and 12 reverse indices in all possible combinations. 
These 96 combinations of barcodes may be used to identify 96 different samples, 
each associated with a unique pair of barcodes. 
The sequencing reads obtained were mapped with CLC Genomics Workbench to 
reference sequences including various numbers of CAG and CCG repeats (1 to 
200 CAG repeats and 1 to 20 CCG repeats) and the region flanking the repeats. 
See Chapter 3 for more details about: quality assessment of the raw data, 
alignment parameter optimisation, read alignment to the reference and 
genotype identification and visualization of the data. The optimal alignment 
parameters of the reads were determined based on the improved alignment 
quality and the highest proportion of reads that were aligned to the reference.  
4.2.2 Genotyping of the HD alleles in affected individuals  
Read mapping of expanded alleles revealed that the MiSeq sequencing approach 
can be used to genotype the expanded HD alleles. The sequencing reads were 
obtained for both the normal and the expanded allele for each individual. The 
vast majority of reads (>90%) could be correctly mapped to the reference 
sequences for each patient. In most samples, the expanded alleles were 
detected. Sequencing data have been generated for 409 samples. From this 
data, we were able to determine the genotype.  
The MiSeq sequencing result for an HD patient is presented in Figure 4-1. The 
CAG repeat size distribution from that patient shows the mode at 25 and 43 CAG 
with 7 CCG repeats, i.e. 25 and 43 CAG repeats occur most frequently. That 
patient is heterozygous for 25 and 43 CAG repeats, as well as homozygous for 7 
CCG repeats. The normal HD allele has 25 CAG repeats with 7 CCG repeats and 
the expanded allele has 43 CAG repeats and 7 CCG repeats. CAG and CCG PCR 
slippage are also seen, in which multiple reads were mapped against references 
of different lengths as seen in the allele distributions (Figure 4-1). 
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Figure 4-1 Genotyping of the CAG repeat in an HD patient using MiSeq sequencing. The 
number of sequencing reads mapped (y-axis) to the reference sequences associated with a 
different number of CAG repeats (x-axis). Allele length distribution is for one HD patient. 
The normal allele aligned against the 7 CCG repeats and 25 CAG repeats, represented as the 
highest peak. Also, expanded allele reads aligned against the 7 CCG repeats and 43 CAG 
repeats, represented as the second highest peak.  
 
All expanded alleles detected had the typical allele structure: 
(CAG)nCAACAGCCGCCA(CCG)n i.e. no atypical expanded alleles were identified in 
our data from the sequencing of Venezuelan HD patients. Atypical alleles 
structures have been previously detected from sequencing normal HTT alleles 
from unaffected individuals from the Scottish and Venezuelan populations 
(Chapter 3). 
An example of mapped reads for three HD patients shows the CAG repeat at a 
mode of 40, 50 and 74 CAG repeats as shown inFigure 4-2. We used Tablet to 
visualize the read mappings results produced by the MiSeq sequencing (Milne et 
al., 2013). Analysing the mapped reads confirms the presence of the expanded 
CAG alleles and 7 CCG repeats, and that both flanks to the repeats have the 
expected sequence, as no mismatches with the reference sequence were seen. 
These data confirm that it is possible to sequence HD expanded alleles at a 
mode of up to 74 CAG in the presence of normal allele. However, we are unable 
to reveal the 3’-flanking region for long CAG alleles (mode =≥74 repeats). 
Therefore, the reverse read can be used to genotype the CCG repeats and the 
3’-flanking DNA sequence, and to detect any variants in that region and for 
haplotype analysis. 
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Figure 4-2 Mapped reads from the expanded alleles of three individuals with 40, 50 and 74 
CAG repeats using MiSeq sequencing. Each sample reads were aligned against a set of 
reference sequences with (CAG) 1-200 and (CCG) 1-20 using CLC genomics workbench 
software. The CAG repeats, CCG repeats, the intervening sequences and the flanking 
regions are seen in the mapped reads. The intervening sequence is: CAACAGCCGCCA and 
is located between the CAG and CCG repeats. All three different alleles have 7 CCG repeats 
on their chromosomes. Tablet was used to visualise the aligned reads for all the three 
alleles obtained from CLC genomics workbench.  
 
We analysed the CAG allele frequency distribution for all individuals. To capture 
a wide distribution of CAG changes across different repeat lengths, we 
illustrated the read length distributions of HD CAG repeat lengths for six 
individuals with different CAG repeats (Figure 4-3). The mapped reads of HD 
alleles shows multiple reads were mapped against references of different 
lengths. For each allele, the CAG/CCG genotype was defined as the genotype of 
the reference against which the highest number of reads had aligned, which is 
the mode of CAG distribution. Both CAG and CCG repeat sizes were determined 
for all individuals. The read count distribution shows expanded CAG alleles at 
modes of 40, 45, 50, 54, 60 and 72 CAG repeats respectively (Figure 4-3). All the 
expanded alleles aligned to the 7 CCG reference. The highest peak is defined as 
the primary allele, which is expected to be the length allele, transmitted from 
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the affected parent. The aligned reads, which are to the left of the main allele, 
represent repeat unit losses that most likely occur due to backward PCR 
slippage. PCR slippage is biased toward deletion mutation resulting in the 
generation of products smaller than the template molecule (Pearson et al., 
2002). The proportion of those reads becomes greater with increasing allele size, 
i.e. the proportion is higher for 50 CAG repeat than in the 40 CAG repeats as 
shown in Figure 4-3.  
 
Figure 4-3 Allele length distributions for the CAG alleles in six different HD patients 
inheriting 40, 45, 50, 54, 60 and 72 CAG repeats obtained from MiSeq sequencing. 
Percentage of sequencing reads mapped (y-axis) to the reference sequences associated 
with different CAG repeats and 7 CCG reference (x-axis). All expanded alleles aligned to 7 
CCG reference. The CAG genotype is defined as the genotype of the reference against 
which the highest number of reads had aligned. The main peaks for the allele read count 
distribution are 40, 45, 50, 54, 60 and 72 for each individual.  
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The peaks that are to the right of the main allele represent repeat unit gains 
captured by the MiSeq sequencing approach (Figure 4-3). Those reads are likely 
to derive from both forward PCR slippage and somatic instability. We think most 
of these reads are due to somatic instability because it is expansion-biased. As 
somatic mosaicism is allele length dependent and expansion-biased (Kennedy et 
al., 2003; Veitch et al., 2007), it is expected to result in a high proportion of 
reads larger than the progenitor allele in larger alleles. The proportion of those 
reads appears to be higher for larger alleles as shown in Figure 4-3. The repeat 
length distributions revealed the longer alleles had a higher proportion of PCR 
slippage and putative somatic mosaicism compared to the shorter alleles. The 
somatic mosaicism and PCR slippage will be discussed in detail in Chapter 5.  
For the expanded CAG alleles (≤50 repeats), the main alleles are clearly 
recognized. We believe the mode of the CAG distribution is equal to the 
progenitor allele, which is a single length allele, inherited from the affected 
parent. For small expanded alleles (40 to 50 CAGs), the slope of the CAG 
distribution to the right of the main allele is steeper than the slope to the left. 
As the CAG alleles become >50 CAG, the slope to right of the main alleles 
becomes less steep, and for very large alleles (72 CAG), the distribution becomes 
symmetrical. Therefore, the progenitor alleles cannot be clearly identified in 
such alleles, due to PCR slippage and potentially somatic mosaicism (see Chapter 
5 for more details about PCR slippage and somatic mosaicism). Therefore, we 
are not able to accurately genotype the expanded alleles with more than 50 CAG 
repeats because the reads associated with alleles longer than the inherited CAG 
repeats will affect the distribution of allele read length. Also because backwards 
slippage, which depends on allele length, may result in reads associated with 
alleles shorter than the inherited CAG repeats being more or less the same as 
the number of reads for the main allele. 
In order to genotype expanded alleles (≤50 repeats), we examined the expected 
distribution of CAG repeats obtained from MiSeq sequencing to attempt to 
define the progenitor allele. The top graph represents the distribution of CAG 
repeats with peaks biased toward deletions (Figure 4-4). This generates a tail of 
products smaller than the starting molecules, and only a few reads from longer 
products as seen at the top distribution on Figure 4-4. This distribution is likely 
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generated by backward PCR slippage generating mostly repeats smaller than the 
starting molecules (green peaks to the left). Repeat slippage is common during 
PCR of repeats sequences and can result in backward slippage events of n-1, n-2, 
n-3, etc. The red peaks to the right of the main allele could be potentially 
somatic mosaicism captured by MiSeq sequencing, as the somatic instability of 
expanded alleles is expansion-biased. Therefore, the genotype of the expanded 
allele represented by this distribution would be the main peak, which 
represented as n (Figure 4-4). 
 
Figure 4-4 CAG repeat distribution in two different expected shapes obtained from MiSeq 
sequencing. The main allele is shown in blue (n), contractions (n-1 to n-10) in green, and 
expansions (n+1 to n+10) in red. 
 
The bottom distribution on Figure 4-4 shows asymmetrical shape for the 
distribution of CAG repeats with many reads shorter and longer than the main 
allele. High levels of both somatic instability and PCR slippage result in this 
shape of the distribution, and no single clear peak is detected. This has been 
seen with very long alleles (>50 CAG) and that allele could be shifted to the right 
or left of the distribution. The peaks to the left of the main allele (n) 
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distribution are most likely generated by PCR slippage, generating products a 
multiple of repeats smaller than the starting molecule. This could shift the main 
allele to the left of the distribution because the longer the template, the more 
backward slippage. Also, peaks to the right of the main allele (n) are probably 
mostly generated due to somatic mosaicism. That could shift the main allele to 
the right of the distribution. Thus, we are not certain if the main allele is shifted 
to the left by slippage on the distribution or to the right by somatic instability, 
or whether the main allele remains as a major peak in the middle of the 
distribution, which is the mode. Although it remains unclear how to define the 
inherited progenitor allele, we decided to identify it for alleles with more than 
50 CAG repeat also by the mode of the distribution.  
4.2.3 CAG distribution in expanded HD alleles  
We assessed CAG repeat length in the 409 affected individuals of HD families of 
the Venezuelan cohort (Figure 4-5). The CAG repeat size on expanded HD 
chromosomes ranged from 40 to 74 CAG repeats (mean = 45.56± 0.2 and median 
= 45), and the normal chromosomes from these patients ranged between 10 and 
39 CAG repeats (mean = 21.2 and median = 18) (our results from Chapter 3). The 
most frequent alleles were with 45 (15.3%), 44 (11.5%) and 42 (11.5%) CAG 
repeats (Figure 4-5).  
The distribution of the CAG repeats in HD patients revealed that the repeat 
range between 40 to 50 repeats was most common (382 alleles, 91.4%), with 
alleles greater than 50 CAG repeats being much less frequent (36 alleles, 8.6%). 
One 74 repeat allele was found which was the highest CAG repeat size in our 
study.  
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Figure 4-5 Distribution of expanded CAG alleles of the Huntington disease (HD) gene in 418 
chromosomes from 409 HD patients of the Venezuelan population from MiSeq sequencing. 
The range of 40 and above CAG repeats is defined as a full penetrant range. The CAG repeat 
size on the expanded alleles ranged between 40 and 74 CAG repeats, with 45 CAG repeats 
being the most frequent. 
 
Nine individuals (2.2%) were homozygous for the expanded alleles, having alleles 
containing 40 CAG repeats or more on both chromosomes. Previous studies on HD 
showed homozygosity rarely occurred and it ranged from 0.1 to 0.4%, which is 
lower than our obtained result (Kremer et al., 1994; Alonso et al., 2002). Of 
these, three of CAG homozygous individuals were homozygous for exactly the 
same number of CAG and CCG repeats. All three individuals were homozygous 
for 7 CCG repeats, and one of them has 44 CAG repeats, one has 45 CAG repeats 
and the last one has 48 CAG repeats. Therefore, those individuals may be truly 
homozygous because they had one of the most frequent alleles in the mutant 
range, although we cannot rule out the failure of amplifying the second allele. 
The remaining six individuals were homozygous for 7 CCG repeats and different 
CAG repeats in the mutant range, these individuals carrying CAG repeat numbers 
of 42/46, 44/47, 45/47, 47/49, 40/50 and 50/53 as their genotypes on both 
chromosomes. Those individuals are true homozygotes, as two expanded alleles 
were detected in our data. Because most of these CAG repeats are the most 
frequent, we are confident that the homozygous individuals are true 
homozygotes. Therefore, the CAG repeat distribution was obtained for 418 
chromosomes from 409 HD patients. 
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4.2.4 Comparison between genotyping CAG repeats by MiSeq 
sequencing and fragment length analysis 
To further investigate allelic variability in genotyping CAG repeats, we have now 
sequenced and genotyped the HTT repeat in 742 (333 unaffected (our result 
from Chapter 3) and 409 affected) individuals from the Venezuelan cohort. 
Among the 742 unaffected and affected individuals, 707 had also been 
genotyped for the number of CAG repeats by fragment length analysis from 
buccal samples. This was performed previously in the Lab, by Dr. Nicola Veitch 
(unpublished data). This allowed a direct comparison to be made between the 
numbers of CAG repeats estimated by MiSeq sequencing and by fragment length 
analysis for those individuals. 
 
Figure 4-6 The correlation between CAG repeat number obtained by MiSeq sequencing and 
fragment length analysis for buccal DNA samples for 707 individuals (1,414 alleles).Blue 
circles represent the estimated CAG repeat by MiSeq sequencing compared to the number 
of repeats estimated by fragment length analysis that had been generated and measured 
previously Dr. Nicola Veitch. These alleles are from unaffected and affected individuals. 
 
To compare the numbers of CAG repeats estimated by MiSeq sequencing and by 
fragment length analysis for buccal samples, we plotted the number of CAG 
repeats obtained by MiSeq sequencing and fragment length analysis for buccal 
samples for each individual (Figure 4-6).  
Our results showed high similarity in determining the number of CAG repeats 
between MiSeq sequencing data and fragment length analysis for buccal samples 
(r2=0.986) (Figure 4-6). The remaining variation (2%) is explained by differences 
  Chapter 4, 99 
 
in estimation of CAG repeats by one or two repeats by fragment length analysis 
compared to MiSeq data. However, there are four alleles in the plot that are 
estimated to be expanded alleles from the fragment length analysis results and 
to be normal alleles from our MiSeq data (Figure 4-6). These outliers are 
overestimated of the number of CAG repeats by many repeats by fragment 
length analysis in comparison to MiSeq data. This could happen as result of 
human error in the laboratory such as labeling errors or swapped samples. 
Also, the differences in our data compared to the fragment length method could 
be due to the presence of atypical allele structures within normal alleles that 
sometimes cannot be amplified using the PCR method. This can cause inaccurate 
determination of the number of CAG repeats. For the atypical alleles, it is likely 
that the intervening primer used for PCR genotyping method misprimes at more 
than one location, leading to an ambiguous length profile. Another explanation 
of the variation in estimation of expanded alleles in these two methods is that 
genotyping of large alleles is compromised by a high level of instability that 
might be hard to detect using fragment length analysis.  
Fragment length analysis approaches may fail to identify atypical sequence 
variants or flanking sequence differences, and may result in inaccurate 
genotyping of expanded alleles due to the high level of instability. However, 
using NGS sequencing approach by MiSeq alleles has a high-throughput 
genotyping of CAG repeats, and has the potential to detect insertions, deletions 
or other sequence variants within or flanking the repeat. 
4.2.5 Analysis of CCG repeats in expanded HD alleles.  
The size of CCG repeats in the HTT gene and the frequency of each allele were 
analysed in HD chromosomes. One CCG allele was identified from sequencing 
and genotyping HD alleles of the HD patients. CCG 7 is the only detected CCG 
allele in 409 individuals. In contrast, we found different CCG alleles from 
genotyping the normal HTT chromosomes in the Scottish and Venezuelan 
populations (Chapter 3). The CCG alleles in the normal chromosomes from these 
patients were 6, 7, 9, 10 and 11 CCG repeats (Chapter 3). Analysis of CCG 
repeats haplotypes revealed that the expanded alleles presented only one 
haplotype with the 7 CCG allele.  
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4.2.6 The correlation between the CAG repeats on the normal and 
expanded alleles 
We tested whether subjects with expanded CAG repeat lengths had a different 
range of normal CAG repeat length. We analysed the relationship of the number 
of CAG repeats between the normal and mutant alleles (40 to 53 CAG repeats) 
from heterozygous HD patients in the Venezuelan population (Table 4-1). We 
excluded the homozygous cases in this analysis as they have expanded alleles on 
both chromosomes. CAG repeats of greater than 53 CAG repeats were not 
included in the analysis, as they are less frequent alleles, therefore we can not 
detect the association between these alleles.  
 
Table 4-1 The expanded allele associated with the normal allele for each individual from 
heterozygous HD patients from Venezuela. 
 
There was no obvious correlation between the range of normal allele sizes and 
the expanded allele (Table 4-1). The mean and median were determined for 
each normal CAG repeat range for HD patients carrying each expanded CAG 
repeat. The mean and median of normal alleles were similar for all expanded 
alleles from 40 to 53 CAG repeats. Figure 4-7 shows the CAG repeat size in the 
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normal and expanded HD alleles for all heterozygous HD patients of the 
Venezuelan population. There were no clear differences for the normal allele 
ranges associated with each expanded CAG allele. 
 
Figure 4-7 The normal and expanded alleles sizes in 400 heterozygous HD subjects from the 
Venezuelan population. The expanded alleles represented in red squares and the normal 
alleles represented in blue circles. Expanded allele ranged between 40 to 74 CAG repeats 
and the normal allele ranged between 10-39 CAG repeats.  
 
4.2.7 CAG repeat length in the mutant HD allele and sex 
We had assessed the effect of sex on the mutant CAG repeat sizes of affected 
individuals (Figure 4-8). Among 409 individuals, 173 were males, 225 were 
females and the remaining individuals (11) were of unknown sex from the 
Venezuelan population. The analysis includes 398 individuals of known sex. The 
CAG repeat size was from 40 to 68 in male patients (mean= 45.4, median =45) 
and 40 to 74 CAG repeats in female patients (mean = 45.7, median = 45). We 
found the CAG repeat size was not correlated with the sex of the patients since 
the mean and median of CAG repeats for both sexes were similar even though 
the expanded CAG repeat range was larger for female patients (Figure 4-8). Our 
results demonstrated no difference in the CAG repeat size between sexes.  
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Figure 4-8 The CAG repeat size effect for the sex of 398 affected individuals from the 
Venezuelan population. The expanded CAG size ranged from 40 to 68 in male patients and 
from 40 to 74 in female patients. The CAG repeat size medians are 45 for both sexes and the 
means are 45.40 and 45.67 for male and females, respectively. 
 
4.2.8 CAG repeat length and phenotype 
The expanded CAG repeat is the major modifier of the age at onset in HD. 
Although the dominant inheritance of HD implies that one expanded allele is a 
trigger for the HD pathogenesis (Lee et al., 2012), normal CAG alleles have been 
suggested in few studies, but not all, to modify the onset of the disease (Djoussé 
et al., 2003; Li et al., 2003). We therefore looked at the correlation between 
the phenotype and genotype of HD, particularly on the effect of the length of 
the expanded and normal CAG repeats.  
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Figure 4-9 The relationship between the age at disease onset is shown for both the normal 
and expanded CAG alleles in 169 Venezuelan HD patients. The graph on the left shows no 
correlation between the normal CAG alleles and age at onset in HD patients (r2=0.004, 
P=0.394). The graph on the right shows the inverse correlation between the expanded CAG 
alleles and age at onset (r2=0.587, P < 0.001). This graph shows exponential regression lines 
fitted to the age at onset and the expanded CAG repeat length in HD. 
 
We analysed 169 patients with HD with known age of disease onset. The 
relationship between age at onset and the CAG repeat size in HD alleles in 
Venezuelan affected subjects is shown in Figure 4-9. The age of onset of these 
HD subjects ranges from 8 to 60 years (median =34.5). This result showed that 
CAG repeat size is the main determinant of age at onset in HD patients, 
accounting for 58.7% of the variation in age at onset in the non-linear regression 
correlation. As expected, there was an inverse correlation between the age at 
onset of symptoms and the number of CAG repeats. An exponential regression 
model yielded adjusted R-squared values of 0.587 for the correlation between 
CAG repeats and age at onset, indicating that there are factors other than the 
expanded CAG allele length that modifies age at onset and disease pathogenesis 
in HD. The wide range of onset ages associated with any given repeat length 
points also to the possible influence of other genetic or environmental factors. 
Therefore, this variation in age at onset precludes an accurate estimate of when 
the disease will manifest for any single individual. 
We also tested whether the normal CAG alleles had an effect on the age of 
disease onset in HD patients. Our results showed no significant effect of the 
normal CAG allele on age at onset (r2=0.004, P=0.394) (Figure 4-9). Thus, our 
finding indicates the expanded CAG allele length is the most important factor in 
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modifying age at onset of HD and that normal CAG allele length does not play a 
significant role in the pathogenic process of the disease onset.  
4.2.8.1 Phenotype-Genotype correlation of homozygous HD and also the 
effect of sex 
We identified 9 homozygous individuals, indicating a CAG repeat expansion on 
both alleles, as mentioned earlier. Homozygosity has not been reported to 
influence the age at onset compared with heterozygosity, but there was an 
impact of HD homozygosity on disease progression and severity (Alonso et al., 
2002; Squitieri et al., 2003). 
 
Figure 4-10 The relationship between age at onset in 169 individuals with HD and expanded 
CAG alleles in homozygous and heterozygous cases and also the effect of sex. The graph 
on the left shows the longer expanded alleles for HD cases with homozygous individuals 
(with 2 expanded alleles >40 CAG repeats) as red triangles and heterozygous individuals as 
black circles. The exponential regression lines fitted to the age at onset and CAG repeat 
length for the heterozygous individuals (r2= 0.589, P<0.001) and for the homozygous 
individuals: the linear regression fitted to the age at onset and CAG repeat length (r2= 0.626, 
P= 0.061). The graph on the right shows the exponential regression between the CAG repeat 
length and age at onset with adjusted R squared 0.502 and 0.636 for males and females 
respectively. The blue squares represent males and red circles represent female HD 
patients. 
 
We compared the homozygous subjects’ age at onset, as the only clinical feature 
available for our data, with 163 heterozygous cases. The age at onset was not 
determined for some of the homozygous cases. Therefore, 6 individuals were 
included in the study for whom we have the clinical age at onset. For the 
homozygous individuals, we plotted the longer CAG allele length against the age 
at onset. We found the correlation between the CAG repeat and age of disease 
onset in the heterozygotes cases (r2=0.589, P<0.001) for an exponential 
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regression model. A linear regression fitted the correlation between the CAG 
repeat and age at onset for the homozygous individuals, giving an adjusted r2 of 
0.626 and P value of 0.061, which is a marginally significant relation. The mean 
distribution of age at onset was different for heterozygous and homozygous 
individuals (34.83 and 27.83 respectively). Student’s t-test was used to compare 
mean age at onset between the homozygous and heterozygous individuals (using 
SPSS). The result shows a significant difference between the mean age at onset 
between homozygous and heterozygous individuals (t-test, t=1.908, P= 0.029). 
Also, to evaluate the relationship between the age at onset, and the inherited 
allele length for the homozygous and heterozygous individuals, we used a linear 
regression model using SPSS statistics software (IBM). We found that the 
homo/heterozygous cases were significantly correlated with age at onset 
(P=0.039) (model 1, Table 4-2). Also, the t-test result was significant between 
the mean age at onset for homozygous and heterozygous cases. Thus, our result 
determined the homozygous individuals have an earlier age at onset and 
subsequently they are more severely affected than heterozygous individuals. 
 
Table 4-2 Regression model of the relationship between the age at onset, and the inherited 
allele length for the homozygous and heterozygous cases in 169 individuals and also for the 
relationship between the age at onset and the inherited allele length for male and female 
cases. Allele length, homo/heterozygous cases and sex of the patients were used as 
independent variables in the regression models using SPSS statistics software (IBM). The 
table shows the adjusted squared coefficient of correlation (adjusted r2) and statistical 
significance (P), the coefficient, standard error, t-statistic and statistical significance (P) 
associated with each parameter in each model. 
 
The graph in Figure 4-10 illustrates the correlation between the expanded CAG 
repeats and age at onset between sexes for HD individuals; including 105 
females and 64 males. There were many previous studies investigating the 
difference in age at onset of HD between sexes in different populations 
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(Telenius et al., 1993; Kremer et al., 1995). We sought to examine this 
correlation in our data for the Venezuelan population. The correlation between 
the age at onset and expanded CAG repeats in male was r2=0.502 and 0.636 
among female. There was a slight difference in the correlation between male 
and female. However, the mean distribution of age at onset was similar for male 
and female (34.23 and 35.07 respectively). The mean age at onset was not 
significantly different between male and female (t-test, t= 0.583, P=0.28). 
Therefore, our result revealed no sex effect for the age at onset in HD patients. 
We also investigated the sex-dependent effect of the relationship between age 
at onset and inherited allele length using a linear regression model. These 
analyses revealed a non-significant difference (P =0.212) between males and 
females in a phenotype-genotype correlation (model 2, Table 4-2). From these 
two models, we can establish that the age at onset is dependent on the allele 
length and there were differences in the phenotype-genotype correlation 
between homozygotes and heterozygotes individuals. However, there were no 
differences in the phenotype-genotype correlation in patients of either sex. 
4.3 Discussion  
In this chapter, we described genotyping of the expanded CAG repeat in HD by 
next generation sequencing as a new sequence based approach. We have 
established that it was possible to sequence and genotype normal HD CAG 
alleles, including the polymorphic CCG repeats and the flanking sequences, using 
the MiSeq platform by amplifying the region using locus-specific primers 
combined with MiSeq sequencing adapters (Chapter 3). We have expanded this 
to show we are also able to genotype the expanded CAG allele including the 
polymorphic CCG repeats and the flanking sequences using MiSeq platform. 
Using this approach we sequenced 409 buccal swab DNAs from the US-
Venezuelan Collaborative Research Project consisting of affected individuals 
from HD families from Venezuela. The libraries were produced using the MiSeq 
compatible PCR primers with the locus-specific primers using protocols 
previously optimised (Chapter 3). Those libraries were sequenced using a 
standard 2x300 bp run or 400/200 bp parameters in both forward and reverse 
directions. During the library preparation, each individual was associated with a 
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unique barcode combination included in the sequencing adapters incorporated in 
the PCR primers. The sequencing reads obtained were then mapped with CLC 
Genomics Workbench to reference sequences including various numbers of CAG 
and CCG repeats (1 to 200 CAG repeats and 1 to 20 CCG repeats) and the region 
flanking the repeats. 
These data have revealed accurate genotypes for the expanded CAG repeat and 
flanking regions for most individuals. Good quality sequencing reads were 
obtained for both the normal and the expanded allele for each individual. HTT 
CAG/CCG genotypes were obtained for 409 affected individuals from the 
Venezuelan population. From this data, we were able to sequence CAG repeats 
up to 74 repeats with the presence of the normal alleles for most of the 
samples. However, we noticed that we were unable to reveal the 3’-flanking 
region from the mapped reads for patients with 74 CAG repeats. Thus, the 
reverse read can be used to genotype the CCG repeat and the 3’-flanking DNA 
sequence to detect any variants in that region and for the haplotype analysis. 
Sequencing longer alleles can be done by genotyping the CAG repeats from the 
forward strand and the CCG repeats from the reverse strand because we cannot 
match or merge the reads in the middle of the repeats. We also investigated the 
utility of reverse reads and that these can be used to improve the efficiency of 
genotyping the CCG repeat and the 3’-flanking DNA sequence. 
We analysed the distribution of the expanded CAG allele across different CAG 
repeats. The read length distribution for MiSeq sequencing was used in the 
analysis to examine the wide distribution of CAG changes across different repeat 
lengths. We have shown in this chapter the CAG read length distributions for 6 
individuals, with expanded CAG alleles at modes of 40, 45, 50, 54, 62 and 74 
repeat. The data revealed the repeat length distribution is more variable for the 
longer alleles compared than the shorter alleles. Overall, longer alleles had a 
higher proportion of (n-1 and n+1) reads that are shorter and larger than the 
main peaks when compared to shorter repeat length alleles. It was noticeable 
that the progenitor alleles of CAG repeats (>50 CAG) have progenitor alleles that 
cannot be clearly identified due to PCR slippage and potentially somatic 
mosaicism (see Chapter 5 for more details about PCR slippage and somatic 
mosaicism). Thus, we are not confident about the genotypes of the expanded 
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alleles with more than 50 CAG repeats. The read length distributions of those 
alleles were associated with alleles longer than the inherited CAG repeats which 
affects the distribution of allele reads. Although it remains unclear how to 
define the inherited progenitor allele for larger alleles with more than 50 CAG 
repeats, we decided to identify the progenitor allele as the mode of the CAG 
repeat distribution. 
Accurate determination of CAG repeat length is critical in genetic counselling for 
affected individuals, as it makes a difference in predicting the average age at 
onset. Also, determining the CAG repeat size accurately can allow us to 
differentiate whether that individual is in the affected range, low penetrance, 
or not at risk for HD. 
The CAG size distribution of these HD patients’ chromosomes ranges from 40 to 
74 CAG repeats. The most frequent alleles had 45 repeats. The CAG repeat 
range between 40 to 50 repeats was most common, comprising 91.4% of the total 
alleles, with alleles greater than 50 CAG repeats being less frequent (8.6%). The 
distribution of CAG repeats among HD cases did not differ significantly from 
previously published data with the same population (The U.S.–Venezuela 
Collaborative Research Project and Wexler, 2004). The number of CAG repeats 
in HD samples ranged from 40 to 86 repeats in 956 affected individuals from the 
Venezuelan population, with 44 CAG repeats being the most frequent (The U.S.–
Venezuela Collaborative Research Project and Wexler, 2004). Expansions 
between 40 to 50 repeats were most common, representing 90% of the expanded 
alleles. This is similar to our findings.  
Comparing our obtained results from genotyping CAG repeats from MiSeq 
sequencing and fragment length analysis genotypes for the same samples showed 
there were similarities between both methods (r2=0.986). However, the slight 
differences could be due to a failure of fragment length analysis in identifying 
atypical sequence variants, flanking sequence differences, inaccurate 
genotyping of expanded alleles due to a high level of instability or human error. 
Therefore, an NGS sequencing approach using MiSeq allows a high-throughput 
genotyping of CAG repeats and has the potential to detect insertions, deletions 
or other sequence variants within or flanking the repeat. 
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All expanded alleles were associated with 7 CCG repeats in the Venezuelan 
population, which reveals the CCG repeat is stably transmitted. The lack of 
variation in CCG repeats supports a possible common source of mutation in 
Venezuela due to a founder effect inheriting 7 CCG repeats on the expanded 
alleles. In contrast, the study of the CCG repeats in other ethnic populations, 
revealed each ethnic population shows a predominance of certain CCG alleles 
that can vary between 6 to 12 CCG repeats, with CCG 7 and 10 being the most 
frequent. For example, in Japanese and Chinese populations, the expanded 
alleles were associated with 10 CCG repeats (Morovvati et al., 2008). The CAG 
repeat number in Chinese normal allele was higher in 10 CCG than in 7 CCG 
alleles. In contrast, the expanded alleles in the Western population were 
associated with 7 CCG, although the 10 CCG was present in some pathogenic 
chromosomes (Barron et al., 1994; Squitieri et al., 1994; Costa et al., 2006). 
This suggested that their mutations originated from a different origin. The 
differences in CCG alleles in different populations could be related to the 
differences between populations, in which other modifiers and the haplotype 
may be involved in the expanded chromosomes. 
All detected expanded HD alleles retained the expected structure of CAG and 
CCG repeat: (CAG)n CAACAGCCGCCA(CCG)n . Our analysis revealed no atypical 
alleles identified from sequencing of Venezuelan HD patients. In contrast, 
analysis of normal HTT alleles from unaffected individuals from the Scottish and 
Venezuelan populations revealed atypical allele haplotypes in the normal alleles 
(Chapter 3). Also, some atypical expanded alleles have been detected 
previously. These atypical alleles differ structurally mainly within the 
intervening sequence, but also can differ in the number of CCT repeats present 
downstream of the CCG repeats. The expanded alleles sequenced here were 
associated with typical haplotype could be due to a founder effect in the 
Venezuelan population of Lake Maracaibo, so the mutation has a common ethnic 
descent with HD families.  
In HD, we have seen atypical normal alleles (Chapter 3) and no atypical 
expanded alleles. Dr. Marc Ciosi has seen mutant atypical alleles, but they are 
already described in normal alleles (unpublished data). This suggests the 
atypical expanded alleles in HD arise from the general population. However, 
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there were no atypical alleles in the general population for DM1 and the atypical 
alleles, interrupted with variant repeats, seen in DM1 affected families (Braida 
et al., 2010). Thus, the atypical expanded alleles in DM1 may arise from de novo 
mutations in DM1 patients. 
We analysed the relationship of the number of CAG repeats between the normal 
and mutant alleles. There was no correlation between the normal allele length 
and the expanded CAG allele. The mean and median of normal alleles were 
slightly similar for all expanded alleles from 40 to 53 CAG repeats. Thus, our 
findings showed the length of the CAG repeat on the normal allele does not 
influence the expanded CAG alleles.  
Also, we investigated the effect of sex on mutant CAG repeat sizes of affected 
individuals from the Venezuelan population. There is a slight difference in the 
correlation test between male and female. However, the mean and median of 
CAG repeat were similar for male and female. We did not observe any 
differences in correlation between the CAG repeat size and the sex of the 
patients, even though the expanded CAG repeat range was larger for female 
patients. Our result obtained similar mean and median of CAG repeats for both 
sexes, even though the expanded CAG repeat range was larger for female 
patients. Our results demonstrated no difference in the CAG repeat size 
between sexes. 
We analysed the relationship between the number of CAG repeats within the 
normal and mutant alleles and the age at onset for 169 patients with clinically 
known age at onset. Within these patients, the number of CAG repeats of the 
normal allele was found uncorrelated to the age of disease onset. However, we 
demonstrated an inverse correlation between the expanded CAG allele length 
and age at onset of HD. The regression model showed that 69% of the variation 
of the age at onset was accounted for by the number of CAG repeats of the 
expanded alleles. Our analysis confirmed there was no evidence that normal 
allele length modifies the age at HD onset, and that rather length of the 
expanded allele is the major factor in modifying the age at onset in HD. The 
remaining variation in age at onset could be generated by other genetic or 
environmental factors. 
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Furthermore, we analysed the association of CAG repeat length of homozygous 
and heterozygous patients as well as the different sexes effect on age at onset. 
We found there were no differences in the genotype-phenotype relationship in 
patients of either sex. Interestingly, our results demonstrated the homozygous 
cases have an influence on age of disease onset. These homozygous individuals 
have an earlier age at onset than heterozygous individuals. Therefore, the 
homozygosity for HD is expected to result in a more severe phenotype and rapid 
disease progression.  
This finding is different to previously published studies on the effect of 
homozygosity on age at disease onset. An earlier study reported a similar age at 
onset for homozygous and heterozygous individuals, but homozygotes had a more 
severe phenotype of HD (Squitieri et al., 2003). These different findings could be 
because this study was conducted on a small number of HD patients (eight 
homozygotes and 75 heterozygotes). In addition, it may be difficult to determine 
the accurate age at onset in HD due to an overlap of cognitive, motor and 
psychiatric symptoms in the early stages of HD. Our data suggest that 
homozygous individuals have an earlier age at onset of disease than 
heterozygotes. 
We noticed that the frequency of homozygotes (2.2%) for HD is higher in the 
Venezuelan family compared to previous studies in Caucasian populations. 
Previous studies on HD showed homozygosity rarely occurred, and it ranged from 
0.1 to 0.4%, which is lower than our obtained result (Kremer et al., 1994; Alonso 
et al., 2002). This is most likely because of the high frequency of the HD 
mutation in the Venezuelan cohort. In addition, studies in other polyglutamine 
expansion disorders, such as the spinocerebellar ataxias (SCA3 and SCA6) and 
dentaterubro-pallidoluysian atrophy (DRPLA) have reported a more severe 
phenotype in homozygotes than in heterozygotes, with an unknown reason for 
these differences (Gusella and MacDonald, 2000). 
Patients with homozygous HD mutations are an important aspect for genetic 
counselling, given the fact that all their offspring will inherit the HD mutation 
and will be affected by the disease, unless a contraction of the CAG repeat tract 
occurs, which is highly unlikely. Therefore, additional counselling is very 
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important, as it is essential for the patients to know about the increased risk of 
transmitting the mutation to their offspring.  
Our results indicate the expanded CAG allele length is the primary determinant 
of age at onset and the repeat length is inversely correlated with age at onset. 
We also observed that one unit of CAG repeat increase causes a decrease in age 
at onset of approximately 2 years. This is similar to the previously published 
data (Goldberg et al., 1993; Gusella and MacDonald, 2009). The broad range of 
age at onset associated with each expanded allele size could be due to other 
genetic or environmental modifying factors. The importance of defining these 
factors is that they may be targets for delaying the onset of disease and slowing 
the progression in HD patients. Moreover, the identification of CAG repeat 
length is not a certain predictor of onset age, due to variation in age at onset for 
each CAG repeat size.  
In summary, in addition to genotyping HTT alleles by NGS technology, our 
studies in the phenotype-genotype emphasize the importance of the expanded 




  113 
 
 
Chapter 5 Somatic mosaicism of expanded CAG 
repeats in HD patients of the Venezuelan cohort: 
a modifier of disease severity 
5.1 Introduction 
The length of the expanded HD alleles in the germ-line is unstable through 
intergenerational transmission, with a major bias toward an increase in size in 
paternal transmission (Duyao et al., 1993; Snell et al., 1993; Goldberg et al., 
1995; Falush et al., 2000). This causes the anticipation phenomenon, where the 
age of onset decreases and the severity of the disease increases in successive 
generations (Nahhas et al., 2005). Most juvenile HD cases are reported in 
patients with paternal inheritance, which is characterized by inheritance of very 
large CAG repeats and early age at onset.  
A number of studies have shown that there is a variation in repeat size within 
and between tissues of affected individuals with a higher level of somatic 
instability observed in affected brain regions relative to cerebellum and blood in 
HD patients (Telenius et al. 1994; De Rooij et al. 1995). The sensitive small pool 
PCR (SP-PCR) technique has been used to analyse the mutation length profile 
from different brain regions in HD cases (Kennedy et al., 2003). Brain samples 
from two individuals with Vonsattel grade 0, which means no neuropathological 
changes were identified in the striatum (Vonsattel et al., 1985), were examined. 
According to the Vonsattel grading system HD autopsy brains were classified into 
five grades (0 to 4) according to neuropathological severity. Each grade reflects 
the extent of neuronal loss by macroscopic and microscopic examination of the 
striatum. These two individuals are likely to be pre-symptomatic, as they both 
died (~ 6 and 13 years) earlier than the expected age at onset of neurologic 
symptoms. The mutation length profiles showed differences in mutational 
instability in each specific brain region and mutation length changes were 
expansion-biased. Interestingly, the greatest instability was observed in these 
two individuals brains in the region most affected in HD patients, the striatum. 
The same pattern was also seen in a knock-in mouse model (where expanded 
CAG repeats were inserted into the mouse Htt locus) in which a higher mutation 
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level was observed in striatum compared to cortex and cerebellum (Kennedy and 
Shelbourne, 2000). These somatic expansions are also quite remarkable in their 
size in HD patients. Striatal cells may acquire expansions that exceed several 
hundred or even a thousand repeats in length, which reflects up to a 20 times 
length increase in comparison to the allele size inherited from the affected 
parent (Kennedy et al., 2003). These data have shown that allele length 
expansion in the striatum, the most affected brain region; occurs prior to the HD 
pathogenesis and before the onset of symptoms.  
Interestingly, although such very large expansions were observed in these 
individuals with no detectable pathology, there is significant neuropathology 
seen in individuals with end-stage HD disease (Kennedy et al., 2003). Brain 
samples were examined by SP-PCR for an end-stage HD patient who died 10 
years after disease onset. Although there was no formal nueropathological 
grading of this sample according to the Vonsattel’s HD grading system, there was 
notable striatal atrophy and cell death in the autopsy brain specimen. A high 
level of mutation instability was present in the cortex, but not in the striatum, 
which is expected to exhibit the largest level of instability. This observation 
suggests that the cells with the largest repeat expansions in the striatum might 
be lost during the disease process. In this study, the evaluation of somatic 
mosaicism from a small number of samples makes it difficult to draw clear 
conclusions about the differences in mutation length changes in each HD disease 
stage, given that the greatest expansions are associated with specific target 
tissues, and this somatic instability occurs prior to the HD pathogenesis. These 
findings have led to the hypothesis that the somatic instability of the CAG repeat 
may contribute to the tissue-specific pathology and the progressive nature of the 
disease. 
The report by Kenndey et al., 2003 was very interesting showing there were long 
expansions in striatal tissue; however those analyses were based on bulk DNA, 
and it was not clear whether those large expansions were observed in the 
neurons or in the supporting glial cells. In order to address that question, 
Shelbourne et al. 2007 used laser capture microdissection to selectively choose 
either neurons or glial cells based on cell surface markers and assess the repeat 
lengths in those specific cell types (Shelbourne et al., 2007). They were able to 
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show that indeed repeat length expansions were greater in neurons than they 
were in glial cells from two affected individuals with advanced stage disease. 
These findings are very important and show that repeat length expansions are 
able to accumulate in non-dividing cells and the repeat lengths are greater in 
neurons. This is consistent with the hypothesis that neurons die because they 
have bigger repeats. Laser capture microdissection studies on mutation length 
also show that striatal neurons tend to have the longest expansion compared to 
those from cortex in two individuals with early-stage disease. This finding is 
consistent with the idea that CAG repeat lengths in striatal neurons increase 
early during the disease process. This evidence supports the hypothesis that 
somatic increases of repeat length might contribute to cell type differences in 
vulnerability in HD. Their findings also demonstrated that somatic instability 
might influence disease progression. 
To determine the association between somatic instability in HD patients and 
variation in the age of disease onset in HD, SP-PCR was used to quantify the CAG 
repeats at the single molecule level in cortex samples from postmortem brain 
(Swami et al., 2009). Selecting the cortex over the striatum in this study to 
measure somatic instability in HD was because the striatum is more vulnerable 
to damage and subject to neuronal loss in HD, thus cannot be easily examined in 
autopsy brain (Kennedy et al., 2003). The study involved an analysis of 48 
patient cortex brain regions, with 24 cases of extreme early onset and 24 with 
extreme late-onset (Swami et al., 2009). Those patients developed symptoms at 
either an earlier or later age than expected age at onset relative to the number 
of repeats inherited. They observed the level of somatic instability of CAG 
repeat varies between all individual’s cortex samples, with a significant bias 
towards expansions. As expected, a greater degree of somatic mosaicism in HD 
brain was found in individuals with longer CAG repeat length.  
To test whether there was an association between variation in age at onset and 
somatic instability, the magnitude and frequency of CAG repeat expansions for 
the cortex samples were determined for the extreme early and extreme late 
onset groups (Swami et al., 2009). The results showed there were no differences 
in the mean CAG expansion, the total expansion frequency, or the frequency of 
expansion of at least 10 CAGs between the groups. However, they noted that the 
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largest expansions were found in individuals with extreme early onset. To 
evaluate if the greater somatic expansions were associated with earlier disease 
onset, they measured skewness from the distribution of mutant CAG alleles in 
the cortex. Skewness is a measurement of the symmetry of the distribution of 
expanded CAG repeat lengths. The overall distributions of repeat length changes 
were skewed to the right, as most repeat length changes were expansions. Thus, 
samples that exhibit greater somatic expansion would show greater positive 
skewness than those with smaller somatic expansions. The result showed a 
negative correlation between residual variation in age at onset and skewness. 
This evidence showed that somatic mosaicism of the mutant allele in the brain is 
significantly associated with age of disease onset after accounting for the effect 
of CAG repeat length. These data thus support the hypothesis that somatic 
instability contributes to the pathogenic process, with higher somatic instability 
directly linked to disease progression and earlier age at onset.  
Although detailed studies have been carried out on somatic mosaicism in the 
affected brain regions, it is difficult to further determine the possible 
contribution of somatic instability to disease age at onset and the nature of HD 
pathogenesis in human autopsy brain material. Brain tissues cannot be evaluated 
until death, and it is difficult to analyse the most affected tissues because many 
cells have already been lost during the disease process. Obviously, brain samples 
cannot be obtained from living HD individuals at the time of disease onset. 
Therefore, other tissues that allow us to test a larger number of samples in 
living individuals are preferable to use for measuring somatic instability. 
Few studies on human peripheral tissues have been carried out to study HD 
instability. It has been previously reported the blood DNA showed a relatively 
low level of somatic mosaicism (Telenius et al., 1994; Leeflang et al., 1995). 
Although buccal cell DNA showed a low level of repeat length variation and small 
allele length changes in affected individuals, somatic mosaicism is measurable in 
buccal cell DNA (Veitch et al., 2007). A study of the somatic instability of HD 
was carried out in buccal cell swabs from HD patients from Venezuela collected 
by The US-Venezuela Collaborative Research Project team. First, they 
determined the level of somatic mosaicism using SP-PCR within 20 individuals, 
who had inherited CAG repeat lengths between 40 and 66 repeats. These data 
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showed the level of somatic mosaicism is low in most cases in buccal cells, 
except in the very longest HD alleles (~75 CAG repeats), which have a higher 
level of somatic instability. Given that most affected individuals inherit the 
classic range of HD (40 to 50 CAG repeats) and a relatively small number of HD 
patients (16%) inherit long alleles (Gusella and MacDonald, 2000), by using SP-
PCR and agarose gel-based methods we cannot quantify somatic instability in the 
majority of cases with HD. Therefore, a sensitive single molecule PCR assay was 
established to investigate mutation length changes in buccal swab cells, which 
allows for accurate sizing of a single repeat difference in a polyacrylamide gel 
(Veitch et al., 2007). Samples from 12 patients who were all 39 years old at the 
time of sampling, but with variable CAG repeats (39 to 48 repeats), were 
examined. Individuals were matched for age at sampling to ensure the effects of 
age did not confound the association between somatic instability and allele 
length. For each individual, a DNA sample was diluted 50 times to produce an 
average of 0.5 molecules of the template in 10 µl reaction and the sample was 
amplified by PCR. After that, PCR products were resolved by agarose gel 
electrophoresis to detect the presence of expanded alleles. This step was 
necessary as agarose gel electrophoresis is more cost-effective than 
polyacrylamide gel electrophoresis. The analyses of the polyacrylamide gel 
electrophoresis use fluorescently labelled primers to visualise the DNA in the gel 
and automated DNA sequencing machine that makes the procedure more 
expensive, time-consuming and requires special facilities and makes this 
protocol impractical for most laboratories. Then, the size of the expanded 
alleles was precisely determined by using either the ABI polyacrylamide gel or 
capillary electrophoresis automated sequencing system. The somatic mutation 
frequencies detected were generally low in buccal cells, but with a varying 
degree of mutation between individuals. Although the level of somatic 
mosaicism is low in buccal cells and patients may acquire very large expansions 
in brain tissues, this data confirmed that the inherited allele length is the major 
modifier of somatic instability and accounts for ~70% of the variation observed in 
individuals with identical age at sampling. Using single-molecule PCR is 
sensitive, but is impractical and labour intensive for high throughput analysis in 
a large cohort of patients. To overcome the limitation of previous methods, a 
novel method should be developed to facilitate high throughput analysis of 
somatic instability. 
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Studies on HD strongly implicate somatic instability in disease pathogenesis and 
the tissue specificity of the disease. Thus, understanding the mechanisms and 
role of genetic instability remains an important subject in HD research and may 
provide a potential route to therapy. Previously (in Chapters three and four), it 
was demonstrated that using high throughput next generation sequencing (NGS), 
we were able to derive accurate somatic genotypes of normal and expanded 
alleles in addition to the repeat structures from buccal DNA samples. The aim of 
the current chapter therefore, was to quantify somatic mosaicism of the CAG 
repeats in HD directly from NGS read length distributions. We hypothesise that 
the main drivers for somatic mosaicism are repeat length and age and that 
individual-specific residual variation for both effects will also be associated with 
disease severity. In this chapter, we will address the issues associated with NGS 
technology as an approach to quantify somatic mosaicism of the CAG repeat in 
HD. Thus, we sought to measure the degree of somatic variation in buccal cell 
DNA of large numbers of HD patients by quantifying the effects of allele length 
and age at sampling in generating somatic mosaicism, and to test whether 
somatic mosaicism contributes to disease severity. 
5.2 Results 
5.2.1 Suitable statistical measures for quantifying somatic 
mosaicism and the role of allele length and age in defining 
instability. 
In order to determine the utility of an NGS based approach in being able to 
define somatic mosaicism, we used MiSeq sequencing data from all individuals as 
described in the previous chapters. HTT alleles were amplified from each 
individual from buccal swab DNAs from the US-Venezuelan Collaborative 
Research Project. DNA samples were successfully genotyped using PCR 
amplification with MiSeq adapter primers that flank the CAG·CTG repeat tract of 
the HTT locus, followed by sequencing the products using the Illumina MiSeq 
platform. Those reads were aligned to custom references to reveal read length 
distributions from each individual from which we were able to determine the 
genotype in terms of numbers of CAG repeats for both normal and expanded 
alleles (Chapter 3 and 4). We also determined the presence or absence of 
atypical structures in HTT alleles. Most samples were successfully genotyped by 
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MiSeq sequencing. All affected individuals with expanded alleles had pure CAG 
repeats and were present on the typical allele structure with CCG 7 repeats. 
To evaluate the instability of the HTT CAG repeat, we first analysed our very 
large dataset from the Venezuelan cohort comprising 740 individuals (439 
unaffected and 301 affected) to examine both normal and expanded CAG 
repeats (Figure 5-1). The large numbers of samples available for analysis allowed 
us to capture the effect of different CAG repeat lengths on repeat instability. 
This analysis included all samples with CAG repeats in the normal range, 
excluding any samples for individuals who have atypical HTT allele structures 
because they don’t match exactly the reference which can modify the allele 
length distribution. We also excluded any individual with two HTT alleles that 
were less than 6 repeats apart, as read length distributions from the two alleles 
overlap and therefore we cannot unambiguously assign reads to either allele. 
 
Figure 5-1 Distribution of CAG repeats of 740 HTT alleles.The distribution is shown for the 
number of CAG repeats observed on HTT normal and expanded alleles ranging from 10 to 
50 repeats in unaffected and affected individuals. 
 
Also, individuals for whom we did not have details about age at sampling were 
removed from the subsequent analysis, as well as any samples that have a low 
number of reads. We excluded samples with the low number of reads because of 
problems, with random sampling errors incorrectly addressing the amount of 
somatic mosaicism and slippage, and because of potential confounding effects of 
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background that either result from contamination or primer barcode swapping 
effects. Alleles with more than 50 CAG repeats were also removed from further 
analysis as the progenitor allele cannot be clearly identified in such alleles due 
to PCR slippage and potentially somatic mosaicism. 
The data used for the expanded allele measurement (40 to 50 CAG repeats) 
corresponds to most (90%) of the HD MiSeq data collected for expanded alleles. 
In order to analyse the data and evaluate the read length distribution for each 
sample, Alastair Maxwell, who is a bioinformatician working on a Cure 
Huntington’s Disease Initiative (CHDI) project, designed a Python script that 
arranges all sample output files in one file that centralises the reads to the 
progenitor allele peak. This makes measuring somatic mosaicism much easier, 
allowing us to examine the reads around the progenitor alleles in one file.  
5.2.1.1  CAG repeat length effects on the magnitude of repeat changes  
We analysed the wide distribution of CAG length changes on the magnitude of 
expansion and contraction across different CAG repeats. Read length 
distributions of HTT CAG repeat lengths are shown in Figure 5-2 for six 
individuals, five with the normal CAG range (10, 15, 20, 25 and 31 CAG repeats) 
and one with a CAG repeat expansion (40 CAG repeats). The mapped reads of 
HTT alleles showed multiple reads were mapped against references of different 
lengths. The main peak is the most common allele, represented as (n) in blue, 
which is the number of reads corresponding to the highest peak of an allele read 
count distribution: 10, 15, 20, 25, 31 and 40 CAG for the HTT allele (Figure 5-2). 
This peak is defined as the progenitor allele length, i.e. the single allele 
transmitted from the affected parent.  
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Figure 5-2 Qualitative assessment of CAG allele length distributions in 6 different 
individuals who have different CAG repeats (10,15, 20, 25, 31 and 40 CAG repeats).The 
proportion of allele length was quantified from the MiSeq sequencing read distribution, the 
inherited allele length (blue), contractions (green), and expansions (red). 
 
Green peaks (n-1 to n-10 peaks), which are to the left of the main allele, 
represent repeat unit losses that most likely occur due to backward PCR 
slippage. The PCR slippage is biased toward deletion and results in generating 
products smaller than the starting molecules (Pearson et al., 2002). 
The n-1 reads are relatively low for small alleles within the normal size. For 
larger alleles (40 CAG repeats), the proportions of n-1 reads are greater than in 
normal alleles as seen in Figure 5-2. The degree of n-1 reads appears to 
correlate strongly with the CAG repeats length. The red peaks to the right of the 
main allele (n+1 to n+10) are the number of reads corresponding to additional 
CAG repeat gains, and peaks larger than (n) are likely to be somatic variants 
captured by MiSeq sequencing approach (Figure 5-2). As somatic mosaicism is 
allele length dependent and expansion-biased, it is expected to result in a 
higher proportion of reads larger than the progenitor allele in larger alleles. 
Indeed, the proportion of reads (n+1) appears to be higher for larger alleles as 
shown in Figure 5-2. The individual with 40 CAG repeats has a higher proportion 
of reads in n+1 peak than the individuals with the normal size of CAG repeats. 
Overall, the repeat length distributions revealed that longer progenitor repeat 
had a higher proportion of n-1 and n+1 reads compared to shorter repeat 
lengths.  
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5.2.1.2 Repeat length dependent PCR slippage.  
In order to identify the determinants of the proportion of reads shorter than n, 
we calculated the proportion of (n-1) reads relative to the number of reads for 
the main allele. There was a very strong correlation (r2= 0.978, P < 0.001) 
between (n-1) reads and inherited allele length (Figure 5-3). Therefore, the 
proportion of (n-1) reads is dependent on allele length, and ~ 98% of the 
variation is accounted by allele length. This is consistent with the number of (n-
1) reads being driven largely by PCR slippage. We would also expect that somatic 
instability would be highly age-dependent. Although it is possible that age-
dependent somatic mosaicism contributes toward the remaining 2% of the 
unexplained variability, it is clear that most of the n-1 read variation is highly 
repeat length-dependent, which is consistent with it being primarily driven by 
PCR slippage. 
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Figure 5-3 The relationship between the degree of repeat length variation and inherited 
repeat length in 740 alleles including normal and expanded alleles ranging from 10 to 50 
CAG repeats. The scatter plot on the top display the proportion of n-1 reads relative to the 
main allele in green dots. The lines fitted to the scatter plot reveals a strong correlation 
(r2=0.978, P <0.001) between the n-1 reads and inherited allele length. The scatter plot on the 
bottom displays the n+1 reads relative to the main allele in red dots. The lines fitted to the 
scatter plot reveal an exponential association (r2=0.942, P < 0.001) between the n+1 reads 
and inherited allele lengths. The degree of repeat length variation was measured from MiSeq 
read count distribution (see Chapter 3 and 4).  
 
Then, the frequency of (n+1) reads compared to the inherited allele reads was 
tested in the same way as the (n-1) reads (Figure 5-3). The read length 
distributions were examined to test whether there is any evidence of somatic 
mosaicism. As expected, there was a significant correlation between the (n+1) 
reads and inherited allele length. However, the shape of the distribution was 
very different from the distribution of n-1 reads. Although allele length is a 
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major determinant, the shape is clearly different in these two distributions. This 
shape is obviously not linear, and if fitted with a simple linear regression model, 
the correlation coefficient was relatively lower (r2 = 0.52). Analysis of a range of 
curve estimation regression models revealed an exponential association (r2 =0. 
942, P < 0.001) was found to best describe the relationship between allele 
length and n+1 reads for the overall distribution than a single line across the 
entire CAG repeat sizes. We noticed the slope of the curve correlating CAG 
repeats length over 40 repeats with n+1 reads is steeper in this range than in the 
normal range. Therefore, we considered whether a two-segment regression 
response could improve the correlation and produce a better fit for the data. 
To fit the two response models at each CAG repeat length range, we split the 
data into two groups at the point of 40 CAG repeats as shown in Figure 5-4. This 
allows more meaningful comparisons to be made between two regression models 
within the different CAG repeat ranges. We plotted the CAG repeat length for 
the normal and expanded alleles against the n+1 reads for each individual.  
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 Figure 5-4 The relationship between n+1 reads and the inherited CAG repeat in the normal 
allele range and mutant range. The scatter plot on the top displays the proportion of n+1 
reads relative to the main allele in the normal allele length range. The two lines fitted to the 
scatter plot reveal a linear regression (r2=0.663, P <0.001) and an exponential regression 
(r2=0.644, P  <0.001) between the n+1 reads and inherited allele lengths. The scatter plot on 
the bottom displays the proportion of n+1 reads to the main allele in mutant CAG range. The 
lines fitted to the scatter plot to reveal a linear association (r2=0.646, P < 0.001) between the 
n+1 reads and expanded CAG repeats.  
 
For the data in the range of normal alleles, the distribution of n+1 reads fits 
linear regression (r2= 0.664, P <0.001) with inherited allele length ( Figure 5-4). 
Exponential association analysis of the data showed a slightly lower correlation 
coefficient (r2= 0. 644, P <0.001), therefore the linear correlation fits the data 
better. The distribution of n+1 reads for expanded alleles displayed a good fit to 
a linear association (r2= 0.646, P <0.001) ( Figure 5-4). The remaining variation in 
n+1 reads of affected HD allele range that is not explained by the repeat length 
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is possibly age-dependent somatic instability. The level of variation in the n+1/n 
reads was obviously greater in the expanded alleles than in the normal alleles. 
Clearly, there are two responses between n+1 reads and CAG repeat size. Also, 
there is a clear division in the data from the linear curve in the normal range to 
linear regression fit to the mutant range. These data allowed us to assess the 
allele length distribution and relate these to the inherited allele length using 
NGS read distribution.  
5.2.1.3 Age-dependent somatic instability in HD individuals  
Having established the repeat length is the major determinant of read length 
variability and showing that people with the same CAG repeat appear to have a 
different degree in variation in n-1 and n+1 reads, factors other than HD CAG 
repeat size may influence instability. Thus we tested whether the residual 
variation of CAG repeat is influenced by age at the time of sampling. Therefore, 
we sought to determine the effect of age at sampling on the relative frequency 
of allele length changes that have a specific CAG repeat length of both normal 
and mutant alleles.  
The wide range of CAG repeats sizes in our dataset allowed us to perform an 
analysis of the effect of age at sampling on the variation of repeat instability in 
specific CAG repeats. This dataset is composed of n-1/n, and n+1/n reads for all 
individuals inheriting one of four different repeat sizes of CAG repeats in the 
normal range (15,17, 18 and 20 CAG repeats) and one of four different repeat 
sizes in the mutant range (41, 43, 46 and 48 CAG repeats). These CAG repeats 
were selected because they are associated with the most frequent alleles.  
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Figure 5-5 The correlation between n-1/n reads and age at sampling for four normal and four 
expanded alleles. A. The correlation between the proportion of n-1 reads relative to the main 
allele for CAG repeat numbers in the normal range: 15, 17, 18 and 20; 15 CAG repeats (r2 = 
0.013, P = 0.743), 17 CAG repeats (r2 =  0.024,  P  =  0.05), 18 CAG repeats (r2 = 0.013, P = 
0.231) and 20 CAG repeats (r2 = 0.022, P = 0.532). B. The correlation between the proportion 
of n-1 reads to the main allele for four CAG repeat numbers in the affected range: 41, 43, 46 
and 48 CAG repeats; 41 CAGs (r2 = 0.026, P = 0.491), 43 CAG repeat (r2 = 0.021, P = 0.607) 46 
CAG repeat (r2 = 0.039, P = 0.191), and 48 CAG repeat (r2 = 0.012, P = 0.406).  
 
In this dataset, there was no relationship between age at sampling and n-1/n 
reads for normal repeats 15 CAG repeats (r2 = 0.013, P = 0.743), 17 CAG repeats 
(r2 = 0.022, P = 0.05), 18 CAG repeats (r2 = 0.013, P = 0.231) and 20 CAG repeats 
(r2 = 0.022, P = 0.532)(Figure 5-5). P-values were non significant for all CAG 
repeats expect for 17 CAG repeat which was marginally significant. Probably this 
would be non significant after performing a correction for multiple testing. 
There is no evidence of any age effect; therefore there is no effect of somatic 
instability.  
Also, there was no correlation between n-1/n reads and age at sampling in the 
expanded allele ranges, 41 CAGs (r2 = 0.026, P = 0.491), 43 CAG repeats (r2 = 
0.021, P = 0.607), 46 CAG repeats (r2 = 0.020, P = 0.191), and 48 CAG repeats (r2 
= 0.012, P = 0.406)(Figure 5-5). However, P-values were not significant for any of 
the expanded alleles. Age at sampling did not significantly alter the frequency of 
the n-1 reads. These data showed a higher level of n-1 reads with larger CAG 
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repeats, that is most likely explained by PCR slippage and not by age-dependent 
somatic mosaicism. These data further suggest n-1 reads are most likely driven 
by backward PCR slippage, as it is allele length dependent and not age-
dependent. 
  
Figure 5-6 The correlation between n+1/n reads and age at sampling for the normal and 
expanded CAG repeats. A. The correlation between the proportion of n+1 reads relative to 
the main allele for four CAG repeat numbers in the normal range: 15, 17, 18 and 20: 15 CAG 
repeats (r2= 0.011, P= 0.667), 17 CAG repeats (r2= 0.001, P= 0.291), 18 CAG repeats (r2= 0.095, 
P = 0.032) and 20 CAG repeats (r2= 0.043, P = 0.145). B. The correlation between the 
proportion of n+1 reads relative to the main allele for four CAG repeat numbers in the 
affected range: 41, 43, 46 and 48 CAG repeats: 41 CAG (r2= 0.698, P <0.001), 43 CAG repeats 
(r2= 0.822, P <0.001) 46 CAG repeats (r2= 0.739, P <0.001), and 48 CAG repeats (r2= 0.751, P 
<0.001). 
 
There was no correlation between the proportion of n+1/n reads and age at 
sampling for alleles in the range 15 to 20 CAG repeats (Figure 5-6). Analysing the 
normal alleles showed no significant effect of age at sampling on the repeat 
length changes for 15, 17 and 20 CAG repeats: 15 CAG repeats (r2 = 0.011, P = 
0.667), 17 CAG repeats (r2 = 0.001, P = 0.291) and 20 CAG repeats (r2= 0.043, P = 
0.145). For 18 CAG repeats (r2= 0.095, P = 0.032) there was a significant 
correlation with age that might not show any significant P-value if we do 
multiple testing corrections. Overall, the CAG repeat in the normal range 
showed no consistent changes with age.  
As expected, there was a significant correlation between the (n+1)/n reads and 
age at sampling with mutant alleles (Figure 5-6): 41 CAGs (r2 = 0.698, P <0.001), 
43 CAG repeats (r2 = 0.822, P <0.001), 46 CAG repeats (r2 = 0.739, P <0.001), and 
48 CAG repeats (r2 = 0.751, P <0.001). Older patients had more expansions for 
any particular repeat number, and the slope was much steeper with larger 
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alleles. These data are not consistent with PCR slippage and suggest a high 
proportion of the n+1 reads are mediated by allele length and age-dependent 
somatic mosaicism. These findings support the view that age plays a major role 
in determining HD CAG instability that is quantified by n+1 reads.  
5.2.1.4 A model to quantify somatic instability in expanded CAG repeats  
We have generated clear evidence that n+ measurement for alleles over 40 
repeats likely contains a measure of somatic instability. We are aiming to 
develop a somatic instability quantification method that is applicable to high 
throughput assays and also, to gain insight into factors that influence the level 
of somatic mosaicism in buccal DNA of HD patients and relate these to disease 
severity. The total data set comprised 301 individuals, of which two are 
homozygous, and 299 are heterozygous, who have a CAG allele more than 40 
repeats.  
In the previous section (5.2.1.2), we quantified putative somatic mosaicism from 
MiSeq read count distribution using the ratio n+1/n, where n is the number of 
reads corresponding to the highest peak of an allele read count distribution and 
n+1 is the number of reads corresponding to one additional CAG repeat gain 
larger than n. This proportion of reads may oversimplify the somatic instability 
measure for these sequenced reads larger than n, as reads of n+2, n+3, n+4, 
etc., are also present in some distributions.  
 
Table 5-1 Measurement of somatic mosaicism in MiSeq data from expanded alleles. (n) is 
the number of reads corresponding to the highest peak of an allele read count distribution 
obtained from MiSeq sequencing. 
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To define appropriate measures for quantifying somatic instability in HD MiSeq 
data, we have investigated four measures (Table 5-1). We have correlated the 
proportion of reads larger than n against allele length. By quantifying the 
proportion of these reads, we can test whether there is any evidence that it may 
be reflecting somatic mosaicism. Table 5-1 illustrates the instability indices used 
for quantifying somatic mosaicism. First, the instability index was calculated by 
dividing the number of reads for one read larger than the progenitor allele by 
the number of reads of the progenitor allele, which is presented as n+1 divided 
by n. This has been selected because most expansions are seen in the n+1 peak. 
Then, the second instability index was derived by dividing the sum of the reads 
from n+1 to n+5 by the number of reads for the progenitor allele that is 
presented as n+5/n. These reads were included in the instability index as some 
samples have reads observed with those peaks that may be reflecting higher 
levels of somatic mosaicism. Likewise, n+10/n was chosen as an instability index 
because some samples have reads in this range. Reads for n+10 was chosen as 
the higher boundary of the interval because it includes 99.9% of the sequenced 
reads longer than inherited allele. The last index selected is n+10 where the 
peak heights were multiplied by the changes from the progenitor allele. This 
instability index yields an average gain per read that gives more weight to large 
expansions as they likely result from multiple events rather than a single event. 
We then attempted to determine whether the different possible somatic 
instability measures might be considered as an indication of somatic mosaicism. 
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Table 5-2 Regression model of the relationship between somatic mosaicism (SM), and the 
inherited allele length and age at sampling (AS) using SPSS statistics software (IBM). The 
table shows the adjusted squared coefficient of correlation (adjusted r2) and statistical 
significance (P) associated with each model by testing four different somatic mosaicism 
measure (SM measure) as described in Table 5-1. n=number of reads aligned for the main 
HD allele, primers are HD primers used in amplifying the HD allele and run is the MiSeq run 
in which samples were sequenced using the MiSeq platform.  
 
To assess the utility of these measures, we performed a series of statistical 
analyses (Table 5-2). We first evaluated the relationship of allele length to 
somatic mosaicism measures using linear regression models. Using a simple 
linear regression model, we found that CAG repeat length is correlated with 
somatic mosaicism and accounts for ~50 to 60% of the variation in somatic 
instability among somatic instability measures (Table 5-2, model 1). From this 
model, we can establish that CAG repeat length is the major determinant of 
somatic instability in HD (r2=0.52 to 0.64). Previously a similar analysis using 
single molecule PCR on a small subset of Venezuelan samples revealed that the 
inherited allele length explained approximately 70% of the variation in somatic 
mosaicism (Veitch et al., 2007). This is higher than observed in our study. 
However, all individuals in that study were selected with the same age, which is 
different from our study that includes individuals with variable age at sampling. 
Nonetheless, the degree of somatic variation was different for individuals with 
the same inherited allele length, suggesting that factors other than HD repeat 
size contribute to the somatic mosaicism. Given that the measure of somatic 
instability is likely to change through the individual’s lifetime (Kennedy et al., 
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2003), we then tested this hypothesis using regression analysis. As expected, age 
at sampling was correlated with somatic instability (r2= ~ 0.15) (Table 5-2, 
model 2). Therefore, a more complicated model may be required to elucidate 
the factors involved in somatic variation that includes the allele length and age 
at sampling. 
We also evaluated additional models that include both variables. Thus, we 
tested a model with both allele length and age at sampling effects on somatic 
instability measures (Table 5-2, model 3), as well as another model for these 
two factors and their interaction (model 4). Both models showed an 
improvement in explaining the variation in somatic instability (Table 5-2, model 
3 and 4, r2= ~ 0.8, P < 0.001) over model 1 and 2. Lastly, we assessed the 
contribution of other factors in addition to allele size, age at sampling and their 
interaction. These factors are the different HD flanking primers used in 
amplifying the HD allele, and the MiSeq run in which the samples were 
sequenced in MiSeq platform. My colleague Marc Ciosi who is working on the 
CHDI project, prepared one of the libraries that includes 92 samples. He used 
the inner primers (31329F/33934) to amplify HD alleles in those samples. The 
rest of the samples were amplified using the intermediate primers (HS 319F-
3395.5), resulting in sequence reads with different length flanking sequences. 
Also, each library has been sequenced on different MiSeq runs, which might 
introduce a variation between libraries, as there are differences in quality and 
the total number of reads generated by different MiSeq runs. Therefore, we 
tested another model with all variables considered above and a primer 
parameter (Table 5-2, model 5) and another model with a possible run effect 
(model 6). Lastly, we assessed a model with the same factors as model 4 and 
both run and primers effects (Table 5-2, model 8). With the addition of the 
primers and run variables into the model, the coefficients and the model did not 
show any improvement over model 4. The primers and runs show minor 
differences, and none of the individual parameters were significant on their 
own. Thus, the primers and run variables did not explain a significant proportion 
of the variation in the somatic mosaicism models. 
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Figure 5-7 Comparison of standardized residual variation of the selected Somatic 
mosaicism model. Scatterplots show the relationship between standardised residuals of the 
selected model for each measure. The somatic mosaicism measures were explained in 
Table 5-1. The selected model is model 4 that is described in Table 5-2. 
 
To confirm all the parameter effects, stepwise linear regression was performed 
in SPSS software for model selection. This step is essential in order to remove 
the weakest correlated variable and to identify the most relevant descriptive 
variables for somatic instability among all the models considered. The selected 
model was model 4 that will be used in further analysis (Table 5-2, model 4). In 
each case, the run and primers effects were excluded from the models, as they 
were not significant.  
To gain some idea whether these different somatic measures were assessing the 
same information, we quantified the residual variation for all individuals for 
each of the four measures of somatic mosaicism under model 4. The 
standardized residuals were used for pairwise comparisons between the 
measures (Figure 5-7). The four measures contain very similar information about 
quantifying somatic instability as shown by the significant correlations between 
the standardised residuals of the somatic instability model for these measures 
(Figure 5-7). Those residuals were similar, but not exactly the same with r2 of 
0.85 between measures 1 and 2 and r2 of 0.84 between measure 1 and 3 (Figure 
5-7). In contrast, the correlation between measure 1 and 4 was lower (r2= 0.63) 
than the correlation between measure 1 and measures 2 and 3. The low 
correlation between measures 1 and 4 could be results of increased noise in one 
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of the measures. Alternatively, measure 4 might be revealing some other aspect 
of somatic mosaicism that is more related to the frequency of larger expansions. 
We cannot distinguish between these two possibilities in measure 4. However, 
we expect that allele length and age at sampling to be the primary driver of 
somatic mosaicism. Therefore, it is likely that any measure of somatic mosaicism 
should be well explained by those two variables. By considering at the overall 
adjusted r2 for the same model that incorporate allele length, age and the 
interaction, we realised that the measure 1 has the most of it’s variation 
explained using that model r2 of 0.9 whereas measure 4 has r2 of 0.8. Although 
we cannot completely exclude the idea that a different biological feature is 
being revealed in measure 4, it seems more likely that measure 4 is 
incorporating a greater degree of noise than present in measure 1. Measures 2 
and 3 were related to slightly less variation in somatic instability that is 
explained by age, and allele length with all models than measure 1 and also 
their residual variation was highly significant with the n+1 measure. In addition, 
measure 4 was associated with a low variation in somatic instability for all 
models, and it’s residual variation compared with measure 1 was low. This 
suggests all four measures are measuring something very similar, and the n+1/n 
had the highest r2 value, so was chosen as the most useful model. Among the 
four measures, measure (1), which is the proportion of n+1 divided by n, was 
strongly correlated with the other three measures and associated with the 
highest adjusted r2. The measure 1 will be used for subsequent phenotypic 
analysis. Table 5-3 shows the regression analysis model summary for the selected 
model and measure of the relationship between somatic instability, inherited 
allele size and age at sampling (r2= 0.903, P < 0.001). The model accounted for 
90% of the variation in somatic mosaicism and was a highly significant model. 
This model was fitted to measure somatic mosaicism from HD affected 
individuals who inherited CAG repeats between 40 and 50. The model showed 
the changes in somatic instability increased as a function of repeat length and 
time of sampling and their interaction. 
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Table 5-3 The selected model for somatic mosaicism measure showing the relationship 
between somatic mosaicism (SM), and the inherited allele length and age at sampling (Age 
S) using SPSS statistics software (IBM).The table shows the adjusted squared coefficient of 
correlation and statistical significance (P), the coefficient, standard error, t-statistic and 
statistical significance (P) associated with each parameter in the model. 
 
5.2.2 Genotype and phenotype correlation 
CAG repeats number is the primary determinant of age at onset of HD. However, 
wide ranges of ages of onset are observed for individuals with identical inherited 
CAG repeat numbers. A strong inverse correlation exists between the CAG repeat 
size and age at onset for motor signs in HD. The CAG repeat length contributes 
to approximately 70% of the variability in age at onset, indicating that modifying 
factors other than CAG repeat are likely to be involved in determining the age of 
onset (Wexler et al, 2004). Analysis of the Venezuelan kindred estimates ~40% of 
this variability in age at onset is attributable to genetic factors other than the 
HD gene, and ~60% is environmental factors (Wexler et al, 2004). We 
hypothesised that part of that variation in age at onset is mediated by somatic 
instability. 
5.2.2.1 Variation in age at onset  
In order to examine the correlation between age at onset of symptoms and the 
inherited CAG repeat length in the HD patients of the Venezuelan cohort, the 
CAG repeat length in the HD gene was plotted against age at onset for 137 HD 
patients (Figure 5-8). This sample includes all individuals that were heterozygous 
for an HD mutation and for whom we have a clinical age at onset and repeat 
length data. There was a statistically significant negative correlation between 
the CAG repeat size and age of disease onset in HD patients (r2 =0.46, P < 0.001). 
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Figure 5-8 The relationship between CAG repeats and Age at onset in 137 HD patients who 
have CAG repeats between 40 and 50.The straight line shows the regression line for all HD 
patients using a linear model (r2= 0.462, P- value < 0.001). This data revealed that the 
inherited CAG repeats are a major modifier of the disease onset and severity in HD patients. 
 
Three different methodological approaches have been used previously to 
investigate the correlation between CAG repeat size and age of disease onset. 
Some studies used linear regression to assess the correlation between the two 
variables. The second type was to estimate the correlation between CAG and the 
natural logarithm of age at onset, as an exponential relationship was noticed in 
the data. In a dataset with a wide range of alleles from 40 to 110 CAG repeats, 
an exponential model was shown to fit the data better than a linear model 
(Andresen et al., 2007). The third approach was to assess the correlation 
between the natural logarithm of both age at onset and the CAG repeat (The 
U.S.–Venezuela Collaborative Research Project and Wexler, 2004). We therefore 
tested three models for each different method used in previous studies for the 
age at onset and allele length (Table 5-4). Both models (2 and 3) showed no 
improvement in explaining the variation in age at onset, despite the logarithmic 
transformation of the variables. We found that the correlation coefficient 
between the two variables was slightly higher using linear regression (r2 =0.46, P 
< 0.001) (model 1,Table 5-4) compared to the logarithm of the age at onset and 
logarithms of both CAG repeat and age of onset. Examination of the relationship 
between CAG repeats and age at onset showed the data might have non-linear 
components. Therefore, we also tested both quadratic and exponential models 
of the CAG repeats. There was no additional variation explained with these 
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models (quadratic, adjusted r2=0.46, P < 0.001, exponential, adjusted r2=0.45, P 
< 0.001), we therefore assumed the linear regression provides the best fit for 
the data among the three models. 
 
Table 5-4 Regression model between age at onset (Ao) and allele length.The table shows the 
adjusted squared coefficient of correlation and statistical significance (P), the coefficient, 
standard error, t-statistic and statistical significance (P) associated with allele length in 
each model. 
 
We also evaluated whether analysis of subjects with an exclusion of the data 
outliers might provide a better correlation to age at onset variation. We also 
considered excluding individuals who inherited alleles of 40 and 41 repeat 
because very few individuals have those CAG repeat and they appeared to be 
outliers. Thus, we tested a model with exclusion of outliers as well as removing 
these outliers and CAG repeats from 41 to 42 CAG repeats and separate analysis 
of those individuals excluded from the model (Table 5-4, model 4 and 5). We 
obtained a statistically significant result with an increase of the correlation 
coefficient r2=0.552, r2=0.558 for model 4 and 5 respectively. Both models 
showed an improvement in explaining the variation in age at onset over model 1, 
but they are not widely different from model 1. Therefore, the last model in 
which we exclude the outliers and individuals who inherit 40 and 41 CAG repeat, 
didn’t explain additional variation compared to model 4. Therefore, the selected 
model for the linear regression analyses between CAG repeat and age at onset 
was model 4, which will be used in the further analysis for 135 individuals. 
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Thus, our results revealed that the inherited allele length is an important 
determinant of disease severity in HD, accounting for 55% of the variation in age 
at onset in the linear regression correlation. The remaining variation (45%) of 
the age of onset must be explained by factors other than the inherited CAG 
repeat number. This is especially true for individuals with identical repeat 
lengths showing wide variability in age at onset. For example, individuals with 
44 CAG repeats exhibit age at onset between 30 to 50 years of age. The wide 
range span in age at onset suggests the extensive variation in onset age is not 
explained by CAG repeat size alone. Also, it is clear the correlation coefficient 
for the association between age at onset and allele length in our model is lower 
than in a previous study. Andresen et al. have analysed the inherited allele 
length in the range from 40 to 110 CAG repeats in 443 Venezuelan patients, 
which accounts for approximately 70% of the variation in age at onset (Andresen 
et al., 2007). The narrow repeat length range in our data and relatively low 
number of samples could explain the obtained different correlation coefficient 
from previous studies since the coefficient tends to be higher for tests measuring 
a wide range of data. 
5.2.3 Does the level of somatic instability contribute to the age of 
HD disease onset? 
In HD patients, inherited CAG repeat length is the major determinant of disease 
severity. Clearly, longer CAG repeats cause more severe HD in humans. Longer 
alleles lead to a greater level of somatic mosaicism that is biased toward 
expansions. Therefore, it is logical to assume that somatic instability contributes 
to the pathogenic process of the disease. Individuals in whom the repeats 
expand more rapidly than average for a particular CAG repeat number would 
have an earlier age of onset than expected and vice versa. We thus expect there 
is an inverse correlation in residual variation in age at onset that is independent 
of the effect of the repeat size and residual variation somatic instability, which 
is independent of the effect of age at sampling and the repeat size. In order to 
investigate the age-dependence of somatic instability, we used simple linear 
regression of residual variation in age of onset (model 1, Table 5-4) and residual 
variation of somatic instability (model 4, Table 5-2) in the 135 individuals. 
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Figure 5-9 The relationship between the residual variation in age at onset and residual 
variation in somatic instability. The graph shows the relationship between standardized 
residual variation in age at onset not accounted for CAG repeats (model 1,Table 5-4), and 
standardized residual variation in somatic instability not accounted forage at sampling and 
CAG repeats (model 4, Table 5-2) in 137 HD patients. Linear regression shows a negative 
correlation (r2= 0.04) but it is not significant (P = 0.47). 
 
Our analysis did not provide direct evidence or support the correlation between 
the residual variation of both age at onset of HD and somatic instability (r2= 
0.001, P = 0.47) (Figure 5-9). This non-significant association between age at 
onset and somatic instability was not expected, as we assumed that the somatic 
instability accounted for some of the variation in HD age at onset and the repeat 
expands more rapidly for individuals who have an earlier age at onset.  
5.3 Discussion  
The expanded CAG repeat at the HD locus is unstable, which means it can 
mutate through germline transmission and also within individual tissues. The 
repeat is somatically unstable in a process that is tissue-specific, age-dependent 
and expansion-biased (Kennedy et al., 2003). It has been shown that in HD, 
there is a noticeable correlation between the tissues vulnerable to 
neuropathology and those exhibiting a great level of somatic instability of the 
repeats. This observation has led to the hypothesis that somatic instability 
contributes to HD pathogenesis and progression.  
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The somatic instability has been investigated by bulk PCR amplification and 
subsequent Genescan analysis of PCR products. This does not provide a full 
presentation of the repeat sizes, or reflect the dynamic nature of CAG repeat 
instability in the HD patients. Although earlier studies using single molecule PCR 
analysis showed success in precisely estimating the repeat size and somatic 
instability, this approach is impractical and labour intensive for high throughput 
analysis in a large cohort of patients. To overcome the limitations of using 
previous approaches in evaluating somatic instability, we thus used high 
throughput NGS to quantify somatic mosaicism of the CAG repeats in HD directly 
from NGS read length distributions. Our hypothesis was that the main drivers for 
somatic mosaicism are repeat length and age, and that individual-specific 
residual variation for both effects is also associated with disease severity.  
In this study, we have analysed the pattern of somatic instability in buccal cell 
DNAs from unaffected and affected individuals from the Venezuelan kindred. 
This was done in order to investigate the role of various factors in somatic 
instability and to test whether somatic mosaicism contributed to disease 
severity. Our data highlighted the importance of factors such as CAG repeat 
length and age at sampling. We described the detailed pattern of read length 
distributions in the normal and expanded alleles from unaffected and affected 
individuals. 
We also analysed the wide distribution of CAG length changes across different 
CAG repeat numbers. The read distribution of n-1 and n+1 reads were used in 
the analysis, to examine the role of CAG repeat number in the repeat changes. 
The data revealed that the repeat length distribution was slightly changed in the 
majority of normal alleles, while the longer alleles showed considerable levels of 
changes in the read distribution. Overall, the repeat length distributions 
revealed that longer repeat had a significantly higher proportion of n-1 and n+1 
reads when compared to shorter repeat length. For further analysis of the n-1 
and n+1 reads, we calculated the proportion of n-1 and n+1 reads compared to 
the number of reads for the main allele. These data allowed us to evaluate the 
allele length distributions and relate these to the inherited allele length using 
NGS read distributions.  
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We investigated the effect of age at sampling on the relative frequency of 
repeat length changes on both normal and mutant alleles. To do this, we 
correlated the n-1/n and n+1/n reads against age at sampling for four normal 
and four expanded alleles. These data showed age at sampling has an impact on 
the mutant repeat instability. Overall, there was no significant level of 
instability in the normal alleles, but with mutant alleles, instability was 
observed in all expanded alleles, and an even greater level was observed with 
increasing age. This is consistent with the greater level of somatic mosaicism 
observed in the expanded alleles (Veitch et al., 2007). These data confirmed 
that for expanded CAG alleles somatic instability is age-dependent and 
expansion-biased and the normal alleles are highly stable. These analyses 
revealed clear differences in the patterns of instability between the normal and 
mutant alleles. This analysis suggests the allele length and age are major 
modifiers of somatic mosaicism as expected from previous studies, and that NGS 
approach can be used to quantify somatic mosaicism in HD patients. 
There is strong evidence from our data that n+ measurement for alleles between 
40-50 CAG repeats likely to contain a measure of somatic instability in samples. 
The aim was to develop a somatic instability quantification method that is 
applicable to high throughput assays. Here we show that the somatic expansions 
increase linearly with increasing allele length in human HD patients. These 
analyses revealed that CAG repeat length is a major modifier of somatic 
instability, accounting for 64% of the variation in somatic instability. The data 
show the level of somatic expansion is highly dependent on CAG repeat size. 
Notably, age at sampling alone has a low correlation coefficient with the level of 
somatic instability. The age effect has not explained the variation in somatic 
instability measure; this most likely occurs from age at sampling bias in HD 
patients in which individuals with larger alleles tend to be sampled at a much 
younger age, and individuals with shorter alleles tend to be sampled at an older 
age. Nonetheless, age was confirmed as a major factor in determining the level 
of somatic instability by using multivariate analyses that confirm the interaction 
between age at sampling and allele length. The variation in somatic instability 
was explained by CAG repeat length and age at sampling, explaining 90% of the 
variation. 
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For somatic mosaicism, each expanded allele contains molecules of different 
lengths and each may have a different value of the estimated inherited allele 
(n). Amplified PCR slippage molecules will generate molecule of n-1, n-2, n-3, 
etc, for each template molecule. The overall profile from a person will consist 
of all profiles added together. For a patient, n-1, n-2, etc. reads for estimated 
(n) will also include n-1, n-2, n-3 reads from other longer expansions generated 
by somatic instability. Therefore, the number of n+1, n+2, n+3, etc. reads for 
the distribution will be underestimated due to backward slippage events. Also, 
the n reads is also underestimated. To date, we have not attempted to correct 
for that effect.  
We also studied the association between age at disease onset and the CAG 
repeat length in the HD patients. Our results indicate there is a significant role 
for expanded CAG repeat length in modifying age at disease onset. This 
association appears to fit with a linear regression model, as there was no 
evidence for improved fit using a non-linear model such as quadratic and 
exponential. These data revealed that allele length explains 55% of the variation 
in age at onset. This suggests that other genetic and environmental factors may 
determine the remaining variation in age of disease onset, and may modify 
disease outcome. Our result has emphasised a significant role of the expanded 
CAG repeat in modifying age at onset, indicating that expanded allele length is 
the initial trigger of HD pathogenesis and the predominant factor determining 
the rate of the processes that lead to disease onset.  
Here, we have estimated the allele length and evaluated repeat dynamics in 
buccal cell DNA using NGS technology. We can confirm buccal DNA can be used 
in a detailed analysis of somatic instability and genotype-phenotype correlation, 
as it is a good source for sizing the CAG repeat and estimating somatic 
instability. Although we are evaluating the somatic instability in peripheral cells, 
it is important to consider the repeat length will be much larger in the affected 
tissues than the periphery. An analysis of DNA from buccal cells is a good source 
to test large numbers of samples from living individuals for measuring somatic 
instability. Nonetheless, somatic instability has been reported to be low in 
buccal cell samples for HD patients using the single molecule PCR approach 
(Veitch et al., 2007). Although somatic mosaicism in buccal cells was very low in 
  Chapter 5, 143 
 
that study, they confirmed the allele length is a major determinant of variation 
in somatic instability. We therefore rationalise the established utility of using 
high throughput approaches to quantify somatic instability and display a great 
understanding of the genotype-phenotype relationship in HD.  
There has been much debate in the field whether age at onset and disease 
severity are influenced by somatic instability. This is a critical question, as the 
answer determines whether the pathogenic effect of expanded alleles can be 
modulated by CAG repeat instability. Therefore, we evaluated the residual 
variation of somatic instability not explained by allele length and age at 
sampling that is likely reflecting the specific mutation rate variation between 
individuals. We expect those individual specific differences will be associated 
with disease severity and the somatic instability will have an influence on age at 
onset. In disagreement with previous observations of repeat instability and age 
at onset of Myotonic dystrophy type 1 (DM1) patients, we did not find any 
evidence that the residual variation in somatic instability is an explanation for 
any portion of the variance in age at disease onset that is not explained by the 
allele length (Morales et al., 2012). The evidence from the DM1 study suggests 
that the residual variation of somatic instability is individual specific and 
heritable as a quantitative trait and that residual variation is associated with 
residual variation in age at onset in DM1 patients. These data revealed the 
somatic instability accounted for some of the variation in age at onset and the 
repeat expands more rapidly for individuals who have an earlier age at onset in 
DM1 patients. However, it is important to note that correlation between residual 
variations of somatic instability and age at onset is relatively low (r2=0.068). 
That implicates the role of individual specific environmental or genetic factors 
as a modifier of the individual-specific differences in the level of somatic 
instability. Furthermore, it has been reported that CAG repeat expansion in 
postmortem DNA is associated with an earlier age of disease onset, suggesting 
that somatic instability is a significant predictor of the age of onset and disease 
progression (Swami et al., 2009). Although the published data implicating 
somatic mosaicism as an important component of the disease pathway are 
compelling and that somatic instability plays a role in age at onset, we could not 
replicate these findings in our study. 
  Chapter 5, 144 
 
This non-significant correlation is supported by the absence of positive 
correlation of age at sampling on somatic instability, or inherited repeat length 
variation on age at onset in this Venezuelan cohort. This could also result from a 
relatively low number of samples in this analysis and the difficulties of precisely 
assigning age at onset to a patient. It is important to consider the measurement 
of somatic instability from the non-target tissue is likely underestimating the 
real repeat dynamics in affected tissues.  
Nonetheless, the great part of the variation in the association between these 
two residual variables is likely explained by unknown environmental and genetic 
factors. The remaining variance has been reported to be heritable indicating the 
presence of genetic modifiers, which may have an effect on the disease onset 
and progression of HD. These genetic factors may play a role in repeat instability 
and could act either in cis or trans. Although cis-acting modifiers can influence 
somatic instability, sequences close the CAG repeat are unlikely to be 
responsible for differences in somatic instability in the Venezuelan kindred, as 
the HD chromosomes derive from the same founder chromosome (The U.S.–
Venezuela Collaborative Research Project and Wexler, 2004). Therefore, it is 
more likely these genetic modifiers act in trans influencing somatic instability in 
these patients. This has been suggested in a previous study with the limited 
number of patients with HD from the Venezuelan cohort (Leeflang et al., 1995). 
Additional studies confirmed the role of trans-acting modifiers in HD CAG repeat 
instability and HD CAG dependent phenotypes in mice (Wheeler et al., 2003; 
Pinto et al., 2013). 
The most obvious candidates for trans-acting modifiers of somatic instability are 
the DNA mismatch repair genes. These modifier genes have been shown to be 
critical in generating somatic repeat expansion in mice. Deficiency of Msh2, 
Mlh1 and Mlh3 mismatch repair genes delay the disease pathology and 
completely suppress the somatic instability (Wheeler et al., 2003; Pinto et al., 
2013). In humans, several analyses have identified DNA repair genes as a likely 
explanation of variable instability and disease onset and progression, such as 
FAN1, MTMR10, RRM2B and PMS2 (GeM-HD Consortium, 2015; Bettencourt et al., 
2016). These modifier genes may modify the level of repeat instability and 
account for variable levels of and disease severity and differences in age at 
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onset between individuals. Such modifier genes would provide potential new 
targets for therapeutic interventions in HD that alter the HD disease in human 
patients delaying disease onset and progression. If somatic expansion contributes 
to disease, then a therapeutic approach could be possible by inhibiting the 
somatic expansion that occurs in the brain during the lifetime. Nevertheless, the 
absolute importance of somatic expansion in disease progression remains 
obscure. Understanding the repeat instability mechanisms in HD patients could 
ultimately provide the possible therapy aimed at preventing CAG repeat 
expansion.  
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Chapter 6 Testing candidate DNA repair genes 
as potential trans-acting modifiers of genetic 
instability in HD 
6.1 Introduction  
It is clear that most of the variation in age at onset is explained by the expanded 
allele size. Even though all HD patients have the same mutation, two individuals 
with identical CAG repeat are unlikely to present with symptoms at exactly the 
same age. The variability in age at onset and disease manifestation has 
suggested the existence of modifier factors, and the search for these factors has 
captured significant attention. These could theoretically be environmental or 
genetic factors.  
The identification of disease-modifying genetic factors from human HD subjects 
can yield clues for therapeutic development aimed at delaying or preventing the 
disease onset. Specific genes, pathways, and processes offer a promise of being 
identified using modern genetic techniques and could permit the development of 
new therapeutic interventions that target these pathways. Nonetheless, 
investigating modifier genes may be limited by naturally occurring genetic 
variation in human populations. Other reasons for seeking to identify these 
modifiers is to permit more informative clinical trials by recruiting a more 
homogeneous patient population and reducing genetic variation between 
individuals. 
The HD-MAPS (Modifiers of Age at onset in Pairs of Sibs) study recruited affected 
sibling pairs and revealed evidence for the heritability of residual variation in 
age at onset (Li et al., 2003). They suggested that 56% of the variation in age at 
onset may be attributable to other genes capable of modifying HD pathogenesis. 
Subsequently, a similar study confirmed in the large HD Venezuelan Kindred that 
approximately 40% of the variability in age at onset after accounting for the 
effect of CAG repeat length was attributable to genetic factors other than the 
HTT gene (The U.S.–Venezuela Collaborative Research Project and Wexler, 
2004).  
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Earlier studies on human genetic modifiers in HD have relied on a genome-wide 
genetic linkage of both sib-pairs and extended families to search for 
chromosomal locations, which are potentially harbouring modifiers (Li et al., 
2003, 2006; Gayán et al., 2008). The genomic regions implicated in these studies 
are large and have not led to identification of specific genes or sequence 
variants responsible for the variability in age at onset. Notably, genome wide 
genetic linkage studies detected multiple loci in distinct population samples. 
Also, some studies attempting to identify these genetic modifiers were small 
candidate gene studies. These studies were all superseded by the one large 
genome-wide association studies (GWAS) of HD modifiers that is an unbiased 
approach to identify naturally occurring genetic variations that modify the 
disease process. This study performed by the Genetic Modifiers of Huntington’s 
Disease (GeM-HD) Consortium, discovered significant modifier associated with 
modification of age at onset of the motor sign (The GeM-HD Consortium, 2015). 
GWAS was carried out on 2,131 individuals of European ancestry who carried 
between 40 and 55 CAG repeats. HD subjects were genotyped with the Illumina 
Omni2.5 array. Analysis of the GWAS data revealed a genome wide significant 
level in one gene on chromosome 8 and one on chromosome 15, with two 
independent signals at the same locus. This study identified new genetic 
modifiers that are located in the FAN1 and MTMR10 regions on chromosome 15 
as well as the RRM2B gene on chromosome 8. In addition, a further interesting 
locus on chromosome 3 is the MLH1 gene. Although this locus did not achieve 
genome wide significance, MLH1 was revealed as a potential modifier. This locus 
is particularly attractive given that MLH1 is known to regulate somatic instability 
of CAG repeats and is a modifier of the phenotype in mouse HD knock-in models 
(Pinto et al., 2013). This study supports MLH1 as a candidate gene that modifies 
HD pathogenesis and implicates DNA mismatch repair as a process of HD 
modification. 
Interestingly, none of the most significant modifier genes in chromosome 15, 8 
or 3 from the GWAS analysis corresponds to any suggested modifier genes or 
linkage regions identified in previous studies in HD subjects (Li et al., 2003, 
2006; Gayán et al., 2008). The discrepancy between GWAS and the Venezuela 
linkage study may be a consequence of genetic heterogeneity, (in which 
mutations at different loci are responsible for the disease phenotype), and 
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therefore different modifier alleles, reflecting the different ethnic background 
in these populations. In addition, the increased sample size in recent GWAS 
delivered a more accurate assessment of the relationship between allele length 
and age at onset, yielding residuals that more accurately account for the effect 
of repeat length on age at onset. 
Furthermore, pathway analyses from GWAS that examined whether variations 
associated with the age at onset cluster in genes with common biological 
function showed that variants in genes involved in DNA repair pathways 
associated with residual variation in age at onset (The GeM-HD Consortium, 
2015). Those genes in the DNA repair pathway were replicated and validated in a 
separate study of HD and polyglutamine spinocerebellar ataxia (SCA) patients 
(Bettencourt et al., 2016). They tested the association of DNA repair genes with 
residual variation in age at onset. The study involved 1,462 patients of HD and 
SCAs type 1, 2, 3, 6, 7 and 17. SNPs were chosen from the most significant SNPs ( 
p < 0.1) selected from the GeM-HD study. All these SNPs cluster in DNA repair 
pathways. In addition, SNPs from RRM2B and UBR5 genes were added to the 
study, as they are members of DNA repair pathway that were marginally 
significant in the GeM-HD analysis, but those genes have significant genome wide 
P-value (Table S5 of the GeM-HD article). The most significant SNPs were chosen 
for each gene as well as a small number of proxy SNPs in close LD (r2 >0.8) with 
these most significant SNPs in the GeM-HD study. SNP analysis, which tested the 
effect of 22 SNPs on age at onset, was examined. The analysis of the combined 
samples for all polyglutamine diseases (HD and SCAs) yielded a significant 
association at FAN1 and PMS2 and for all the SCAs patients yielded association 
with PMS2. These genes’ involvement is likely explanation of modifying disease 
onset and progression in HD. This study suggested that modulation of somatic 
instability may also be important in genetic variation that alters age at onset of 
polyglutamine diseases. 
The data from the GWAS showed that genes involved in DNA mismatch repair are 
modifying age of onset in HD patients. Studies in HD mouse models have 
revealed that DNA mismatch repair genes are required to generate somatic 
expansions (Wheeler et al., 2003; Pinto et al., 2013). These have been carried 
out by an elimination of HD CAG repeat instability in Hdh knock-in mice. Hdh 
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knock-in mice were crossed with mismatch repair genes knockout mice to 
generate mouse models that have a targeted mismatch repair inactivating 
mutation and test the relative contribution of these genes in the mouse models. 
The effect of the mismatch repair genes knockout is to eliminate somatic 
expansion. The data have shown the genetic variations on MSH2, MLH1 and MLH3 
mismatch repair genes in HD mice models underlie differences in CAG repeat 
somatic expansion. The deficiency of these mismatch repair genes suppresses 
the somatic instability and delay the phenotype (Wheeler et al., 2003; Pinto et 
al., 2013). These data support the role of the mismatch repair pathway in 
somatic instability. 
In addition, several analyses have identified DNA repair genes as a likely 
explanation of variable instability and disease progression in human HD (GeM-HD 
Consortium, 2015; Bettencourt et al., 2016). There is also evidence from DM1 
patients for an association between variants in the MSH3 gene and variation in 
the degree of somatic instability (Morales et al., 2016).  
Therefore, a plausible mechanism to explain the possible mechanism by which 
DNA mismatch repair genes modify HD is that they act through modifying the 
rate of somatic expansions in HD patients. Thus, reduced activity of the DNA 
mismatch repair pathway would be expected to reduce the severity of HD 
symptoms. Therefore, we sought to investigate whether the most significant 
SNPs reported in GWAS also have a modifier effect on somatic instability in HD. 
In this regard, we analyzed SNPs from both GeM-HD and the follow-up study 
(Bettencourt et al., 2016) to evaluate whether these variants modify the somatic 
instability.  
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Figure 6-1 KASP assay principle. In the first round of PCR, one of the allele-specific forward 
primers matches the target SNP with common reverse primers to amplify the target region. 
The 3 prime parts of both forward primers are complementary to the target DNA and differ in 
the 3' end of each SNP. Each forward primer also includes unique additional nucleotides 
that are not complementary to the target DNA. These nucleotides are referred as the tail 
sequence at the 5' end that an important role for signal generation by hybridizing to either 
the HEX or FAM fluorophore. At the first round of PCR, the tail sequences will have been 
incorporated into the PCR product. During PCR round 2, the complementary sequences to 
the allele-specific tail sequences are first generated. In the third round of PCR, the presence 
of tail sequences allows the FAM labelled oligonucleotides to bind. The FAM labelled oligo 
binds to new complementary tail sequences and is no longer quenched and emits 
fluorescence. After a further round of PCR, the level of allele-specific tail increases. The 
fluor labelled part of the FRET cassette is complementary to new tail sequences and binds, 




Given the progress in high throughput SNP genotyping available, several 
variables need to be considered including throughput, cost, turnaround time, 
sensitivity, reliability, flexibility and number of SNPs genotyped per run. The 
candidate genes approach is more suitable for our experiment than GWAS, as we 
aimed to genotype a relatively small cohort and thus less powered by GWAS. LGC 
genomics has developed high-throughput technology named Kompetitive Allele 
Specific PCR (KASP) (www.lgcgenomics.com). KASP was used to validate some of 
the candidate genes for HD and SCA modifier genes that were identified by 
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GWAS (Bettencourt et al., 2016). The advantage of using KASP over other 
methods is the ability to design an assay to genotype virtually any SNP or 
insertion and deletion that makes KASP a very flexible method.  
 The KASP assay utilizes a homogeneous fluorescence-based genotyping system 
(Semagn et al., 2014). The KASP assay uses allele-specific oligo extension and 
fluorescence resonance energy transfer (FRET) for signal generation. KASP can 
distinguish between two alleles for each SNP. For each SNP, one common reverse 
primer paired with one of the two specific forward primers (one for each SNP 
allele) designed for KASP assay are used (Figure 6-1). Each forward primer has a 
nucleotide sequence that is specific to one of the labelled fluorophores. As PCR 
proceeds, one of the fluorophores, corresponding to the amplified allele, is 
incorporated into the template DNA, and it is no longer bound to its quencher 
complement. As the fluorophore is no longer quenched, the fluorescent signal is 
generated. This fluorescence is detected at the end of the assay using a qPCR 
machine or a FRET capable plate reader. Genotyping of the samples is obtained 
from the proportion of fluorescence from HEX, FAM, or both. If the genotype at 
given SNP is homozygous, one of the fluorescent signals will be generated. If the 
individual is heterozygous, the result will be a mixed fluorescent signal. The 
KASP chemistry can be performed in 96, 384 and 1,536 well plate formats. KASP 
genotyping is available as reagent kit to use in any labs and as a genotyping 
service through LGC labs in North America and Europe. This technology provides 
cost-effective and greater flexibility for researchers in generating data for 1 to 
thousands of SNPs for over thousands of samples able to be analyzed (Semagn et 
al., 2014).  
The aim of this study was to develop KASP-based assays to genotype candidate 
modifier genes of genetic instability in the Venezuelan cohort of HD patients. 
Our hypothesis was that the variants in DNA repair genes might modify CAG 
instability of HD and subsequent severity. 
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6.2 Materials and Methods  
6.2.1 HD allele genotyping and measurement of somatic 
mosaicism  
The CAG repeats were amplified from each individual from buccal swab DNAs 
from the US-Venezuelan Collaborative Research Project. DNA samples were 
genotyped using PCR amplification with MiSeq adapter primers that flank the 
CAG·CTG repeat tract of the HTT locus, followed by sequencing the products 
using the Illumina MiSeq platform as described in Chapter 3. We also used MiSeq 
read length distributions to measure the degree of somatic instability of the 
expanded CAG repeats for each individual using the previously described method 
as in Chapter 5. For each individual, the residual variation in somatic instability 
that was not accounted for by CAG repeat length, age at sampling and their 
interaction, was determined. This individual-specific difference in somatic 
instability might be attributable to genetic modifier genes. We included 412 HD 
patients, 59 unaffected individuals and 20 control samples with known high-
quality blood DNA samples for genotyping. 
6.2.2 SNP selection criteria  
SNPs were selected from the genes most significant by associated (P < 1 ×10-6) 
with residual variation in age at onset from the GeM-HD study (see Table 1 of 
the GeM-HD article). Additional SNPs in the DNA repair pathways were selected 
from a follow-up study of GeM-HD analysis (Table S4 of the GeM-HD article) 
(Bettencourt et al., 2016). In this regard, we selected 31 SNPs from this study to 
evaluate whether these loci are associated with HD somatic instability. Also, we 
chose 9 SNPs out of 11 from the GeM-HD study that are most significant by 
associated residual variation of age at onset (see Table 1 of the GeM-HD article). 
Two SNPs were in common between these two studies and were included once. 
SNPs in the MSH3, MSH6, PMS1, PMS2, MLH1, MLH3, FAN1, RRM2B, UBR5 and 
LIG1 candidate modifier genes were tested in our analysis. 
6.2.3 KASP genotyping 
SNP genotyping was performed using custom KASP assays through LGC Genomics 
labs in Hoddesdon, UK. This service includes assay validation with their samples 
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and also our submitted or supplied DNAs, and optimization of assay conditions 
and primer sequences. LGC service lab runs customer samples and provides 
genotyping data. DNA samples were assembled in a 96 well plate. We included 
two no-template controls on each genotyping plate to improve confidence in the 
validity of the genotyping results. Also, positive controls were added to each 
plate for assay validation, but these controls were of unknown genotypes, but 
with good DNA quality and high concentration compared to the buccal swab 
DNAs. 
The assay for several SNPs was designed in reverse orientation to the 
chromosome (rs1037700, rs1037699, rs3512, and rs20579). For this reason, for all 
SNPs in reverse orientation, genotypes resulting from these KASP assays will be 
complementary to those using HGVS nomenclature. This is reflected where the 
minor allele for these SNPs differs from GeM-HD but corresponds to the same 
allele (Table 6-1). 
Primers were designed by LGC Genomics based on the SNP locus sequence, and 
KASP assay carried out according to the company’s protocol 
(http://lgcgenomics.com). Following KASP PCR, plates were read, and the 
genotyping data analysed using cluster analysis viewing software. For our data, 
cluster analysis was performed using SNP viewer software that enables 
genotyping and cluster plot data to be viewed by the plate 
(https://www.lgcgroup.com/products/genotyping-
software/snpviewer/snpviewer-help/#.WfxP7hS3mOp). The detected signal from 
each sample is represented as an independent data point on the cluster plot. 
The fluorescent signals from samples with the same genotype cluster together on 
the cluster plot (Figure 6-2). One axis is used to plot the FAM fluorescence value 
and the second axis is used to plot the HEX fluorescence value for each sample. 
Homozygous samples for the allele reported by FAM will produce FAM 
fluorescence only during the reaction, and that data point will be plotted close 
to one of the axes. In the same way, a sample that is homozygous for the allele 
reported by HEX will produce HEX fluorescence only during the KASP reaction. 
Heterozygous samples contain both alleles reported by FAM and HEX 
fluorescence and generate half as much FAM and HEX fluorescence as the 
samples that are homozygous for these alleles. This data point will be plotted in 
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the centre of the plot, representing half FAM and half HEX signal. No 
fluorescence will be generated for non-template controls, and the data point 
will be plotted in the origin. We can determine the genotypes of all samples 
based on the relative position of each cluster.  
6.2.4 Statistical analysis  
The somatic instability was corrected for repeat length, age at sampling and 
their interaction for each individual, which was performed using linear 
regression as described in Chapter 5. The residual variation in age of onset not 
accounted for by allele length was also estimated for each individual (as 
described in Chapter 5). This residual variation of somatic instability and age at 
onset provides a phenotype for the SNP analysis. Those residuals were estimated 
using SPSS statistics software (IBM). 
Allele frequencies, Hardy-Weinberg equilibrium tests, linear regression analyses 
and family-based association study were performed using gPLINK (version2.050) 
(http://zzz.bwh.harvard.edu/plink/gplink.shtml). The gPLINK is a Java-based 
program that provides graphical user interphase for the commonly used PLINK 
software (command line options) (Purcell et al., 2007). The gPLINK programme 
offers a simple, user-friendly tool for performing a wide range of basic and 
large-scale genetic analyses. The software includes only common PLINK 
commands, however it is possible to create any PLINK command that has not 
been incorporated into gPLINK. A regression analysis was performed to test the 
association of the residual variation of somatic instability with each SNP 
genotype. Also, we did a family-based quantitative trait association analysis 
(QFAM) that combines a linear regression of phenotype on genotype with a 
permutation test, which accounts for relatedness among family members. P-
values <0.05 were considered statistically significant. The analysis tests whether 
there was an association of residual variation in somatic instability across all 
SNPs. For multiple corrections, we used the Bonferroni multiple significance 
tests. We compared the significance to that obtained from previous analysis in 
order to assess the association of these SNPs with the disease phenotype. 
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6.3 Results 
6.3.1 Pilot study  
The DNA concentration was quantified for a few samples from the Venezuelan 
cohort. We found their concentrations varied from 0.5 to 20 ng/μl. Some of the 
buccal swab DNA samples are at a lower concentration than the recommended 
DNA concentration (5 ng/μl) that is required for KASP genotyping. Therefore, a 
pilot study was necessary to test the probability of the buccal swab DNA samples 
from HD patients of Venezuelan cohort being genotyped when their 
concentrations are low. 
LGC recommended conducting this pilot study that includes a minimum of 22 
buccal swab DNA samples and two positive controls of known high-quality DNA. 
These samples were run by LGC lab to enable efficient cluster analysis for this 
study. These 22 samples were selected randomly to be representative of all 
samples in the cohort. Genotyping 31 SNPs in 24 samples was conducted by LGC 
lab by sending 95 μl DNA for each sample. Of the 31 SNPs used for genotyping, 
19 SNPs (61%) were validated in our buccal DNA samples (Table 6-1). Although 
with LGC control samples, 26 SNPs were validated, 7 SNPs could not be validated 
in our samples due to these SNPs being sensitive to low DNA concentrations. The 
19 validated SNPs were used to genotype all the DNA samples in the Venezuelan 
cohort. 
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Table 6-1 SNP sequences for SNP KASP assay design.The genotypes for SNPs in reverse 
orientation to chromosome given by KASP assays are complementary (reverse) to HGVS 
nomenclature. 
6.3.2 Genotyping candidate genes  
We tested 19 markers for the KASP assay that have been validated through LGC 
lab. The analyses comprised 412 patients’ samples (229 females, 168 males and 
15 unspecified) that were chosen for this study. An additional 59 unaffected 
individuals and 20 controls from Scottish population were also genotyped. These 
HD subjects were members of 130 families used in this study. The family size 
ranged from 1 to 20 individuals with an average of 3.6, consisting of 44 (33.8%) 
families of 1 individual, 34 (26.2%) families of 2 individuals, and 17 (13.1%) 
families of 3 individuals. Families with 1 individual represent one affected 
individual data point with missing parental genotypes. The remaining 35 (26.9%) 
of families have 4 or more individuals, in which 7 (5.34%)of these families have 
10 to 20 individuals. Those affected individuals selected for the study have one 
HD allele of 40-50 CAG repeats and known residual variation of somatic 
instability measure.  
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Figure 6-2 SNP viewer of KASP assay results for rs6151792 on one of the plates that 
contains 94 samples. Genotypes with a “C” are represented by blue dots across the bottom 
right cluster and those with a “T” by red dots in the upper left cluster. The data points in the 
centre of the plot, representing C:T heterozygous genotypes are represented as green dots. 
The two black dots near the bottom left are negative controls that have no fluorescence 
generated. The pink dot is a sample with unknown genotype. 
 
For each SNP, three primers were designed, and two alleles were labelled with 
either FAM or HEX. The SNP sequences used for designing primers are provided in 
Table 6-1. An example genotyping result of a KASP assay using SNP viewer 
software is illustrated in Figure 6-2. The KASP assay was performed on 94 
genotypes from our data illustrating the T/C SNP in three distinct clusters. As a 
result, the blue or red or green coloured dots represent the genotypes of each 
sample in the plot. For the rs6151792 marker, samples homozygous for the major 
allele (C) are shown in blue dots, while the red dots are samples homozygous for 
the minor allele (T) and C:T heterozygotes are shown in green dots. The no 
template controls were included across several plates of samples submitted for 
genotyping. These controls are expected to have no signal or very weak signal. 
Our results showed that the no template DNA controls clustered together and 
rarely produce signals.  
The fluorescent signal from each individual DNA sample is represented as an 
independent data point on the cluster plot. Each data point represents one 
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sample genotyped for one SNP. Therefore, genotyping of 491 samples with 19 
SNPs results in 9,329 data points. However, a proportion of the data points 
reveal unknown or unassigned genotypes. The frequency of these unknown 
genotypes is 206 data points (2.2%), 9,123 data points (97.8%) were informative 
for further analyses. Some samples were not scored for different SNPs due to 
either a weak amplification or uncertainty in differentiating the homozygote and 
heterozygote genotypes. 
 
Figure 6-3 KASP genotyping data for 491 samples for 19 SNPs.The analysis of data points 
obtained for each SNP showed that between 93% to 99.5% of samples were genotyped for 
each SNP. 
 
We also checked the genotyping success of samples and SNPs. In general, 
genotyping was of good quality and consistent within the families. Eighty-four % 
(16/19) of SNPs had data from 97% of samples (Figure 6-3). The number of 
genotypes obtained for all SNPs ranged from 93.5% to 99.5%. The overall 
genotyping efficiency of these patients was 97.8%. 
For five SNPs (rs1805323, rs61752302, rs148491145, rs150393409, rs146353869) 
no individual tested was homozygous for the minor allele. Of these SNP targets, 
one SNP (rs144287831) was homozygous for all the genotyped HD patients, i.e. 
monomorphic; the rest were polymorphic between individuals. The 
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monomorphic SNP was removed from further analysis because there is no power 
to detect association with such variants.  
 
Figure 6-4 The frequency of minor alleles of 18 SNPs tested in HD patients. The number of 
SNPs for each MAF range is plotted, and the MAF ranged from <0.05 to 0.30. A large 
proportion of SNPs have a MAF of <0.10. 11% of SNPs were very common (MAF > 0.20). 
Many (44%) rare SNPs were also detected (MAF<0.05). 
 
The frequency of each SNP is given in terms of the minor allele frequency (MAF). 
For each SNP, the MAF was determined from all samples. The characteristics of 
SNPs used in our study are shown in Figure 6-4. MAF ranged from 0.004 to 0.292 
in HD patients and the majority of SNPs have MAF of <0.10. We found many rare 
SNPs (44% of the 18 SNPs) having a MAF of < 0.05 and also 28% of SNPs with a 
MAF between 0.05 and 0.10 (Figure 6-4). We also detected two of 18 SNPs (11%) 
which were common with a MAF > 0.20. The remaining 17% of SNPs have a MAF 
in the range of 0.10-0.20. These common SNPs comprise the majority of 
heterozygous individuals in the population. The presence of common SNPs within 
the study is important to find the alleles specifically associated with the disease 
phenotype.  
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Figure 6-5 Minor allele frequency (MAF) comparison of 19 SNPs between HD patients from 
Venezuelan, European and Peruvian populations.Minor allele frequency for HD patients in 
our study was compared to MAF in European and Peruvian populations from 1000 genome 
project data. 
 
The obtained minor allele frequency from our samples was compared with the 
1000 genome project data for Peru, which we expect to be similar genetically to 
Venezuela, and also allele frequency in Europe. The distribution of minor alleles 
frequencies of each SNP in the Venezuelan, Peruvian and European population is 
shown in Figure 6-5. Minor allele frequencies of all SNPs were broadly similar 
across the Venezuelan and Peruvian population. However, it is notable the 
Venezuelan population had a significantly higher MAF in rs72734283 and rs3512 
compared to Peruvian. Significant differences in allele frequency of these two 
SNPs could be due to ethnic differences or the differences in sample size in 
determining MAF in these populations (MAF of Peruvian was estimated from 1000 
genome project study from 85 individuals). There were substantial ethnic 
differences in MAF across all three populations; European population had a 
higher MAF (0.456) in rs175080 than the Venezuelan (MAF=0.0887) and Peruvian 
populations (MAF=0.176). The minor allele was not detected for rs144287831 
from HD patients of the Venezuelan population. When compared this SNP’s MAF 
in the Peruvian (0.106) and European population (0.325), MAF of rs144287831 is 
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high in other populations and is expected to be detected in the Venezuelan 
population. These findings suggest the lack of variation might be attributed to 
an error in genotyping. Therefore, this SNP was eliminated from the further 
studies.  
 
Table 6-2 Characteristics of single nucleotide polymorphisms (SNPs) used in our study. 
Genes annotated by the SNPs are indicated. Minor allele frequency and P value for Hardy–
Weinberg equilibrium were estimated for HD patient, unaffected individuals and control 
samples in our study. Chr = chromosome; MAF = minor allele frequency; HWE = Hardy–
Weinberg equilibrium. 
 
We tested all SNPs to see whether they fit the expected genotype frequency 
distribution under the assumption of Hardy-Weinberg equilibrium (HWE). HWE is 
a mathematical equation that can be used to determine if allele and genotype 
frequencies in a population will not change from generation to generation. Since 
gPLINK software considers only founders for the analysis and therefore no HWE 
result would be given for only sibling dataset (where parental genotypes are 
unknown), a single individual was selected from each family pedigree of the 131 
families to test for HWE accurately. These individuals were selected from each 
family for either parental genotypes or one of the siblings if the parental 
genotypes are missing. 
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The observed genotype frequencies of most of SNPs were in Hardy–Weinberg 
equilibrium except, rs5893603 (P=0.004) (we considered a p-value >0.01 
significant for our data set) (Table 6-2). In our data, rs5893603 has a very low 
minor allele frequency (MAF=0.007) in HD patients compared to the Peruvian 
population (MAF=0.029) and also this minor allele was not detected in 
unaffected individuals from the Venezuelan population (MAF=0). It is unlikely to 
detect any association with a very rare variant; therefore this SNP was 
eliminated from any further analysis. The genotype frequencies of all SNPs were 
in Hardy–Weinberg equilibrium for unaffected individuals. However, rs1805323 
was not in HWE for control samples, this could result from the DNA for the 
controls being of good quality and at a higher concentration than the buccal DNA 
for unaffected and affected individuals from the Venezuelan population and 
subsequently DNA will amplify at a slightly different rate and generate a 
different level of a fluorescent signal. Therefore, inconsistent DNA quantity and 
quality across the plate might cause the heterozygous group (green dots) to 
migrate toward the homozygous group (red dots) and the apparent heterozygous 
in the genotyping plot (Figure 6-6). Also, the position of the homozygous control 
sample (blue dot) is skewed, making genotype scoring difficult. This SNP 
(rs1805323) was excluded from the analysis because the genotypes were 
ambiguous. 
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Figure 6-6 KASP assay result for rs1805323 on two plates, each contains 94 sample. 
Genotype with a "C:C" are represented by red dots across the upper left cluster and those 
with C:A genotypes in the middle representing heterozygous genotypes that are presented 
as green dots. The blue dot in the plot represents A:A genotypes. The two black dots are 
negative controls that have no fluorescence generated. The control samples have a higher 
concentration than the affected samples DNA that might cause the background signal from 
the DNA that causes the apparent heterozygous in the genotyping plot. 
 
6.3.3 Identification of SNPs associated with somatic instability  
The resulting genotypic data were used for this study to examine the effect of 
these SNPs on somatic instability. The respective genotypes were determined in 
all HD patients. In order to identify a possible modifying effect of SNPs on the 
somatic instability of the analysed HD patients, we determined the standardised 
residual variation of somatic instability for each individual after accounting for 
the effect of allele length, age at sampling and their interaction. Regression 
analysis was performed using the somatic instability measure as a dependent 
variable and the size of CAG repeat, age at sampling and their interaction as an 
independent variable (as described in Chapter 5). This residual variation 
represents a quantitative measure to test association with the trans-acting 
modifier gene genotypes. The residual variation values represent a specific 
measure of the tendency of the repeat to expand or contract for each individual. 
This residual variation measure ranged approximately from -2.323 to 4.523. The 
standardised residuals are normally distributed with a mean of 0. Individuals 
with a standardised residual greater than 0 have higher than the average somatic 
instability and are expected to develop the symptoms earlier than the average 
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for their CAG repeat length. In the same way individuals with standardised 
residuals, less than 0 have less somatic instability than the average and might 
develop the symptoms later than the average. 
Association of allele dosage of each SNP was tested first by performing a linear 
regression with the standardised residual variation of somatic instability in 
gPLINK. The analysis of phenotype-genotype association is a regression of 
phenotype on genotype that ignores family structure in the given samples and 
analyses the data as if all individuals are unrelated. Failure to account for 
relatedness among families in linear regression analysis might result in false 
positive associations. As the relatedness is known in our data, a family-based 
association study can be used. Although the main focus of gPLINK is for 
population-based samples, there is some support for family-based association 
tests with quantitative phenotype (called the "QFAM" test within gPLINK), which 
uses permutation to account for the individuals' relatedness (Purcell et al., 
2007). This test combines a simple linear regression of phenotype on genotype 
with a permutation test, which corrects for family structure. Genotypes are 
divided into between and within family components, and these components are 
permuted independently at the level of the family, and the association analysis 
is performed on the within-family component, between family component or 
their sum for a total association test to form a new score for each individual. 
The family structure and family-based association test are investigated using 
both parental genotypes. In cases where parental genotypes are not available, 
siblings are used. The programme breaks down each pedigree into nuclear 
families and classifies them as those where both parents have genotypes and 
those in which they are not known. This approach provides a 
phenotype/genotype association test that accounts for the relatedness between 
individuals. 
Association testing used an additive genetic model of allele dosage in gPLINK as 
the default for analysis. We can also assess tests that assume dominant or 
recessive genetic models of the minor allele. The additive model assumes two 
copies of minor allele have twice the effect on the phenotype of having a single 
copy. The dominant model assumes that an effect of phenotype is related to the 
presence of at least one copy of the minor allele and the recessive model 
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assumes that effect of phenotype is related to having two copies of the minor 
allele. Each bi-allelic locus was encoded using an additive genetic model in 
which genotypes were converted onto an ordinal scale of 0 for homozygous 
reference, 1 for heterozygous and 2 for the homozygous variant.  
 
Table 6-3 SNP association of candidate SNPs with a residual variation of somatic instability 
in HD patients. Beta and P value of the association analysis of candidates SNPs with 
somatic instability are estimated. 
 
We did family-based association tests with quantitative phenotype, which was a 
residual variation in somatic instability for each individual, to determine the 
effect of all SNPs on somatic instability. Quantitative phenotype data were 
analysed under an additive model using the QFAM module of PLINK. We set the 
number of permutations to 100,000 and ran QFAM as a total association that 
combined within and between family tests. QFAM use a permutation test to 
obtain an empirical P-value while maintaining for family structure. Among the 16 
SNPs, only one variant, rs3512 SNP (P= 0.009) was significantly associated with 
somatic instability (Table 6-3). The remaining SNPs were not associated with 
somatic instability in the examined HD patients (Table 6-3). Furthermore, the 
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presence of each additional minor allele G allele of the rs3512 variant was 
associated with an increase in the residual variation of somatic instability in HD 
patients (Figure 6-7). The mean standardised residual variation in somatic 
insatiability for rs3512 was -0.129 for individual homozygous for C reference 
allele, 0.0164 for C/G heterozygous and 0.270 for individual homozygous for G 
allele. 
To control for testing multiple SNPs, a Bonferroni correction was applied across 
all SNPs in our analyses and considered P values of less than 0.05 as statistically 
significant. The Bonferroni correction adjusts P values when several dependent 
or independent statistical tests are being performed on a single dataset. The 
detected association was not significant after Bonferroni correction for multiple 
testing of 16 SNPs; this SNP (rs3512) was not statistically significant (P= 0.152).  
 
Figure 6-7 rs3512 genotype dependent standardised variation in somatic instability. 
Standardised residual variation in somatic instability that was corrected for by CAG repeat 
length, age at sampling and their interaction, was calculated. The box indicates the upper 
and lower quartiles of the standardised residual of somatic variation for each for rs3512 
genotypes. The median is represented by a line dividing box. The lower values correspond 
to less somatic variation than expected and thus smaller residuals and the higher values 
correspond to more somatic variation than expected and thus higher residuals. 
 
Although this cohort of HD patients is relatively large for a rare disease, it is 
nonetheless relatively small for detecting the contribution of modifier genes. 
Thus, in order to minimise the loss of power caused by a relatively small cohort 
and testing multiple SNPs, we selected a subset of SNPs for the analysis. Three 
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of these SNPs (rs1037700, rs1037699 and rs3735721) on chromosome 8 were 
found to be in high LD (r2 > 0.8). Therefore, two of them were removed from 
further analysis. In addition, we excluded the SNPs that having a low minor 
allele frequency of <10%. Therefore, nine additional SNPs were removed from 
the analysis including the one SNP that was on LD on chromosome 8.The ability 
to detect association of rare variants (MAF <10%) is generally low. We restricted 
the analysis to SNPs that are not in LD (r2 < 0.8) and also SNPs with high minor 
allele frequency (MAF>10%). This subset of data was selected for analysis 
because it might increase the significance of multiple corrections.  
 
Table 6-4 Association between SNP genotypes and residual variation of somatic instability 
for SNPs with high minor allele frequency (MAF >10%) and that are not in LD (r2<0.8). The 
association of SNPs with the residual variation was determined via family-based association 
test for quantitative trait in gPlink software and also the adjusted P values are given after 
Bonferroni correction. The observed rs3512 association (P = 0.0457) was significant after 
multiple test correction (Bonferroni corrected value <0.05). 
 
The aim of these analyses was to evaluate the improvement of the association of 
these SNPs with variation in somatic instability. rs3512 remains significant (P = 
0.0457) after multiple corrections (Bonferroni corrected P value<0.05), showing 
that the minor allele is associated with residual variation in somatic instability in 
HD (Table 6-4). This SNP’s effect is expected to modify disease phenotype or 
progression, and the change in somatic instability depends on the SNP 
genotypes. 
6.3.4 Identification of SNPs that modify age at disease onset  
It has been shown that high levels of CAG repeat expansions in postmortem brain 
DNA is associated with an earlier age of disease onset, suggesting that somatic 
instability is a significant predictor of the age of onset and disease progression 
(Swami et al., 2009). The main modifying factor in age at onset is the CAG 
SNP	ID	 Gene p	value 	adjusted	p	value
rs3512 FAN1 0.0091 0.0457
rs5742933 PMS1 0.1627 0.8137
rs20579 LIG1 0.2031 1
rs72734283 MLH3 0.6718 1
rs1799977 MLH1 0.7819 1
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repeat length that contributes to approximately 70% of the variability, indicating 
that other modifying factors are likely to be involved in determining the age of 
onset (Wexler et al, 2004). We assume the genetic modifiers of somatic 
instability might also modify age at onset. 
These candidate genes have shown an association with age at onset (GeM-HD 
Consortium, 2015; Bettencourt et al., 2016). Our aim was to genotype these 
candidates SNPs and provide confirmation of suggested loci that modify the age 
of onset of HD. The variability in age at onset attributable to the size of CAG 
repeats was adjusted by linear regression. Thus, we performed regression model 
for an age of onset that accounted for allele length for each individual (as 
described in Chapter 5) with modifier genes. Regression analysis was performed 
using age at onset as a dependent variable, and the size of CAG repeats as an 
independent variable. We did association analysis for the age at onset in the 
same way as for somatic instability as described in section 6.3.3 except that 
included the residual variation in age at onset as a quantitative phenotype in 
order to evaluate the effect of candidate SNPs on the age of onset of 
Huntington's disease. This analysis is stratified by family structure. We used a 
subset of 135 affected individuals (43 males and 87 males), for whom we have a 
clinical age at onset, in the association statistical analyses. Ages of onset range 
from 23 to 65 years with an approximately normal distribution and a mean age of 
onset of 43.8 years. The residual variation in age at onset ranged from -3.65 to 
2.71.  
Surprisingly, the analysis did not show any significant result for the association 
of these candidate genes in explaining any variation in age at onset (Table 6-3). 
The sample size was small to detect any association of SNPs on the variation in 
age at onset of the disease. We didn’t find any association of these candidates’ 
loci in explaining the variation in age at onset. 
6.4 Discussion  
Our data from Chapter 5 enabled us to quantify the effect of the allele length 
and age at sampling, which interact to account for 90% of the variation in 
somatic instability of HD patients. We also confirmed that residual variation in 
somatic instability in buccal cells, which is independent of the allele length and 
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age at sampling, provides evidence that changes in somatic instability increased 
as a function of repeat length and time of sampling and their interaction. We 
hypothesised that individual-specific differences in somatic instability are 
mediated by genetic modifiers. The DNA repair machinery was implicated as a 
modifier of HD age of motor onset in GeM-HD (The GeM-HD Consortium, 2015) 
and the follow-up study (Bettencourt et al., 2016). 
In this study, we are developing a candidate gene-based approach that will 
enable the investigation of known candidate gene modifiers of HD age at onset 
as potential modifiers of somatic instability in HD patients. We sought to test 
whether these modifier genes in other HD populations could validate previous 
findings and ultimately lead to the identification of genetic factors contributing 
to the progression of HD. We tested our hypothesis by quantifying residual 
variation in somatic instability in HD patients from the Venezuelan cohort, and 
genotyping modifier gene polymorphism in the DNA repair pathway. We did 
family-based association tests with a quantitative phenotype, which was the 
residual variation in somatic instability for each individual, to determine the 
effect of all the trans-acting modifier genes on somatic instability.  
The primary analysis for all SNP association showed only rs3512 in FAN1 yielded a 
statistically significant association, but it did not survive after multiple 
corrections. Nonetheless, our secondary analysis examined only the SNPs not in 
LD and high MAF and showed a significant effect for the minor allele of rs3512 
with somatic instability after multiple corrections. No statistically significant 
associations were detected for any of the remaining variants tested between the 
candidate genes and somatic instability.  
The SNP (rs3512) was found to have age at onset modifying effect in HD (The 
GeM-HD Consortium, 2015). rs3512 is in the 3’ UTR (the three prime 
untranslated region) of the FAN1 (FANCD2 and FANCI associated nuclease1) gene 
on chromosome 15. FAN1 is an endo/exonuclease involved in DNA interstrand 
cross-link repair (Kratz et al., 2010; Mackay et al., 2010). This SNP (rs3512) was 
the most significant SNP in a candidate gene study (Bettencourt et al., 2016) and 
was the second most significant signal in GeM-HD (The GeM-HD Consortium, 
2015) and the minor allele was associated with later onset of HD in both studies. 
The association analysis demonstrated the presence of the minor allele of rs3512 
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could delay the age at onset by 1.325 years (The GeM-HD Consortium, 2015). 
Also, there is evidence to suggest the association of this SNP with later age at 
onset by 1.68 years for both HD and SCA patients, and 1.8 years later onset for 
all SCA patients alone (Bettencourt et al., 2016). This effect is expected to 
modify disease phenotype or progression, and the change in age at onset 
depends on the SNP genotypes. 
Individuals carrying minor allele of rs3512 have a higher level of somatic 
instability (Beta=0.249) than average. An increased level of somatic expansion is 
associated with larger CAG repeats, which is related to more severe pathology 
and earlier age at onset (Swami et al., 2009). Therefore, a higher level of 
somatic expansion could be explained by the genetic variation in DNA mismatch 
repair genes that could alter age at onset in HD patients. Unexpectedly, the 
association in our result does not have the same effect as in the previously 
published data. This variant shows consistent replication effect across the 
previous studies. Our results showed this SNP display high MAF (0.26), and the 
minor allele has higher somatic instability (Beta=0.249) than average. An 
increased level of somatic expansion is associated with larger CAG repeats, 
which is associated with more severe pathology and earlier age at onset. 
Therefore, somatic expansion could explain the identification of genetic 
variation in DNA mismatch repair genes that could alter age at onset in HD 
patients. The association identified that increase of somatic instability is 
expected to be associated with earlier age at onset, rather than later as in 
previous studies (GeM-HD Consortium, 2015; Bettencourt et al., 2016). 
Although 412 individuals represent a relatively large cohort for a rare disease, it 
is nonetheless relatively small compared to previous studies and less power for 
detecting the contribution of modifier genes. Thus, undetectable association 
with DNA repair genes in no way excludes them as modifiers of instability in HD. 
Given the challenge to detect modifier gene associations in such rare disorder, 
we have shown evidence that rs3512 is associated with individual-specific 
variation in somatic instability in HD patients. These data suggest that FAN1 is 
involved in somatic expansion in HD, with individuals with the homozygous minor 
allele genotype tending to show higher levels of somatic variation.  
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It would be worth repeating the analysis with larger samples as the power to 
detect the genetic modifiers association increases with increasing sample size. 
We didn’t detect any association of these candidate loci in explaining the 
variation in age at onset. The sample size was relatively small (135 HD patients) 
for age at onset analysis resulting in less power to detect association with 
modifier genes. 
The absence of any detectable association between candidate genes and age at 
onset and also the different association of the minor allele frequency of rs3512 
in our data compared to previously published data could be due to the 
population stratification. This may bias analysis of rs3512 as a modifier of 
disease progression in HD. Also, the causative SNPs in somatic instability might 
be different in South American rather than European populations. These variants 
may be present in a specific gene-environmental interaction that is not shared 
across the different cohorts. Also, another explanation of different results could 
be due to a different expression level of variants in affected tissues, such as the 
brain, compared to other tissues (blood and buccal cells). The same allele might 
be driving higher expression in one tissue and lower expression in another tissue. 
Thus, the same allele could cause a high level of somatic instability in the 
affected tissue and lower somatic instability in unaffected tissues, like the brain 
and buccal cells. Therefore, we could expect to have opposite effect of one 
locus at the level of somatic instability and modifier genes. Thus, phenotype 
seems to be measuring a different aspect of disease somatic instability in 
different tissues. To increase the power of the study, it would be useful to 
obtain a more accurate measure of phenotype from the affected tissues, which 
is difficult to obtain from Huntington disease patients. The most affected area in 
HD is the brain, and notably, the somatic instability of the CAG repeat in the 
brain predicts the disease onset and progression (Swami et al., 2009). Using 
more accurate phenotypes would be likely to enhance the power of genetic 
analyses with such a rare disease. 
After designing the experiment, a second GWAS study identified a significant 
association with other mismatch repair genes (Hensman Moss et al., 2017). They 
genotyped 218 HD patients from the TRACK-HD study using the Illumina 
Omni2.5v1.1 array, and they obtained genotypes for 1,773 HD patients from 
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REGISTRY study. They tested the association of these SNP genotypes with a 
residual variation of progression measures by meta-analysis. They found a 
significant association with the MSH3 gene. Therefore, MSH3 is probably a 
modifier of disease progression in HD that has highlighted the DNA repair 
pathway for therapeutic intervention. MSH3 has also been implicated in the 
pathogenic process of HD and degree of somatic instability in striatal cells of a 
knock-in mouse model of HD (Dragileva et al., 2009). Polymorphisms in the MSH3 
gene were also associated with somatic instability in patients with DM1(Morales 
et al., 2016). Notably, MSH3 was included in our study, but we did not find an 
association. 
Also, we did not replicate the strongest signal in GWAS, which is derived from 
rs146353869 in FAN1 gene that is associated with 6 years earlier age at onset of 
HD. In our data, we identified 11 heterozygous individuals and no homozygous 
for the minor allele. No statistically significant association were detected 
between the rs146353869 and residual variation in somatic instability. Also, to 
confirm the association with age at onset, we have a subset of 135 patients that 
we have a clinical age at onset details. The analysis did not show any significant 
association between this SNP in explaining any variation in age at onset. This is 
likely because we are genotyping a relatively small number of samples, which is 
less powered to find an association with an SNP with a low MAF (0.019). 
Our finding showed that a small amount of variation in HD somatic instability 
could be accounted for by genetic variation in DNA repair pathway. The search 
for modifier genes might have consequences in the understanding of not only 
Huntington's disease but also diseases such as spinocerebellar ataxia and 
myotonic dystrophy. Further study to identify these modifiers might provide 
insight into the pathological process in HD and therefore into therapeutic targets 
for future investigations. 
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Chapter 7 Final discussion and conclusion 
The overall aim of this project was to evaluate the ability of NGS technology to 
genotype CAG repeats of the HTT gene, including the polymorphic CCG repeats 
and the flanking sequences, and to detect the distribution and pattern of 
additional sequence variants within or flanking the repeat. Also, investigations 
of the use of NGS to measure somatic instability was another aim of this study, 
as well as to detect trans-acting modifiers of HD instability and symptomatic 
variability. 
In this study, we report the analysis of the normal alleles in the general Scottish 
population and Venezuelan HD families using NGS approaches and the MiSeq 
platform. In addition, genotyping of the expanded alleles were described from 
the Venezuelan patients by MiSeq sequencing. We report the first sequence data 
for normal and expanded HTT CAG repeats using optimised library preparation 
for MiSeq sequencing. From this data, we established that it was possible to 
sequence and genotype HTT CAG alleles, including the polymorphic CCG repeats 
and the flanking sequences, by amplifying the region using locus-specific primers 
combined with MiSeq sequencing adapter. 
Using this approach we sequenced HTT CAG/CCG repeat from blood DNA samples 
of 210 unaffected individuals from the Scottish population and 742 buccal cell 
swab DNAs from 333 unaffected and 409 affected individuals from the 
Venezuelan HD cohort. Our data have revealed that the distribution of the CAG 
repeat size in the Scottish and Venezuelan population was similar to that 
previously published in the same populations. CCG alleles of 7 and 10 repeats 
account for the majority of normal chromosomes in both populations. The 
carriers of 7 CCG repeats in normal chromosomes were associated with a higher 
mean CAG length and longer CAG repeat lengths on normal chromosomes in both 
populations. All expanded alleles were associated with 7 CCG repeats in the 
Venezuelan population, which reveals that the CCG repeat is stably transmitted. 
In addition, we revealed the existence of atypical allele structures by 
sequencing normal HTT alleles in both populations. No atypical allele structures 
were identified by sequencing expanded alleles. Thus, the lack of variation in 
CCG repeats and the typical allele structures support a possible common source 
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of mutation in Venezuela due to a founder effect, inheriting 7 CCG repeats on 
the expanded alleles and also the typical allele structure. 
From these data, we were able to sequence CAG repeats at a mode of up to 74 
repeats in the presence of the normal alleles for most samples. However, we 
were unable to reveal the 3’-flanking region using 400 bp forward reads for 
patients with 74 CAG repeats or longer. For such long alleles, we investigated 
the utility of reverse reads and found that these can be used to improve the 
efficiency of genotyping of the CCG repeat and the 3’-flanking DNA sequence. 
We thus used the reverse reads to genotype the CCG repeat and the 3’-flanking 
DNA sequence, to detect any variants in that region and for haplotype analysis. 
Sequencing of alleles longer than 74 CAG repeats may be done using that 
approach, i.e. using the forward read to genopype the CAG repeat and the 
reverse reads to genoype the 3’-flank and the CCG repeats. 
Analysis of the haplotypes comprising the polymorphic CAG and CCG repeats has 
revealed that CAG 17-CCG 7 and CAG 17-CCG 10 are the most common 
haplotypes on their normal chromosomes in the Scottish population. Haplotype 
analysis in the Venezuelan population showed that the CAG 17-CCG 7 and CAG 
18-CCG 9 are the most common haplotypes on their normal chromosomes. 
Therefore, the Scottish and Venezuelan populations share the same major HD 
haplotype (CAG 17-CCG 7) that account for ~14 to 19% of their normal 
chromosomes. 
Our analysis of homozygous cases showed that homozygous individuals had an 
earlier age at onset of disease than heterozygotes. Therefore, homozygosity for 
HD is expected to result in a more severe phenotype and rapid disease 
progression. In contrast, an earlier study reported a similar age at onset for 
homozygous and heterozygous individuals, but homozygotes had a more severe 
phenotype of HD (Squitieri et al., 2003). These different findings could be 
because the previously reported study was conducted on a small number of HD 
patients (eight homozygotes and 75 heterozygotes). In addition, it may be 
difficult to determine the accurate age at onset in HD due to an overlap of 
cognitive, motor and psychiatric symptoms in the early stages of HD. Thus, 
patients with homozygous HD mutations are an important aspect for genetic 
counselling, given the fact that all their offspring will inherit the HD mutation, 
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unless a contraction of the CAG repeat tract occurs, which is highly unlikely. 
Counselling is very important for the patients to know about the increased risk 
of transmitting the mutation to their offspring. 
Our data revealed the high frequency of atypical allele structures in normal HTT 
alleles. Most of the atypical alleles have been reported in published data, 
suggesting that we accurately determined the genotype for HD alleles and that 
these atypical alleles are genuine germline variants existing in normal alleles, 
not PCR and/or sequencing errors. Five atypical allele structures were analysed 
from 27 normal alleles in the Scottish population. We also observed three 
atypical normal allele structures from 107 normal alleles from the Venezuelan 
population, which were also found in the Scottish population. Interestingly, 
among the Scottish population, only one of these atypical alleles was not a 
previously described HTT allele. This allele is associated with interruption of 
CCG repeats into the CAG repeat tract, deletion of CAA in the intervening 
sequence, along with an additional CCT sequence to the CCT duplication present 
at the end of the CCG repeat. It must be noted that no expanded atypical alleles 
were detected in the Venezuelan HD patients compared to the analysis of 
normal HTT alleles from unaffected individuals from Scottish and Venezuelan 
populations that revealed atypical allele haplotypes in the normal alleles. 
In parallel to my work, a large screen of HD patients from the Enroll-HD cohort, 
TRACK-HD, and the European Huntington’s Disease Network (EHDN) REGISTRY 
project samples was conducted using MiSeq sequencing (Dr. Marc Ciosi, 
unpublished data). Dr. Marc Ciosi sequenced these alleles and described 
(22/~1,300) mutant atypical alleles in these samples. Most of these variants had 
already been described in normal alleles in the Scottish and Venezuelan 
samples. However, he found one atypical expanded allele structure with no 
interruption between CAG and CCG repeats. Such a lack of interruption between 
CAG and CCG repeats has previously been reported only in intermediate alleles 
(Goldberg et al. 1995, Chong et al 1997). We therefore predict that these 
atypical alleles in HD arise from the general population. Those atypical alleles in 
HD are present in the general population and then they expand to the disease 
size range. However, there were no atypical alleles in general population for 
DM1, while atypical alleles are sometimes seen in DM1 affected families (Dr. 
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Sarah Cumming, Submitted Jun, 2018). Therefore, the atypical expanded alleles 
in DM1 most likely arise from a de novo mutation in patients. Variant repeats in 
DM1, SCA1, and fragile X syndrome have been shown to modify the mutational 
dynamics by reducing the amount of germline and somatic instability (Chung et 
al., 1993; Zhong et al., 1995; Musova et al., 2009; Braida et al., 2010). In 
addition, Goldberg et al. 1995 and Chong et al.1997 have shown that 
intermediate HTT CAG alleles with no interpretation between CAG and CCG 
repeats have a higher germline instability than other intermediate alleles.  
These recent data from our group suggests that in addition to the polyglutamine 
repeat length, sequence variants within the HTT repeat tract may affect disease 
severity (Dr. Marc Ciosi, unpublished data). Atypical alleles may potentially 
expand less or more in both the soma and germline, possibly modifying the 
disease severity. Some atypical alleles may have an impact leading to increased 
severity and level of instability. For instance, individuals having atypical 
expanded alleles with loss of CAA from the CAG repeats tract have more severe 
symptoms than expected based on the number of glutamines (Dr. Marc Ciosi, 
unpublished data). Similarly, four HD patients were described with an atypical 
allele, which is characterised by loss of intervening sequences in the expanded 
alleles, leading to pure tracts of CAG and CCG repeats. These patients are also 
more severely affected than expected (Dr. Marc Ciosi, unpublished data). 
Therefore, pathogenesis and somatic instability are best predicted by the 
number of CAG repeat, not polyglutamine length. Individuals carrying atypical 
alleles with fewer variants CAA are more severely affected and those alleles are 
likely to be unusually unstable through a transmission to offspring relative to the 
number of total glutamine (Goldberg et al. 1995, Chong et al 1997). 
Individuals having atypical alleles with duplication of CAACAG repeats within the 
CAG repeats tracts have less severe symptoms than expected relative to the 
number of polyglutamines (Dr. Marc Ciosi, unpublished data). Atypical alleles 
with more variant repeats would be expected to be less prone to expansion 
when transmitted to the next generation, according to data available for other 
triplet repeat disorders (Chung et al., 1993; Zhong et al., 1995; Musova et al., 
2009; Braida et al., 2010). Notably, the presence of interruptions within atypical 
normal alleles which break the CAG repeat into three smaller repeat tracts in 
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our data (the one atypical normal allele that was first seen in the Scottish 
population, our data from Chapter 3) may stabilise the allele and decrease the 
severity of symptoms if found on the mutant chromosome. 
Thus, we expect atypical allele with more variant repeats to be more stable, 
and those with less variant repeats to be more unstable, predisposing alleles to 
expansion and eventually to disease status. Therefore, for the trinucleotide 
repeats disorders, the interruptions provide genetic stability to the repeat tract 
and the interrupted tracts are less likely to expand upon transmission (Chung et 
al., 1993; Zhong et al., 1995; Musova et al., 2009; Braida et al., 2010).The 
identification of those atypical alleles can be difficult in the HD diagnostic test 
using PCR analysis, as it does not take into account the allele structure. From M. 
Ciois’s data, atypical alleles with loss of CAA are associated with a motor onset 
arising ~10 years earlier and individuals with a duplication of CAACAG within the 
CAG repeats track have a age at motor onset delayed by ~5 years based on total 
number of glutamine (unpublished data). Thus, sequencing those alleles is 
necessary as they have an implication for the individual’s risk, as well as allele 
stability through life and transmission to offspring.  
The NGS approach represents a rapid and a higher throughput method, 
compared to other traditional diagnostic and research methods. These 
traditional approaches used in genotyping HD alleles have some limitations in 
terms of sensitivity, accuracy and measuring somatic instability because they are 
not precise in determining CAG allele sizes and fail to define the extent of 
somatic instability. In addition, these approaches cannot detect any variants 
repeats within or flanking the repeats. Thus, replacing these conventional 
approaches with NGS would allow for a rapid analysis and accurate 
quantification of allele length variation. In addition, it is important to note the 
sensitivity of this sequencing method and the ability to detect insertions, 
deletions or other sequence variants within or flanking the repeat. Therefore, 
NGS is likely to have significant clinical utility. We illustrate the success and 
challenges of using NGS in trinucleotide disorders and suggest that our 
experience is likely to be applicable to many other expanded repeat alleles. 
The present protocol has the potential to improve HD diagnostics as it can reveal 
HTT variants that have been ignored by standard diagnostic protocols. This 
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developed approach can improve the accuracy of diagnostics based on the CAG 
repeat genotyping. It also allows the quantification of CAG repeat somatic 
instability. Our protocol has the advantage of using the dual index approach in 
which 96 samples can be sequenced using MiSeq sequencing. This approach can 
be used to multiplex larger number of samples up to 384 samples using 96 
barcode kits such as the Nextera Index kit, which also reduces the cost per 
sample. A large-scale genotyping study would be useful for a population 
screening approach for HD. Population screening is a necessary step in 
identifying individuals who may be pre-symptomatic or asymptomatic for a 
disease, particularly one with a late age at disease onset. Genetic screening 
could be useful in decisions about lifestyle and reproductive choices. Screening 
for HD in the general population will allow for early and accurate diagnosis. 
Also, that can help in providing early intervention and management of HD 
symptoms. Furthermore, with increasing clinical trials and accelerating 
therapeutic development, affected individuals could start new therapeutics 
early as they become available. Any possible therapy is more likely to slow or 
stabilise the disease rather than to reverse the symptoms, therefore it would be 
useful to identify at risk individuals in the population before they develop 
symptoms. 
We have analysed the pattern of somatic instability in buccal cell DNA in the 
normal and expanded HTT alleles from unaffected and affected individuals of 
the Venezuelan kindred. There was no significant level of instability observed in 
the normal alleles, but with mutant alleles, instability was observed in all 
expanded alleles and an even greater level was observed with older age. These 
data further suggest the allele length and age are major modifiers of somatic 
mosaicism and that the normal alleles are highly stable. 
It has been shown that, in HD, there is a noticeable correlation between the 
tissues vulnerable to neuropathology and those exhibiting a high level of 
instability (Kennedy et al., 2003). This observation has led to the hypothesis that 
somatic instability contributes to the disease pathogenesis and progression in 
HD. Somatic instability is tissue-specific, age-dependent, and expansion-biased 
(Kennedy et al., 2003). In order to test whether the somatic instability of HD 
CAG repeats could be quantified and to understand the role of somatic 
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instability in HD, somatic instability was investigated in HD patients from the 
Venezuelan HD families. We thus used MiSeq read length distributions to 
quantify the degree of somatic mosaicism of the expanded CAG repeats for each 
individual. Our hypothesis was that the main drivers for somatic mosaicism are 
CAG repeat length and age at sampling and that individual-specific residual 
variation for both effects will also be associated with disease severity.  
Our results demonstrated that CAG repeat length is a major determinant of 
somatic instability that accounts for 64% of the variation in somatic instability. 
Age at sampling was also confirmed as a major factor in determining the level of 
somatic instability by using multivariate analyses, confirming the interaction 
between age at sampling and allele length. 90% of the variation in somatic 
instability was explained by CAG repeat length, age at sampling and their 
interaction. The remaining variation could be explained by environmental 
factors and other genetic modifiers. We also observed a significant correlation 
between the expanded CAG repeat length and age at disease onset in HD 
patients. The expanded CAG repeat explains 56% of the variation in age at onset. 
This suggests expanded allele length is the initial trigger of HD pathogenesis and 
a major factor determining the rate of the process. 
Further analysis was carried out to test whether age at onset and disease 
severity are influenced by somatic instability, and to determine whether the 
pathogenic effect of expanded alleles can be modulated by CAG repeat 
instability. We evaluated the residual variation of somatic instability not 
explained by allele length and age at sampling that likely reflects the specific 
mutation rate variation between individuals. We expect those individuals’ 
specific differences will be associated with disease severity and that somatic 
instability will have an influence on age at onset. Our analysis showed no 
association between that the residual variation in somatic instability and the 
variation in age at disease onset that is not explained by the allele length. In 
contrast, there was evidence from a previous study showing a negative 
correlation (r2=0.068, P=0.002) between repeat instability and age at onset of 
DM1 patients (Morales et al., 2012). The evidence from this study suggests that 
the residual variation of somatic instability is an individual-specific and heritable 
quantitative trait and that residual variation in somatic instability is associated 
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with residual variation in age at onset in DM1 patients (Morales et al., 2012). 
Moreover, data from our group on ~400 HD patients from the Enroll-HD cohort 
showed that there is a correlation between repeat instability and age at onset of 
disease (r2=0.02, P=0.002) (Dr. Marc Ciosi). These data revealed the somatic 
instability accounted for some of the variation in age at onset and the repeat 
expands more rapidly for individuals who have an earlier age at onset in both 
DM1 and HD patients. However, it is important to note that the correlation 
between residual variations of somatic instability and age at onset is relatively 
low for both HD patients (r2=0.02) and DM1 patients (r2=0.068). That implicates 
the role of individual-specific environmental or genetic factors as a modifier of 
the individual-specific differences in the level of somatic instability. 
Furthermore, it has been reported that CAG repeat expansion in postmortem 
DNA is associated with an earlier age of disease onset, suggesting that somatic 
instability is a significant predictor of the age of onset and disease progression 
(Swami et al., 2009). Although there are data implicating somatic mosaicism as 
an important component of the disease pathway and that somatic instability play 
a role in age at onset, we could not verify it in our study. This could result from 
the relatively low number of samples in our analysis (135 individuals) that have 
age at onset details and the difficulties of precisely assigning age at onset to a 
patient. In contrast to the Enroll-HD cohort, the phenotype in our study is less 
well characterised and also we tested a relatively small number of patients for 
the analysis. Furthermore, it is important to note the measurement of somatic 
mosaicism from the non-target tissue is likely underestimating the real repeat 
dynamics in the brain. 
Because of PCR slippage, our method has a limitation in detecting and measuring 
somatic contractions. Data from single molecule experiments on HD patients 
showed that there was a low frequency of contractions (Veitch et al., 2007). 
Understanding somatic contractions is important, enabling us to provide insight 
into the contraction mechanisms to study triplet disease disorders and also to 
understand the phenotype-genotype correlation. It might be that expansions and 
contractions involve different mechanisms and also different genetic modifiers. 
A high frequency of contractions might result in individuals with less severe 
symptoms. If so, enhancing repeat contraction could be clinically beneficial. 
Understanding the mechanisms of instability in humans is crucial for the 
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development of therapeutic approaches that target repeat instability and to 
identify genetic factors influencing it. A therapeutic strategy for the expansion 
disorders could work by inhibiting expansions, or by inducing contractions of the 
mutation by reversing the repeat expansion in the mutant genes to the shorter 
length present in the non-disease chromosomes. This targeting therapy may have 
consequences on the downstream pathology and symptoms in HD.  
Given the limitation of our study in addressing the contraction process in HD, our 
group has shown expanded HD allele from a single molecule could be sequenced 
using NGS approach. A single molecule sequencing experiment was conducted 
from a mix DNAs from 25 HD patients carrying between 40 to 67 CAG repeats 
that had been previously sequenced and sized by MiSeq sequencing (Dr. Sarah 
Cumming, unpublished data). MiSeq sequencing of PCR products derived from 
single expanded alleles was carried out to examine the read length distribution. 
The numbers of reads longer than the mode were very small (2-3%), while reads 
shorter than the mode were still very numerous. These data showed that in a 
bulk PCR sequencing experiment the reads shorter than the inherited allele 
length are derived from PCR slippage, and reads larger than inherited allele 
length are mainly due to somatic mosaicism. Although this experiment provides 
evidence for our ability to sequence a single HD molecule, it was time-
consuming and labour-intensive as it involved an SP-PCR approach and detection 
of products by Southern blot hybridisation. 
Avoiding these the labour-intensive preparation steps required for that 
experiment, it could be replaced by a rapid and high-throughput method. 
Interesting data from our group has shown the sequencing of DM1 single 
molecules is possible by tagging each parental molecule with unique sequences 
via PCR followed by MiSeq sequencing (Dr. Khaldah Nasser, unpublished data). 
The aim of this experiment was to distinguish somatic mosaicism from PCR 
slippage and sequencing errors. The idea was to tag each parental molecule with 
unique sequences of 14 random nucleotides in order to distinguish each template 
(Kinde et al., 2011; Kou et al., 2016). Then, these tagged molecules were 
subsequently amplified to generate daughter molecules that were derived from 
parental template molecules. This method allows for the somatic variants 
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present in the parental templates to be copied in derivative molecules and 
therefore discriminated from PCR or sequencing errors. 
Therefore, by applying the same method by tagging each parental HD molecule 
with unique barcoded primers by PCR followed by sequencing, we could more 
accurately evaluate the level of contractions and expansions by comparing the 
read length distribution obtained by single molecule to the sequencing of a bulk 
DNA. This method could be used to provide an understanding of the underlying 
dynamics of the contraction and expansions in HD single molecules, although the 
method could be challenging to amplify a single HD mutant allele as it had 
showed sequencing DM1 normal alleles. 
There is strong evidence that somatic expansions in HD occur in non-dividing 
cells such as neurons (Shelbourne et al., 2007). The presence of expansions in 
non-dividing somatic cells indicates that somatic instability can be induced 
during metabolic pathways other than DNA replication and cell division. The 
data from the HD knock out mice of the mismatch repair genes eliminate the 
somatic expansions and delay the phenotype (Wheeler et al., 2003; Dragileva et 
al., 2009; Pinto et al., 2013). These data support the involvement of the DNA 
repair pathway in somatic instability. However, during gametogenesis, cell 
divisions occur, and these are particularly numerous during sperm production. 
The CAG repeat length may increase during germline transmission of 
premutation and disease-causing alleles, accounting for the phenomenon of 
anticipation, which is mostly seen during paternal transmission. This could 
suggest that cell division may result in repeat length changes in gametes. During 
early development, numerous cell divisions occur, but by birth many tissues will 
be post-mitotic. However, due to the difficulty in obtaining tissues, the level of 
CAG repeat instability during development has not been widely studied, 
therefore it is difficult to determine the mechanisms that may underlie repeat 
instability during development. 
Studies in HD mouse models confirmed the role of trans acting modifiers in HD 
CAG repeat instability and HD CAG-dependent phenotypes (Wheeler et al., 2003; 
Pinto et al., 2013). These modifier genes have been shown to be critical in 
generating somatic repeat expansion in mice. The most obvious candidates for 
trans acting modifiers of somatic instability are the DNA mismatch repair genes. 
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In humans, several analyses have identified polymorphisms in DNA repair genes 
that may help to explain variable disease onset and progression, such as MSH3 
and PMS2 (GeM-HD Consortium, 2015; Bettencourt et al., 2016). Therefore, we 
investigated whether known DNA mismatch repair (MMR) gene modifiers of HD 
age at onset were also modifiers of somatic instability in HD patients. These 
modifier genes in HD could ultimately lead to an identification of genetic factors 
contributing to the progression of HD. 
We did family-based association tests with a quantitative phenotype, which used 
the residual variation of somatic instability for each individual to determine the 
effect of all these trans-acting modifier genes on the somatic instability of the 
analysed HD patients. This residual variation represents a quantitative measure 
to test association with the trans-acting modifier gene genotypes. Our data 
demonstrated a significant effect for the minor allele of rs3512 in FAN1 with 
somatic instability after multiple corrections for SNPs that were not in LD and 
which have a high minor allele frequency. The association analysis demonstrated 
that individuals carrying the minor allele of rs3512 have a higher level of somatic 
instability than average (Beta =0.23). A similar study in our group was carried 
out by Dr. Marc Ciosi in which he identified an effect for the minor allele of 
rs3512 in FAN1 with somatic instability (Beta =0.29) in TRACK-HD patients 
(Dr.Marc Ciosi, unpublished data). In addition, Marc Ciosi had observed a similar 
effect in Enroll-HD patients; there was a significant association of the minor 
allele of rs3512 with somatic instability (Beta =0.018). Our group’s results were 
consistent in demonstrating the individuals carrying the minor allele at rs3512 
have a higher level of somatic instability than average. We were expecting a 
high level of somatic instability to be associated with an earlier age at onset. 
Surprisingly, the association obtained in our results does not have the same 
effect regarding the expected effect on age at disease onset as in the previously 
published data, in which the minor allele was associated with later age at onset 
(GeM-HD Consortium, 2015; Bettencourt et al., 2016). It is worth mentioning 
that our result is the first data to show that the minor allele in FAN1 is 
associated with somatic mosaicism in human HD patients. Furthermore, there is 
no mice data on the effect of FAN1. Our data directly implicates FAN1 in having 
effects on somatic instability and therefore playing a role in expansion pathway. 
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Nevertheless, GWAS and also Marc Ciosi’s data have shown the DNA mismatch 
repair genes modify the age at onset, and that these MMR genes affect the level 
of somatic expansion. Also, the pathway analyses from GWAS highlighted DNA 
mismatch repair as a likely mechanism to modify disease phenotype. While the 
role of FAN1 in mediating somatic expansion in HD was not observed, there was 
suggestive evidence that this gene interacts with MLH1 in the GeM-HD GWAS. 
FAN1 is involved in interstrand DNA cross-link repair (Jin and Cho, 2017). FAN1 
might recruited to the abnormal DNA structures and the mismatch repair gene, 
such as MLH1 is recruited and interacts with FAN1 to recognises and resolve the 
abnormal structures (Smogorzewska et al., 2010). This repair of the strand may 
lead to an expansion of CAG repeats. FAN1 might target these structures and 
interacts with MLH1 that may play a role in modulating repeat instability. This 
SNP in FAN1 is in LD with other SNPs in different genes. Therefore, the causative 
SNP is not known. The SNP rs3512 lies in the 3’UTR of FAN1. The 3’UTR sequence 
contains regulatory elements that determine mRNA stability and localization 
(Arnold et al., 2012). If the SNP is causative, since it lies in the 3’ UTR of the 
gene, it could interfere with mRNA stability and translation through effects on 
polyadenylation, or interactions with regulatory proteins or interactions of the 
transcript with miRNA. Variations in the 3’ UTR of genes could also potentially 
inhibit nuclear-cytoplasmic transport of an RNA, which would lead to reduced 
translation. The mutation found in 3’UTR of FAN1 might therefore alter gene 
expression by various possible mechanisms. 
The absence of any detectable association between candidate genes and age at 
onset and also the different association of the minor allele frequency of rs3512 
in our data compared to previously published data could be due to the 
population stratification. The causative SNPs in somatic instability might be 
different in South American rather than European populations. Also, these 
variants may be present in specific gene-environmental interactions that are not 
shared across the different cohorts. However, this does not seem to be a 
credible explanation, given that Marc Ciosi’s data gave the opposite effect of 
the variant effect than GWAS analysis but both included patients from Caucasian 
populations. 
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Another explanation of different results could be due to different expression 
levels of variants in affected tissues, such as the brain, compared to other 
tissues e.g. blood and buccal cells. The same allele might be driving higher 
expression in one tissue and lower expression in another tissue. Thus, the same 
allele could cause a high level of somatic instability in the affected tissue and 
lower somatic instability in unaffected tissues, like blood and buccal cells. To 
study the tissue-specific gene expression of rs3512 on FAN1 across many tissues, 
we associate this variant with gene expression levels from the Genotype-Tissue 
Expression (GTEx) programme - v7 release 
(https://www.gtexportal.org/home/). We found the highest expression level of 
the variant in brain cortex as compared to other tissues types such as blood. 
Therefore, the minor allele of rs3512 is associated with the same effect of 
expression level in cortex and blood, but it is higher in the brain. We expected 
the minor allele to be overexpressed in affected tissues and underexpressed on 
the unaffected tissues, to clarify our finding that different aspect of disease 
somatic instability is measured in different tissues. The GTEx data did not 
support the lack of correlation between our data and the GWAS data that 
expected to be due to expression changes in FAN1 across unaffected and 
affected tissues. Notably, the GTEx study included complex tissues but does not 
account for the cellular heterogeneity of the tissue, which could mask the 
biological importance of cellular expression and lead to misinterpretation of 
gene expression association.  
Understanding the role of rs3512 in FAN1 could be addressed by using brain 
samples from patients to evaluate the somatic instability and SNP genotypes in a 
human brain, as it is involved in the pathological process of HD. The somatic 
instability of the CAG repeat in the brain predicts the disease onset and 
progression (Swami et al., 2009). However, brain samples are difficult to obtain 
from living patients, which makes it hard to study changes in the brain and 
impossible to perform longitudinal studies. Also, it would be useful to obtain a 
more accurate measure of phenotype to enhance the power of understanding 
the role of somatic instability. For instance, the progression score from TRACK-
HD is considered as a good measure for HD patient phenotype, which reflects the 
progression in the motor, cognitive and imaging measures (Hensman Moss et al., 
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2017). Therefore, obtaining a measure of progression score from HD patients 
could help in assessing somatic instability. 
The power of our study in detecting the association between somatic instability 
and age at onset may have been reduced due to the relatively small samples 
size. It would be worth repeating the analysis with a larger number of samples to 
confirm our results as the power to detect the genetic modifiers association 
increases with increasing sample size. In addition, no statistically significant 
associations were detected for any of the remaining variants tested between the 
candidate genes and somatic instability. The sample size was relatively small 
(135 HD patients) for age at onset analysis, resulting in less power to detect 
associations with modifier genes. 
After designing the experiment, a second GWAS identified a significant 
association with other mismatch repair genes (Hensman Moss et al., 2017). They 
genotyped 218 HD patients from the TRACK-HD study using the Illumina 
Omni2.5v1.1 array and obtained genotypes for 1,773 HD patients from the 
REGISTRY study. They tested the association of these SNP genotypes with the 
residual variation of progression measures by meta-analysis. They found a 
significant association with the MSH3 gene. Therefore, MSH3 is probably a 
modifier of disease progression in HD, highlighting the DNA repair pathway for 
therapeutic intervention. Their data from TRACK-HD was able to give a 
significant association in only 216 subjects. Therefore, a well-characterised 
phenotype is powerful to detect association even with a small number of 
patients. MSH3 has also been implicated in the pathogenic process of HD and 
degree of somatic instability in striatal cells of a knock-in mouse model of HD 
(Dragileva et al., 2009). Polymorphisms in the MSH3 gene were also associated 
with somatic instability in patients with DM1 (Morales et al., 2016). Notably, 
MSH3 was included in our study, but we did not find an association. This is likely 
due to our sample being much smaller than that GWAS used in the study and 
thus less powered to identify the association with this gene. Identification of 
modifier genes for HD somatic instability would provide new targets for 
therapeutic interventions in HD that alter the HD disease in human patients, 
with the potential to delay disease onset and progression. 
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In conclusion, our findings highlighted the importance of the utility of using NGS 
approaches to genotype, characterise the distribution pattern of HD alleles and 
also to quantify somatic instability in the number of CAG repeats. Our study 
offers further relevance to the hypothesis that the repeat instability is age and 
allele length dependent and expansion-biased. The longest CAG repeats show 
wide somatic instability and may offer a mechanistic model to study triplet drug-
controlled instability and genetic factors influencing it. Elucidating the 
mechanisms of repeat instability is crucial for understanding disease 
pathogenesis, and also for the development of therapeutic approaches aimed at 
preventing CAG repeat expansion. If suppressing somatic expansion substantially 
delays the onset of disease, treatment may be possible during a lifetime. 
Identification of interesting variants in the trans-acting modifier gene FAN1 that 
modifies repeats instability of HD and could be used as a therapeutic target. Our 
data provided insight into the role of variants in mismatch repair genes in repeat 
instability in HD. These data can be used for large-scale analysis using well 
phenotyped large cohorts for HD such as Enroll-HD, to address the possible 
dependence of somatic variation of CAG repeats on disease pathology and to 
identify factors acting in cis or in trans to the mutation. In addition, 
identification of the genetic and environmental factors that may influence the 
age at onset could have an impact on patient’s survival or disease risk. A large-
scale analysis could provide a better understanding of phenotype-genotype 
correlation in HD, stratify HD patients to allow the appropriate design of clinical 
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